Qisda — Audit Report / Information 2024

Dec 24, 2024

1

Stock Code:2352

QISDA CORPORATION

Parent-Company-Only Financial Statements

With Independent Auditors’ Report For the Years Ended December 31, 2024 and 2023

Address: No. 157, Shan-Ying Rd., Gueishan Dist., Taoyuan City, Taiwan Telephone: 886-3-359-8800

The independent auditors’ report and the accompanying parent-company-only financial statements are the English translation of the Chinese version prepared and used in the Republic of China. If there is any conflict between, or any difference in the interpretation of the English and Chinese language independent auditors’ report and parent-company-only financial statements, the Chinese version shall prevail.

2

Table of contents

Contents 1. Cover Page 2. Table of Contents 3. Independent Auditors’ Report 4. Parent-Company-Only Balance Sheets 5. Parent-Company-Only Statements of Comprehensive Income 6. Parent-Company-Only Statements of Changes in Equity 7. Parent-Company-Only Statements of Cash Flows 8. Notes to the Parent-Company-Only Financial Statements (1) Organization and business (2) Authorization of the parent-company-only financial statements (3) Application of new and revised accounting standards and interpretations (4) Summary of material accounting policies (5) Critical accounting judgments and key sources of estimation uncertainty (6) Significant account disclosures (7) Related-party transactions (8) Pledged assets (9) Significant commitments and contingencies (10) Significant loss from disaster (11) Significant subsequent events (12) Others (13) Additional disclosures (a) Information on significant transactions (b) Information on investees (c) Information on investment in Mainland China (d) Major shareholders (14) Segment information 9. List of major account titles

Page

1 2 3 4 5 6 7 8 8 8～10 10～26 26 27～60 60～70 70 70 70 70 70～71 72, 73～84 72, 85～90 72, 91～104 72 72 105～118

3

Independent Auditors’ Report

To the Board of Directors of Qisda Corporation:

Opinion

We have audited the parent-company-only financial statements of Qisda Corporation, which comprise the parent-company-only balance sheets as of December 31, 2024 and 2023, the parent-company-only statements of comprehensive income, changes in equity and cash flows for the years then ended, and notes to the parentcompany-only financial statements, including a summary of material accounting policies.

In our opinion, based on our audits and the reports of other auditors (please refer to the Other Matter section), the accompanying parent-company-only financial statements present fairly, in all material respects, the financial position of Qisda Corporation as of December 31, 2024 and 2023, and its financial performance and its cash flows for the years then ended in accordance with the Regulations Governing the Preparation of Financial Reports by Securities Issuers.

Basis for Opinion

We conducted our audits in accordance with the Regulations Governing Financial Statement Audit and Attestation Engagements of Certified Public Accountants and Standards on Auditing of the Republic of China. Our responsibilities under those standards are further described in the Auditors’ Responsibilities for the Audit of the Parent-Company-Only Financial Statements section of our report. We are independent of Qisda Corporation in accordance with The Norm of Professional Ethics for Certified Public Accountant of the Republic of China, and we have fulfilled our other ethical responsibilities in accordance with these requirements. Based on our audits and the reports of other auditors, we believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis of our opinion.

Key Audit Matters

Key audit matters are those matters that, in our professional judgment, were of most significance in our audit of the parent-company-only financial statements of the current period. These matters were addressed in the context of our audit of the parent-company-only financial statements as a whole, and in forming our opinion thereon, and we do not provide a separate opinion on these matters.

3-1

Key audit matters for Qisda Corporation’ s parent-company-only financial statements for the year ended December 31, 2024 are stated as follows:

1. Revenue recognition

Please refer to Note 4(p) for the accounting policy on revenue recognition, and Note 6(v) for the related disclosures of revenue, respectively, to the parent-company-only financial statements.

Description of key audit matter:

Qisda Corporation recognizes revenue depending on the various trade terms in each individual sale transaction, which are considered to be complex in determining the timing of revenue recognition. Therefore, revenue recognition has been identified as one of the key audit matters.

How the matter was addressed in our audit:

In relation to the key audit matters above, our principal audit procedures included performing a sample test on the design and operating effectiveness of Qisda Corporation’s internal controls over financial reporting related to the sales and collection cycle; assessing whether revenue is recognized based on the trade terms with customers through reviewing the related sales contracts or other trade documents; performing a sample test on the sales transactions that took place before and after the balance sheet date to determine when the performance obligation has been satisfied by transferring control over the goods or services to a customer to assess the accuracy of the timing of revenue recognition; reviewing and analyzing the reason for significant sales returns and allowances that took place after the balance sheet date to access the reasonableness of the related accrued sales returns and allowances.

1. Valuation of inventories

Please refer to Note 4(g) for the inventory accounting policy, Note 5(a) for estimation uncertainty of inventory valuation, and Note 6(f) for the related inventory write-down disclosures, respectively, to the parent-company-only financial statements.

Description of key audit matter:

Inventories are measured at the lower of cost and net realizable value. Due to the rapid technological innovations and highly competitive environments in the electronic industry which Qisda Corporation is engaged in, the life cycle of electronic products are short and their market prices fluctuate rapidly, which could possibly result in a price decline and obsolescence of inventory, wherein the inventory cost may exceed its net realizable value. Therefore, the valuation of inventories has been identified as one of the key audit matters.

How the matter was addressed in our audit:

In relation to the key audit matter above, our principal audit procedures included reviewing the inventory aging report and verifying whether the inventory is classified into the appropriate aging classification; selecting samples to assess the reasonableness of the net realizable value of inventories report prepared by Qisda Corporation; and evaluating whether valuation of inventories was accounted for in accordance with Qisda Corporation’s accounting policies.

3-2

1. Assessment of impairment of goodwill from investments in subsidiaries

Please refer to Note 4(n) for the accounting policy on impairment of non-financial assets, Note 5(b) for the estimation uncertainty of impairment of goodwill, and Note 6(g) for the related disclosures of goodwill impairment test, respectively, to the parent-company-only financial statements.

Description of key audit matter:

Goodwill arising from acquisition of subsidiaries, which are included in the carrying amount of investments accounted for using the equity method, is subject to impairment test annually or at the time there are indications that goodwill may have been impaired. The assessment of the recoverable amount of goodwill involves management’s judgment and estimation. Accordingly, the assessment of impairment of goodwill has been identified as one of the key audit matters.

How the matter was addressed in our audit:

In relation to the key audit matter above, our principal audit procedures included obtaining the assessment of goodwill impairment provided by the management; assessing the appropriateness of the valuation model and key assumptions, including the discount rate, expected sales growth rate and future cash flow projections, used by the management in measuring the recoverable amount; evaluating the accuracy of estimates made by the management by comparing the past projections with actual cash flows; performing a sensitivity analysis to assess the impact of variation in key assumptions; and assessing the adequacy of Qisda Corporation’s disclosures with respect to evaluation of goodwill impairment.

Other Matter

We did not audit the financial statements of certain investees accounted for using the equity method of Qisda Corporation. Those financial statements were audited by other auditors, whose reports have been furnished to us, and our opinion, insofar as it relates to the amounts included for those investees, is based solely on the report of other auditors. Those investments accounted for using the equity method amounted to NTD 1,707,402 thousand and NTD 1,554,960 thousand, respectively, constituting 1.59% and 1.55%, respectively, of the total assets as of December 31, 2024 and 2023, and the related shares of profit of subsidiaries amounted to NTD 17,261 thousand and NTD 48,820 thousand, respectively, constituting 0.74% and 1.64%, respectively, of the total income before income tax for the years ended December 31, 2024 and 2023.

Responsibilities of Management and Those Charged with Governance for the Parent-Company-Only Financial Statements

Management is responsible for the preparation and fair presentation of the parent-company-only financial statements in accordance with the Regulations Governing the Preparation of Financial Reports by Securities Issuers and for such internal control as management determines is necessary to enable the preparation of parentcompany-only financial statements that are free from material misstatement, whether due to fraud or error.

In preparing the parent-company-only financial statements, management is responsible for assessing Qisda Corporation’s ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless management either intends to liquidate Qisda Corporation or to cease operations, or has no realistic alternative but to do so.

Those charged with governance (including the Audit Committee) are responsible for overseeing Qisda Corporation’s financial reporting process.

3-3

Auditors’ Responsibilities for the Audit of the Parent-Company-Only Financial Statements

Our objectives are to obtain reasonable assurance about whether the parent-company-only financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditors’ report that includes our opinion. Reasonable assurance is a high level of assurance, but is not a guarantee that an audit conducted in accordance with the Standards on Auditing of the Republic of China will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these parent-company-only financial statements.

As part of an audit in accordance with the Standards on Auditing of the Republic of China, we exercise professional judgment and professional skepticism throughout the audit. We also:

1. Identify and assess the risks of material misstatement of the parent-company-only financial statements, whether due to fraud or error, design and perform audit procedures responsive to those risks, and obtain audit evidence that is sufficient and appropriate to provide a basis for our opinion. The risk of not detecting a material misstatement resulting from fraud is higher than for one resulting from error, as fraud may involve collusion, forgery, intentional omissions, misrepresentations, or the override of internal control.

2. Obtain an understanding of internal control relevant to the audit in order to design audit procedures that are appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness of Qisda Corporation’s internal control.

3. Evaluate the appropriateness of accounting policies used and the reasonableness of accounting estimates and related disclosures made by management.

4. Conclude on the appropriateness of management’s use of the going concern basis of accounting and, based on the audit evidence obtained, whether a material uncertainty exists related to events or conditions that may cast significant doubt on Qisda Corporation’s ability to continue as a going concern. If we conclude that a material uncertainty exists, we are required to draw attention in our auditors’ report to the related disclosures in the parent-company-only financial statements or, if such disclosures are inadequate, to modify our opinion. Our conclusions are based on the audit evidence obtained up to the date of our auditors’ report. However, future events or conditions may cause Qisda Corporation to cease to continue as a going concern.

5. Evaluate the overall presentation, structure and content of the parent-company-only financial statements, including the disclosures, and whether the parent-company-only financial statements represent the underlying transactions and events in a manner that achieves fair presentation.

6. Obtain sufficient appropriate audit evidence regarding the financial information of the investees accounted for using the equity method to express an opinion on the parent-company-only financial statements. We are responsible for the direction, supervision and performance of the audit. We remain solely responsible for our audit opinion.

We communicate with those charged with governance regarding, among other matters, the planned scope and timing of the audit and significant audit findings, including any significant deficiencies in internal control that we identify during our audit.

We also provide those charged with governance with a statement that we have complied with relevant ethical requirements regarding independence, and to communicate with them all relationships and other matters that may reasonably be thought to bear on our independence, and where applicable, related safeguards.

3-4

From the matters communicated with those charged with governance, we determine those matters that were of most significance in the audit of the parent-company-only financial statements for the current period and are therefore the key audit matters. We describe these matters in our auditors’ report unless law or regulation precludes public disclosure about the matter or when, in extremely rare circumstances, we determine that a matter should not be communicated in our report because the adverse consequences of doing so would reasonably be expected to outweigh the public interest benefits of such communication.

The engagement partners on the audit resulting in this independent auditors’ report are Yin, Yuan-Sheng and Chang, Huei-Chen.

KPMG

Taipei, Taiwan (Republic of China) March 5, 2025

Notes to Readers

The accompanying parent-company-only financial statements are intended only to present the financial position, financial performance and cash flows in accordance with the accounting principles and practices generally accepted in the Republic of China and not those of any other jurisdictions. The standards, procedures and practices to audit such parent-company-only financial statements are those generally accepted and applied in the Republic of China.

The independent auditors’ audit report and the accompanying parent-company-only financial statements are the English translation of the Chinese version prepared and used in the Republic of China. If there is any conflict between, or any difference in the interpretation of the English and Chinese language independent auditors’ audit report and parent-company-only financial statements, the Chinese version shall prevail.

4

(English Translation of Parent-Company-Only Financial Statements Originally Issued in Chinese)

QISDA CORPORATION

Parent-Company-Only Balance Sheets December 31, 2024 and 2023

(Expressed in Thousands of New Taiwan Dollar)

Assets Current assets: 1100 Cash and cash equivalents (note 6(a)) 1110 Financial assets at fair value through profit or loss－current (note 6(b)) 1170 Notes and accounts receivable, net (notes 6(d) and (v)) 1181 Notes and accounts receivable from related parties (notes 6(d), (v) and 7) 1200 Other receivables (note 6(e)) 1210 Other receivables from related parties (notes 6(e) and 7) 130X Inventories (note 6(f)) 1470 Other current assets Total current assets Non-current assets: 1510 Non-current financial assets at fair value through profit or loss (note 6(b)) 1517 Financial assets at fair value through other comprehensive income －non-current (note 6(c)) 1550 Investments accounted for using the equity method (note 6(g)) 1600 Property, plant and equipment (notes 6(h), 7 and 8) 1755 Right-of-use assets (notes 6(i) and 7) 1760 Investment property (note 6(j)) 1780 Intangible assets (note 6(k)) 1840 Deferred income tax assets (note 6(s)) 1900 Other non-current assets 1980 Other financial assets－non-current Total non-current assets Total assets	December 31, 2024 Amount % $ 1,861,905 2 169,763 - 10,967,314 10 16,872,354 16 - - 6,850 - 7,120,244 7 46,569 - 37,044,999 35 351,041 - 7,817,376 7 59,071,710 55 1,827,925 2 245,436 - 76,371 - 205,405 - 447,398 1 39,985 - 48,931 - 70,131,578 65 $ 107,176,577 100	December 31, 2023 Amount % 2,532,956 3 133,486 - 8,920,059 9 14,112,765 14 5,160 - 6,717 - 6,199,272 6 50,532 - 31,960,947 32 - - 9,709,736 10 55,698,948 55 2,021,479 2 343,637 - 105,934 - 197,775 - 467,359 1 20,593 - 38,566 - 68,604,027 68 100,564,974 100 Liabilities and Equity Current liabilities: 2100 Short-term borrowings (note 6(l)) 2120 Financial liabilities at fair value through profit or loss－current (note 6(b)) 2130 Contract liabilities－current (note 6(v)) 2170 Notes and accounts payable 2180 Accounts payable to related parties (note 7) 2200 Other payables (note 6(w)) 2230 Current income tax liabilities 2322 Current portion of long-term debt (notes 6(m) and 8) 2280 Lease liabilities－current (notes 6(o) and 7) 2250 Provisions－current (note 6(p)) 2300 Other current liabilities 2365 Refund liabilities－current Total current liabilities Non-current liabilities: 2530 Bonds payable (note 6(n)) 2540 Long-term debt (notes 6(m) and 8) 2580 Lease liabilities－non-current (notes 6(o) and 7) 2550 Provisions－non-current (note 6(p)) 2570 Deferred income tax liabilities (note 6(s)) 2600 Other non-current liabilities (note 6(r)) Total non-current liabilities Total liabilities Equity (note 6(t)): 3110 Common stock 3200 Capital surplus 3300 Retained earnings 3400 Other equity Total equity Total liabilities and equity	December 31, 2024 Amount % $ 8,294,550 8 9,344 - 565,404 1 2,052,607 2 27,294,231 26 1,500,993 1 275,213 - 3,055,306 3 143,029 - 15,806 - 75,763 - 1,332,935 1 44,615,181 42 2,997,185 3 23,485,165 22 227,019 - 71,605 - 10,712 - 207,691 - 26,999,377 25 71,614,558 67 19,274,470 18 2,239,759 2 17,485,381 16 (3,437,591) (3) 35,562,019 33 $ 107,176,577 100		December 31, 2023 Amount % 6,500,000 6 - - 781,653 1 1,757,130 2 24,571,162 24 2,400,945 2 107,814 - 525,193 1 139,704 - 16,426 - 70,427 - 1,489,929 2 38,360,383 38 2,996,090 3 21,405,611 21 370,048 1 82,994 - 15,548 - 276,942 - 25,147,233 25 63,507,616 63 19,667,820 19 1,983,975 2 18,793,317 19 (3,387,754) (3) 37,057,358 37 100,564,974 100

See accompanying notes to parent-company-only financial statements.

5

(English Translation of Parent-Company-Only Financial Statements Originally Issued in Chinese)

QISDA CORPORATION

Parent-Company-Only Statements of Comprehensive Income

For the years ended December 31, 2024 and 2023

(Expressed in Thousands of New Taiwan Dollar, Except for Earnings Per Share)

2024 Amount 4000 Operating revenues (notes 6(v) and 7) $ 76,703,513 5000 Operating costs (notes 6(f), (h), (i), (j), (k), (o), (p), (r), (w), 7 and 12) (73,221,541) Gross profit 3,481,972 5910 Realized (unrealized) gross profit on sales to subsidiaries, associated and joint ventures 126,008 Realized or loss gross profit 3,607,980 Operating expenses (notes 6(d), (h), (i), (j), (k), (o), (r), (w), 7 and 12): 6100 Selling expenses (1,111,706) 6200 Administrative expenses (740,074) 6300 Research and development expenses (1,948,901) 6450 Gain on reversal of impairment loss 31,376 Total operating expenses (3,769,305) Operating income (161,325) Non-operating income and loss: 7100 Interest income (note 6(x)) 77,788 7010 Other income (notes 6(o), (q), (x) and 7) 653,170 7020 Other gains and losses, net (notes 6(g) and (x)) (313,859) 7050 Finance costs (notes 6(o), (x) and 7) (707,532) 7375 Share of profits of subsidiaries, associates and joint ventures (note 6(g)) 2,780,422 Total non-operating income and loss 2,489,989 Income before income tax 2,328,664 7950 Income tax expense (note 6(s)) (164,711) Net income 2,163,953 Other comprehensive income (loss): 8310 Items that will not be reclassified subsequently to profit or loss: 8311 Remeasurements of defined benefit plans (notes 6(r) and (t)) 63,167 8316 Unrealized gains (losses) from investments in equity instruments measured at fair value through other comprehensive income (note 6(t)) (1,860,765) 8330 Share of other comprehensive income (loss) of subsidiaries, associates and joint ventures (notes 6(g) and (t)) (123,932) 8349 Less: income tax related to items that will not be reclassified subsequently to profit or loss - (1,921,530) 8360 Items that may be reclassified subsequently to profit or loss: 8361 Exchange differences on translation of foreign operations (note 6(t)) 2,009,036 8399 Less: income tax related to items that may be reclassified subsequently to profit or loss - 2,009,036 Other comprehensive income for the year, net of income tax 87,506 Total comprehensive income for the year $ 2,251,459 Earnings per share (in New Taiwan Dollar) (note 6(u)): 9750 Basic earnings per share $ 9850 Diluted earnings per share $	2024	% 100 (95) 5 - 5 (1) (1) (3) - (5) - - 1 (1) (1) 4 3 3 - 3 - (3) - - (3) 3 - 3 - 3 1.11 1.10	2023 Amount 75,425,479 (71,847,173) 3,578,306 (37,090) 3,541,216 (1,175,798) (819,338) (2,267,941) 12,981 (4,250,096) (708,880) 99,692 598,674 284,821 (668,058) 3,375,451 3,690,580 2,981,700 (5,967) 2,975,733 1,840 1,466,613 674,731 - 2,143,184 (198,384) - (198,384) 1,944,800 4,920,533	% 100 (95) 5 - 5 (2) (1) (3) -
				(6)
				(1)
				- 1 - (1) 5
				5
				4 -
				4
				- 2 1 -
				3
				- -
				-
				3
				7 1.51
				1.51

See accompanying notes to parent-company-only financial statements.

6

(English Translation of Parent-Company-Only Financial Statements Originally Issued in Chinese)

QISDA CORPORATION

Parent-Company-Only Statements of Changes in Equity

For the years ended December 31, 2024 and 2023

(Expressed in Thousands of New Taiwan Dollar)

Balance at January 1, 2023 Net income in 2023 Other comprehensive income (loss) in 2023 Total comprehensive income (loss) in 2023 Appropriation of earnings: Legal reserve Special reserve Cash dividends to shareholders Shares of changes in equity of subsidiaries, associates and joint ventures Acquisition or disposal of shares of subsidiaries Disposal of equity instruments at fair value through other comprehensive income by investees Proceeds from disposal of forfeited employee stock managed by an employee ownership trust Claim for the disgorgement right Balance at December 31, 2023 Net income in 2024 Other comprehensive income (loss) in 2024 Total comprehensive income (loss) in 2024 Appropriation of earnings: Reversal of special reserve Cash dividends to shareholders Shares of changes in equity of subsidiaries, associates and joint ventures Disposal of equity investments at fair value through other comprehensive income Acquisition or disposal of shares of subsidiaries Proceeds from disposal of forfeited employee stock managed by an employee ownership trust Purchase and retirement of treasury stock Balance at December 31, 2024	Common stock $ 19,667,820 - - - - - - - - - - - 19,667,820 - - - - - - - - - (393,350) $ 19,274,470	Capital surplus 1,949,409 - - - - - - 30,238 1 - 4,252 75 1,983,975 - - - - - 173,946 - 76,226 5,612 - 2,239,759		Retained earnings	Retained earnings	Total retained earnings 24,185,472 2,975,733 - 2,975,733 - - (3,933,564) - (4,690,491) 256,167 - - 18,793,317 2,163,953 - 2,163,953 (2,360,139) - - 137,343 (172,150) - (1,076,943) 17,485,381		Total other equity	Total other equity	Total other equity (5,076,387) - 1,944,800 1,944,800 - - - - - (256,167) - - (3,387,754) - 87,506 87,506 - - - (137,343) - - - (3,437,591)	Total equity 40,726,314 2,975,733 1,944,800 4,920,533 - - (3,933,564) 30,238 (4,690,490) - 4,252 75 37,057,358 2,163,953 87,506 2,251,459 (2,360,139) - 173,946 - (95,924) 5,612 (1,470,293) 35,562,019
			Legal reserve 3,437,862 - - - 832,491 - - - - - - - 4,270,353 - - - - - - - - - - 4,270,353	Special reserve 833,222 - - - - 4,243,165 - - - - - - 5,076,387 - - - - (1,688,634) - - - - - 3,387,753	Unappropriated earnings 19,914,388 2,975,733 - 2,975,733 (832,491) (4,243,165) (3,933,564) - (4,690,491) 256,167 - - 9,446,577 2,163,953 - 2,163,953 (2,360,139) 1,688,634 - 137,343 (172,150) - (1,076,943) 9,827,275		Foreign currency translation differences 875,030 - (198,384) (198,384) - - - - - - - - 676,646 - 2,009,036 2,009,036 - - - - - - - 2,685,682	Unrealized gains (losses) from financial assets measured at fair value through other comprehensive income (5,663,889) - 2,138,796 2,138,796 - - - - - (256,167) - - (3,781,260) - (2,038,122) (2,038,122) - - - (137,343) - - - (5,956,725)	Remeasurements of defined benefit plans (287,528) - 4,388 4,388 - - - - - - - - (283,140) - 116,592 116,592 - - - - - - - (166,548)

See accompanying notes to parent-company-only financial statements.

7

(English Translation of Parent-Company-Only Financial Statements Originally Issued in Chinese)

QISDA CORPORATION

Parent-Company-Only Statements of Cash Flows

For the years ended December 31, 2024 and 2023

(Expressed in Thousands of New Taiwan Dollar)

Cash flows from operating activities: Income before income tax Adjustments for: Adjustments to reconcile profit or loss: Depreciation Amortization Gain on reversal of impairment loss Interest expense Interest income Dividend income Share of profit of subsidiaries, associates and joint ventures Loss (gain) on disposal of property, plant and equipment Loss (gain) on disposal of investments Unrealized (realized) gross profit on sales to subsidiaries, associates and joint ventures Total adjustments for profit or loss Changes in operating assets and liabilities: Changes in operating assets: Financial assets at fair value through profit or loss Notes and accounts receivable Notes and accounts receivable from related parties Other receivables Other receivables from related parties Inventories Other current assets Other non-current assets Net changes in operating assets Changes in operating liabilities: Financial liabilities at fair value through profit or loss Notes and accounts payable Accounts payable to related parties Provisions Contract liabilities Other payables and other current liabilities Other non-current liabilities Net changes in operating liabilities Total changes in operating assets and liabilities Total adjustments Cash provided by (used in) operations Interest received Dividends received Interest paid Income taxes refunded (paid) Net cash provided by (used in) operating activities	2024 $ 2,328,664 336,530 70,862 (31,376) 707,532 (77,788) (484,639) (2,780,422) 573 74,365 (126,008) (2,310,371) (32,318) (2,015,879) (2,759,589) 5,160 (133) (920,972) 4,973 (12,700) (5,731,458) 9,344 295,477 2,723,069 (12,009) (216,249) (1,064,958) (6,084) 1,728,590 (4,002,868) (6,313,239) (3,984,575) 77,788 3,491,097 (689,038) 17,813 (1,086,915)	2023 2,981,700 323,585 67,774 (12,981) 668,058 (99,692) (437,858) (3,375,451) (2,379) (273,124) 37,090 (3,104,978) (28,350) 1,184,034 (2,538,228) 29,059 3,290 329,794 36,329 (9,701) (993,773) (13,030) 886,691 6,745,689 (8,150) 79,300 (660,335) (12,034) 7,018,131 6,024,358 2,919,380 5,901,080 99,692 8,441,851 (653,640) (144,149) 13,644,834 (Continued)

See accompanying notes to parent-company-only financial statements.

7-1

(English Translation of Parent-Company-Only Financial Statements Originally Issued in Chinese)

QISDA CORPORATION

Parent-Company-Only Statements of Cash Flows (Continued)

For the years ended December 31, 2024 and 2023

(Expressed in Thousands of New Taiwan Dollar)

Cash flows from investing activities: Purchase of financial assets at fair value through other comprehensive income Purchase of financial assets at fair value through profit or loss Purchase of investments accounted for using equity method Increase in prepayments for investments Proceeds from disposal of investments accounted for using the equity method Additions to property, plant and equipment Proceeds from disposal of property, plant and equipment Additions to intangible assets Decrease (increase) in other financial assets Net cash used in investing activities Cash flows from financing activities: Increase in short-term borrowings Increase in long-term debt Repayments of long-term debt Payment of lease liabilities Cash dividends to shareholders Purchase of treasury stock Proceeds from disposal of forfeited employee stock managed by an employee ownership trust Claim for the disgorgement right Net cash provided by (used in) financing activities Net increase (decrease) in cash and cash equivalents Cash and cash equivalents at beginning of year Cash and cash equivalents at end of year	2024 $ (40,000) (355,000) (1,512,434) (15,000) - (95,620) 593 (260) (10,365) (2,028,086) 1,794,550 21,209,117 (16,595,193) (139,704) (2,360,139) (1,470,293) 5,612 - 2,443,950 (671,051) 2,532,956 $ 1,861,905	2023 (60,528) (96,126) (7,613,201) - 348,803 (157,079) 3,259 (15,906) 33,393 (7,557,385) 4,630,000 30,964,413 (36,524,399) (137,426) (3,933,564) - 4,252 75 (4,996,649) 1,090,800 1,442,156 2,532,956

See accompanying notes to parent-company-only financial statements.

8

(English Translation of Parent-Company-Only Financial Statements Originally Issued in Chinese)

QISDA CORPORATION

Notes to the Parent-Company-Only Financial Statements For the years ended December 31, 2024 and 2023

(Expressed in Thousands of New Taiwan Dollar, Unless Otherwise Specified)

1. Organization and business

Qisda Corporation (the “Company”) was incorporated on April 21, 1984, as a company limited by shares under the laws of the Republic of China (“ R.O.C.” ) and registered under the Ministry of Economic Affairs, R.O.C. The address of the Company’ s registered office is No. 157, Shan-Ying Rd., Gueishan Dist., Taoyuan City, Taiwan. The Company is engaged in the manufacturing, sales and services of highend monitors and opto-mechatronics products.

2. Authorization of the parent-company-only financial statements

These parent-company-only financial statements were authorized for issuance by the Board of Directors on March 5, 2025.

3. Application of new and revised accounting standards and interpretations

• (a) The impact of the International Financial Reporting Standards (“ IFRS Accounting Standards” ) endorsed by the Financial Supervisory Commission, R.O.C. (“ FSC” ) which have already been adopted.

The Company has initially adopted the following new amendments, which do not have a significant impact on its parent-company-only financial statements, from January 1, 2024:

• ●Amendments to IAS 1 “Classification of Liabilities as Current or Non-current”

• ●Amendments to IAS 1 “Non-current Liabilities with Covenants”

• ●Amendments to IAS 7 and IFRS 7 “Supplier Finance Arrangements”

• ●Amendments to IFRS 16 “Lease Liability in a Sale and Leaseback”

• (b) The impact of IFRS Accounting Standards endorsed by the FSC but not yet effective

The Company assesses that the adoption of the following new amendments, effective January 1, 2025, would not have a significant impact on its parent-company-only financial statements:

• ●Amendments to IAS 21 “Lack of Exchangeability”

(Continued)

9

QISDA CORPORATION Notes to the Parent-Company-Only Financial Statements

• (c) The impact of IFRS Accounting Standards issued by the International Accounting Standards Board (“IASB”) but not yet endorsed by the FSC

The following new and amended standards, which may be relevant to the Company, have been issued by the IASB, but have yet to be endorsed by the FSC:

Standards or Interpretations Content of amendment IFRS 18 The new standard introduces three categories of “Presentation and income and expenses, two income statement Disclosure in subtotals and one single note on management Financial Statements” performance measures. The three amendments, combined with enhanced guidance on how to disaggregate information, set the stage for better and more consistent information for users, and will affect all the entities.

Effective date per IASB January 1, 2027

• ●A more structured income statement: under current standards, companies use different formats to present their results, making it difficult for investors to compare financial performance across companies. The new standard promotes a more structured income statement, introducing a newly defined “operating profit” subtotal and a requirement for all income and expenses to be allocated between three new distinct categories based on a company’s main business activities.

• ●Management performance measures (MPMs): the new standard introduces a definition for management performance measures, and requires companies to explain in a single note to the financial statements why the measure provides useful information, how it is calculated and reconcile it to an amount determined under IFRS Accounting Standards.

• ●Greater disaggregation of information: the new standard includes enhanced guidance on how companies group information in the financial statements. This includes guidance on whether information is included in the primary financial statements or is further disaggregated in the notes.

The Company is evaluating the impact on its parent-company-only financial position and parentcompany-only financial performance upon the initial adoption of the abovementioned standards or interpretations. The results thereof will be disclosed when the Company completes its evaluation.

(Continued)

10

QISDA CORPORATION Notes to the Parent-Company-Only Financial Statements

The Company does not expect the following other new and amended standards, which have yet to be endorsed by the FSC, to have a significant impact on its parent-company-only financial statements:

• ●Amendments to IFRS 10 and IAS 28 “Sale or Contribution of Assets between an Investor and its Associate or Joint Venture”

• ●IFRS 17 “Insurance Contracts” and amendments to IFRS 17 “Insurance Contracts”

• ●IFRS 19 “Subsidiaries without Public Accountability: Disclosures”

• ●Amendments to IFRS 9 and IFRS 7 “Amendments to the Classification and Measurement of Financial Instruments”

• －

• ●Annual Improvements to IFRS Accounting Standards Volume 11

• ●Amendments to IFRS 9 and IFRS 7 “Contracts Referencing Nature-dependent Electricity”

4. Summary of material accounting policies:

The material accounting policies presented in the parent-company-only financial statements are summarized as follows and have applied consistently to all periods presented in these financial statements.

• (a) Statement of compliance

The Company’ s accompanying parent-company-only financial statements have been prepared in accordance with the Regulations Governing the Preparation of Financial Reports by Securities Issuers (the “Regulations”).

(b) Basis of preparation

• (i) Basis of measurement

The accompanying parent-company-only financial statements have been prepared on a historical cost basis except for the following items:

• 1) Financial instruments measured at fair value through profit or loss (including derivative financial instruments);

• 2) Financial assets measured at fair value through other comprehensive income; and

• 3) Net defined benefit liabilities (assets) measured at the present value of the defined benefit obligation less the fair value of the plan assets.

• (ii) Functional and presentation currency

The functional currency of the Company is determined based on the primary economic environment in which the Company operates. The Company’s parent-company-only financial statements are presented in New Taiwan Dollar (NTD), which is the Company’s functional currency. Except when otherwise indicated, all financial information presented in New Taiwan Dollar has been rounded to the nearest thousand.

(Continued)

11

QISDA CORPORATION Notes to the Parent-Company-Only Financial Statements

(c) Foreign currency

(i) Foreign currency transactions

Foreign currency transactions are translated into the functional currency using the exchange rates prevailing at the dates of the transactions. At the end of each reporting period (“ the reporting date” ), monetary items denominated in foreign currencies are translated into the functional currencies using the exchange rate at that date. Non-monetary items denominated in foreign currencies that are measured at fair value are translated into the functional currencies using the exchange rate at the date that the fair value was determined. Non-monetary items denominated in foreign currencies that are measured at historical cost are translated using the exchange rate at the date of the transaction.

Exchange differences are generally recognized in profit or loss, except for an investment in equity securities designated as at fair value through other comprehensive income, which are recognized in other comprehensive income.

(ii) Foreign operations

The assets and liabilities of foreign operations, including goodwill and fair value adjustments arising from acquisition, are translated into the presentation currency of the Company’s parentcompany-only financial statements at the exchange rates at the reporting date. The income and expenses of foreign operations are translated into the presentation currency of the Company’s parent-company-only financial statements at the average exchange rates for the period. All resulting exchange differences are recognized in other comprehensive income.

When a foreign operation is disposed of such that control, joint control, or significant influence is lost, the accumulated exchange differences related to that foreign operation is reclassified to profit or loss. In the case of a partial disposal that does not result in the Company losing control over a subsidiary, the proportionate share of the accumulated exchange differences is reclassified to non-controlling interests. For a partial disposal of the Company’s ownership interest in an associate or joint venture, the proportionate share of the accumulated exchange differences in equity is reclassified to profit or loss.

When the settlement of a monetary receivable from or payable to a foreign operation is neither planned nor likely to occur in the foreseeable future, the monetary item is, in substance, a part of net investment in that foreign operation, and the related foreign exchange gains and losses thereon are recognized as other comprehensive income.

(d) Classification of current and non-current assets and liabilities

The Company classifies the asset as current under one of the following criteria, and all other assets are classified as non-current.

• (i) It is expected to be realized, or intended to be sold or consumed, in the normal operating cycle;

• (ii) It is held primarily for the purpose of trading;

• (iii) It is expected to be realized within twelve months after the reporting period; or

(Continued)

12

QISDA CORPORATION Notes to the Parent-Company-Only Financial Statements

• (iv) The asset is cash or a cash equivalent (as defined in IAS 7) unless the asset is restricted from being exchanged or used to settle a liability for at least twelve months after the reporting period.

The Company classifies the liability as current under one of the following criteria, and all other liabilities are classified as non-current.

• (i) It is expected to be settled in the normal operating cycle;

• (ii) It is held primarily for the purpose of trading;

• (iii) It is due to be settled within twelve months after the reporting period; or

• (iv) The Company does not have the right at the end of the reporting period to defer settlement of the liability for at least twelve months after the reporting period.

• (e) Cash and cash equivalents

Cash consists of cash on hand, checking deposits, and demand deposits. Cash equivalents consist of short-term and highly liquid investments that are readily convertible to known amounts of cash and are subject to an insignificant risk of changes in value. Time deposits that meet the aforesaid criteria and are not held for investing purposes are also classified as cash equivalents.

Bank overdrafts that are repayable on demand and form an integral part of the Company’ s cash management are included as a component of cash and cash equivalents for the purpose of the statement of cash flows.

(f) Financial instruments

Accounts receivable and debt securities issued are initially recognized when they are originated. All other financial assets and financial liabilities are initially recognized when the Company becomes a party to the contractual provisions of the instrument. A financial asset (unless it is an accounts receivable without a significant financing component) or financial liability is initially measured at fair value plus, for an item not at fair value through profit or loss (FVTPL), transaction costs that are directly attributable to its acquisition or issuance. An accounts receivable without a significant financing component is initially measured at the transaction price.

(i) Financial assets

On initial recognition, financial assets are classified as measured at: amortized cost, fair value through other comprehensive income (FVOCI) and fair value through profit or loss (FVTPL). A regular way purchases or sales of financial assets is recognized or derecognized on a tradedate basis.

Financial assets are not reclassified subsequent to their initial recognition unless the Company changes its business model for managing its financial assets, in which case all affected financial assets are reclassified on the first day of the first reporting period following the change in the business model.

(Continued)

13

QISDA CORPORATION Notes to the Parent-Company-Only Financial Statements

• 1) Financial assets measured at amortized cost

A financial asset is measured at amortized cost if it meets both of the following conditions and is not designated as at FVTPL:

• it is held within a business model whose objective is to hold financial assets to collect contractual cash flows; and

• its contractual terms give rise on specified dates to cash flows that are solely payments of principal and interest (SPPI) on the principal amount outstanding.

Subsequent to initial recognition, these assets are measured at amortized cost, using the effective interest method less impairment loss. Interest income, foreign exchange gains and losses, and recognition (reversal) of impairment loss are recognized in profit or loss. Any gain or loss on derecognition is recognized in profit or loss.

• 2) Financial assets measured at fair value through other comprehensive income

A debt investment is measured at FVOCI if it meets both of the following conditions and is not designated as at FVTPL:

• it is held within a business model whose objective is achieved by both collecting contractual cash flows and selling financial assets; and

• its contractual terms give rise on specified dates to cash flows that are solely payments of principal and interest (SPPI) on the principal amount outstanding.

On initial recognition of an equity investment that is not held for trading, the Company may irrevocably elect to present the subsequent changes in the investment’s fair value in other comprehensive income. This election is made on an instrument-by-instrument basis.

Debt investments at FVOCI are subsequently measured at fair value. Interest income calculated using the effective interest method, foreign exchange gains and losses and impairment loss are recognized in profit or loss. Other net gains and losses are recognized in other comprehensive income. On derecognition, other comprehensive income accumulated in equity are reclassified to profit or loss.

Equity investments at FVOCI are subsequently measured at fair value. Dividends are recognized as income in profit or loss unless the dividend clearly represents a recovery of part of the cost of the investment. Other net gains and losses are recognized in other comprehensive income. On derecognition, other comprehensive income accumulated in equity is reclassified to retained earnings and is never reclassified to profit or loss.

Dividend income derived from equity investments is recognized on the date that the Company’s right to receive the dividends is established (usually the ex-dividend date).

(Continued)

14

QISDA CORPORATION Notes to the Parent-Company-Only Financial Statements

• 3) Financial assets measured at fair value through profit or loss

All financial assets not classified as measured at amortized cost or at FVOCI described as above are measured at FVTPL, including derivative financial assets. On initial recognition, the Company may irrevocably designate a financial asset, which meets the requirements to be measured at amortized cost or at FVOCI, as at FVTPL if doing so eliminates or significantly reduces an accounting mismatch that would otherwise arise.

These assets are subsequently measured at fair value. Net gains and losses, including any dividend and interest income, are recognized in profit or loss.

• 4) Assessment of whether contractual cash flows are solely payments of principal and interest

For the purposes of this assessment, “ principal” is defined as the fair value of the financial assets on initial recognition. “Interest” is defined as consideration for the time value of money and for the credit risk associated with the principal amount outstanding during a particular period of time and for other basic lending risks and costs, as well as a profit margin.

In assessing whether the contractual cash flows are solely payments of principal and interest, the Company considers the contractual terms of the instrument. This includes assessing whether the financial asset contains a contractual term that could change the timing or amount of contractual cash flows such that it would not meet this condition. In making this assessment, the Company considers:

• contingent events that would change the amount or timing of cash flows;

• terms that may adjust the contractual coupon rate, including variable rate features;

• prepayment and extension features; and

• terms that limit the Company’ s claim to cash flows from specified assets (e.g. non-recourse features)

• 5) Impairment of financial assets

The Company recognizes loss allowances for expected credit losses (“ECL”) on financial assets measured at amortized cost (including cash and cash equivalents, notes and accounts receivable, other receivables and other financial assets).

The Company measures loss allowances at an amount equal to lifetime ECL, except for the following financial assets which are measured using 12-month ECL:

• bank balances for which credit risk (i.e. the risk of default occurring over the expected life of the financial instrument) has not increased significantly since initial recognition.

(Continued)

15

QISDA CORPORATION Notes to the Parent-Company-Only Financial Statements

The Company measures loss allowances for accounts receivable at an amount equal to lifetime ECL.

Lifetime ECLs are the ECLs that result from all possible default events over the expected life of a financial instrument. 12-month ECLs are the portion of ECLs that result from default events that are possible within the 12 months after the reporting date (or a shorter period if the expected life of the instrument is less than 12 months).

The maximum period considered when estimating ECLs is the maximum contractual period over which the Company is exposed to credit risk.

When determining whether the credit risk of a financial asset has increased significantly since initial recognition, the Company considers reasonable and supportable information that is relevant and available without undue cost or effort. The information includes both quantitative and qualitative information and analysis based on the Company’s historical experience and credit assessment, as well as forward-looking information.

ECLs are probability-weighted estimate of credit losses over the expected life of financial assets. Credit losses are measured as the present value of all cash shortfalls (i.e. the difference between the cash flows due to the Company in accordance with the contract and the cash flows that the Company expects to receive). ECLs are discounted at the effective interest rate of the financial asset.

Loss allowances for financial assets measured at amortized cost are deducted from the gross carrying amount of the assets.

The gross carrying amount of a financial asset is written off when the Company has no reasonable expectations of recovering a financial asset in its entirety or a portion thereof. The Company individually makes an assessment with respect to the timing and amount of write-off based on whether there is a reasonable expectation of recovery. The Company expects no significant recovery from the amount written off. However, financial assets that are written off could still be subject to enforcement activities in order to comply with the Company’s procedures for recovery of amounts due.

6) Derecognition of financial assets

The Company derecognizes a financial asset when the contractual rights of the cash flows from the financial asset expire, or it transfers the rights to receive the contractual cash flows in a transaction in which substantially all of the risks and rewards of ownership of the financial asset are transferred or in which the Company neither transfers nor retains substantially all of the risks and rewards of ownership and it does not retain control of the financial asset.

The Company enters into transactions whereby it transfers assets recognized in its balance sheet, but retains either all or substantially all of the risks and rewards of the transferred assets; in these cases, the transferred assets are not derecognized.

(Continued)

16

QISDA CORPORATION Notes to the Parent-Company-Only Financial Statements

(ii) Financial liabilities and equity instruments

• 1) Classification of debt or equity

Debt and equity instruments issued by the Company are classified as financial liabilities or equity in accordance with the substance of the contractual arrangements and the definitions of a financial liability and an equity instrument. An equity instrument is any contract that evidences a residual interest in the assets of the Company after deducting all of its liabilities. Equity instruments are recognized at the amount of consideration received, less, the direct issuing cost.

2) Financial liabilities

Financial liabilities are classified as measured at amortized cost or FVTPL. A financial liability is classified as at FVTPL if it is held for trading, it is a derivative or it is designated as such on initial recognition. Financial liabilities at FVTPL are measured at fair value and net gains and losses, including any interest expense, are recognized in profit or loss.

Financial liabilities measured at amortized cost are subsequently measured at amortized cost using the effective interest method. Interest expense and foreign exchange gains and losses are recognized in profit or loss. Any gain or loss on derecognition is also recognized in profit or loss.

• 3) Derecognition of financial liabilities

The Company derecognizes a financial liability when its contractual obligation has been fulfilled or cancelled, or has expired. The Company also derecognizes a financial liability when its terms are modified and the cash flows of the modified liability are substantially different, in which case a new financial liability based on the modified terms is recognized at fair value.

The difference between the carrying amount of a financial liability derecognized and the consideration paid (including any non-cash assets transferred or liabilities assumed) is recognized in profit or loss.

• 4) Offsetting of financial assets and liabilities

Financial assets and liabilities are presented on a net basis only when the Company has the legally enforceable right to offset and intends to settle such financial assets and liabilities on a net basis or to realize the assets and settle the liabilities simultaneously.

• (iii) Derivative financial instruments

The Company uses derivative financial instruments to hedge its foreign currency exposures. Derivatives are initially measured at fair value and attributable transaction costs are recognized in profit or loss as incurred. Subsequent to initial recognition, derivatives are measured at fair value, and changes therein are recognized in profit or loss. If the valuation of a derivative instrument is in a positive fair value, it is classified as a financial asset, otherwise, it is classified as a financial liability.

(Continued)

17

QISDA CORPORATION Notes to the Parent-Company-Only Financial Statements

(g) Inventories

Inventories are measured at the lower of cost and net realizable value. The cost of inventories is calculated based on the weighted-average method and includes expenditure incurred in acquiring the inventories, production or conversion costs, and other costs incurred in bringing them to the location and condition ready for sale. Fixed manufacturing overhead is allocated to finished products and work in process based on the higher of normal capacity or actual capacity; variable manufacturing overhead is allocated based on the actual capacity of machinery and equipment. Net realizable value represents the estimated selling price in the ordinary course of business, less, all estimated costs of completion and necessary selling expenses.

(h) Investment in associates

Associates are those entities in which the Company has significant influence, but not control or jointly control, over the financial and operating policies.

Investments in associates are accounted for using the equity method and are recognized initially at cost, plus, any transaction costs. The carrying amount of the investment in associates includes goodwill identified on acquisition, net of any accumulated impairment losses. When necessary, the entire carrying amount of the investment (including goodwill) will be tested for impairment as a single asset by comparing its recoverable amount with its carrying amount. Any impairment loss recognized forms part of the carrying amount of the investment. Any reversal of that impairment loss is recognized to the extent that the recoverable amount of the investment subsequently increases.

The Company’s share of its associates’ post-acquisition profits or losses is recognized in profit or loss, and its share of post-acquisition movements in other comprehensive income is recognized as other comprehensive income with a corresponding adjustment to the carrying amount of the investment. When changes in an associate’ s equity are not recognized in profit or loss or other comprehensive income of the associate, and such changes do not affect the Company’s ownership percentage of the associate, the Company recognizes the change in ownership interests of its associate as “capital surplus” in proportion to its ownership.

Unrealized gains and losses resulting from transactions between the Company and an associate are recognized only to the extent of unrelated investors’ interests in the associate.

Adjustments are made to associates’ financial statements to conform to the accounting polices applied by the Company.

When the Company’s share of losses in an associate equals or exceeds its interest in the associate, the recognition of further losses is discontinued. Additional losses are provided for, and a liability is recognized, only to the extent that the Company has incurred legal or constructive obligations or made payments on behalf of the associate.

When an associate issues new shares and the Company does not subscribe to the new shares in proportion to its original ownership percentage, the Company’s interest in the associate’s net assets will be changed. The change in the equity interest is adjusted through the capital surplus and investment accounts. If the Company’ s capital surplus is insufficient to offset the adjustment to investment accounts, the difference is charged as a reduction of retained earnings. If the Company’s interest in an associate is reduced due to the additional subscription to the shares of associate by other investors, the proportionate amount of the gains or losses previously recognized in other comprehensive income in relation to that associate will be reclassified to profit or loss on the same basis as would be required if the associate had directly disposed of the related assets or liabilities.

(Continued)

18

QISDA CORPORATION

Notes to the Parent-Company-Only Financial Statements

(i) Investment in subsidiaries

When preparing the parent-company-only financial statements, investment in subsidiaries which are controlled by the Company is accounted for using the equity method. Under equity method, profit or loss, and other comprehensive income recognized in parent-company-only financial statement is in line with total comprehensive income attributable to the shareholders of the Company in the consolidated financial statements. In addition, changes in equity recognized in the parent-companyonly financial statements is in line with the changes in equity attributable to shareholders of the Company in the consolidated financial statements.

Changes in a parent’s ownership interest in a subsidiary that do not result in the loss of control as accounted for within equity.

(j) Investment property

Investment property is property held either to earn rental income or for capital appreciation or for both. Investment property is measured at cost on initial recognition. Subsequent to initial recognition, investment property is measured at initial acquisition cost less accumulated depreciation and accumulated impairment losses. The methods for depreciating and determining the useful life and residual value of investment property are the same as those adopted for property, plant and equipment. Cost includes expenditure that is directly attributable to the acquisition of the investment property, bringing the investment property to the condition necessary for it to be available for use, and any borrowing cost that is eligible for capitalization.

Any gain or loss on disposal of an investment property (calculated as the difference between the net proceeds from disposal and the carrying amount) is recognized in profit or loss.

Rental income from investment property is recognized on a straight-line basis over the term of the lease. Lease incentives granted are recognized as an integral part of the total rental income, over the term of the lease.

An investment property is reclassified to property, plant and equipment at its carrying amount when the purpose of the investment property has been changed from investment to owner-occupied.

(k) Property, plant and equipment

(i) Recognition and measurement

Property, plant and equipment are measured at cost, which includes capitalized borrowing costs, less, accumulated depreciation and any accumulated impairment losses.

If significant parts of an item of property, plant and equipment have different useful lives, they are accounted for as separate items (major components) of property, plant and equipment.

Any gain or loss on disposal of property, plant and equipment is recognized in profit or loss.

(ii) Subsequent costs

Subsequent expenditure is capitalized only if it is probable that the future economic benefits associated with the expenditure will flow to the Company.

(Continued)

19

QISDA CORPORATION Notes to the Parent-Company-Only Financial Statements

• (iii) Depreciation

Depreciation is calculated on the cost of assets less their residual values and is recognized in profit or loss on a straight-line basis over the estimated useful lives of each component of an item of property, plant and equipment.

Land is not depreciated. The estimated useful lives for property, plant and equipment are as follows: buildings: 10 to 55 years; machinery and equipment: 2 to 10 years; furniture and fixtures: 3 years; and other equipment: 5 years.

Depreciation methods, useful lives, and residual values are reviewed at each reporting date, with the effect of any changes in estimate accounted for on a prospective basis.

(l) Leases

At inception of a contract, the Company assesses whether a contract is, or contains, a lease. A contract is, or contains, a lease if the contract conveys the right to control the use of an identified asset for a period of time in exchange for consideration.

• (i) As a lessee

The Company recognizes a right-of-use asset and a lease liability at the lease commencement date. The right-of-use asset is initially measured at cost, which comprises the initial amount of the lease liability adjusted for any lease payments made at or before the commencement date, plus any initial direct costs incurred and an estimate of costs to dismantle and remove the underlying asset or to restore the underlying asset or the site on which it is located, less any lease incentives received.

The right-of-use asset is subsequently depreciated using the straight-line method from the commencement date to the earlier of the end of the useful life of the right-of-use asset or the end of the lease term. In addition, the right-of-use asset is periodically evaluated and reduced by impairment losses, if any, and adjusted for certain remeasurements of the lease liability.

The lease liability is initially measured at the present value of the lease payments that are not paid at the commencement date, discounted using the interest rate implicit in the lease or, if that rate cannot be reliably determined, the Company’s incremental borrowing rate. Generally, the Company uses its incremental borrowing rate as the discount rate.

Lease payments included in the measurement of the lease liability comprise the following:

• － fixed payments, including in-substance fixed payments;

• － variable lease payments that depend on an index or a rate, initially measured using the index or rate as at the commencement date.

• － amounts expected to be payable under a residual value guarantee; and

• － payments for purchase or termination options that are reasonably certain to be exercised.

(Continued)

20

QISDA CORPORATION Notes to the Parent-Company-Only Financial Statements

The lease liability is subsequently measured at amortized cost using the effective interest method. It is remeasured when:

• － there is a change in future lease payments arising from the change in an index or rate; or

• － there is a change in the Company’s estimate of the amount expected to be payable under a residual value guarantee; or

• － there is a change of the Company’s assessment on whether it will exercise an option to purchase the underlying asset; or

• － there is a change in the lease term resulting from a change of the Company’s assessment on whether it will exercise an extension or termination option; or

• －

• there is any lease modification in lease subject, scope of the lease or other terms.

When the lease liability is remeasured, other than lease modifications, a corresponding adjustment is made to the carrying amount of the right-of-use asset, or in profit and loss if the carrying amount of the right-of-use asset has been reduced to zero.

When the lease liability is remeasured to reflect the partial or full termination of the lease for lease modifications that decrease the scope of the lease, the Company accounts for the remeasurement of the lease liability by decreasing the carrying amount of the right-of-use asset to reflect the partial or full termination of the lease, and recognize the difference in profit or loss for any gain or loss relating to the partial or full termination of the lease.

The Company presents right-of-use assets that do not meet the definition of investment properties, and lease liabilities as a separate line item respectively in the balance sheets.

The Company has elected not to recognize right-of-use assets and lease liabilities for leases that have a lease term of 12 months or less and leases of low-value assets. The Company recognizes the lease payments associated with these leases as an expense on a straight-line basis over the lease term.

• (ii) As a lessor

When the Company acts as a lessor, it determines at lease commencement whether each lease is a finance lease or an operating lease. To classify each lease, the Company makes an overall assessment of whether the lease transfers to the lessee substantially all of the risks and rewards incidental to ownership of the underlying asset. If this is the case, then the lease is a finance lease; if not, then the lease is an operating lease. As part of this assessment, the Company considers certain indicators such as whether the lease is for the major part of the economic life of the asset.

When the Company is an intermediate lessor, it accounts for its interests in the head lease and the sub-lease separately. It assesses the lease classification of a sub-lease with reference to the right-of-use asset arising from the head lease. If a head lease is a short-term lease to which the Company applies the exemption described above, then it classifies the sub-lease as an operating lease.

(Continued)

21

QISDA CORPORATION Notes to the Parent-Company-Only Financial Statements

For operating lease, the Company recognizes rental income on a straight-line basis over the lease term.

(m) Intangible assets

Intangible assets including acquired software are carried at cost, less, accumulated amortization and accumulated impairment losses. Amortization is recognized in profit or loss using the straight-line method over the estimated useful lives of 1 to 5 years.

The residual value, amortization period, and amortization method are reviewed at least at each reporting date, with the effect of any changes in estimate accounted for on a prospective basis.

(n) Impairment of non-financial assets

The Company assesses at the end of each reporting date whether there is any indication that the carrying amounts of non-financial assets (other than inventories and deferred tax assets) may be impaired. If any such indication exists, then the asset’s recoverable amount is estimated. Goodwill is tested annually or when there are indications of impairment.

For the purpose of impairment testing, assets are grouped together into the smallest group of assets that generates cash inflows from continuing use that are largely independent of the cash inflows from other assets or groups of assets. Goodwill arising from a business combination is allocated to cash-generating units (“CGUs”) or groups of CGUs that are expected to benefit from the synergies of the combination.

The recoverable amount of an individual asset or CGU is the higher of its value in use and its fair value less costs to sell. Value in use is based on the estimated future cash flows, discounted to their present value using a pre-tax discount rate that reflects current market assessments of the time value of money and the risks specific to the asset or CGU.

An impairment loss is recognized if the carrying amount of an asset or CGU exceeds its recoverable amount. Impairment losses are recognized in profit or loss. They are allocated first to reduce the carrying amount of any goodwill allocated to the CGU, and then to reduce the carrying amounts of the other assets in the CGU on a pro rata basis.

An impairment loss in respect of goodwill is not reversed. For other non-financial assets, an impairment loss is reversed only to the extent that the asset’s carrying amount that would have been determined (net of depreciation or amortization) had no impairment loss been recognized for the assets in prior years.

(o) Provisions

Provisions are recognized when the Company has a present obligation (legal or constructive) as a result of a past event, it is probable that the Company will be required to settle the obligation, and a reliable estimate can be made of the amount of the obligation.

A provision for warranties is recognized when the underlying products or services are sold. This provision reflects the historical warranty claim rate and the weighting of all possible outcomes against their associated probabilities.

(Continued)

22

QISDA CORPORATION Notes to the Parent-Company-Only Financial Statements

(p) Revenue recognition

Revenue is measured based on the consideration to which the Company expects to be entitled in exchange for transferring goods or services to a customer. The Company recognizes revenue when it satisfies a performance obligation by transferring control of a good or a service to a customer. The accounting policies for the Company’s main types of revenue are explained below.

(i) Sale of goods

The Company recognizes revenue when control of the goods has been transferred to the customer, being when the goods are delivered to the customer, and there is no unfulfilled obligation that could affect the customer’s acceptance of the goods. Delivery occurs when the goods have been shipped to the specific location, and either the customer has accepted the goods in accordance with the terms of sales, the risks of obsolescence and loss have been transferred to the customer, and the Company has objective evidence that all criteria for acceptance have been satisfied. Sales discount and rebates are recognized and estimated based on historical experience and each contractual term. Revenue is only recognized to the extent that it is highly probable that a significant reversal will not occur. A refund liability is recognized for expected sales discounts and rebate payables to customers in relation to sales made until the end of the reporting period. No element of financing is deemed present as the sales are made with a credit term ranging from 30 to 120 days, which is consistent with the market practice.

The Company’ s obligation to provide a refund for faulty goods sold under the standard warranty terms is recognized as a provision for warranty; please refer to note 6(p).

A receivable is recognized when the goods are delivered, as this is the point in time that the Company has a right to an amount of consideration that is unconditional.

(ii) Rendering of services

The Company’ s revenue from providing product design and development services is recognized in the accounting period in which services are rendered.

• (iii) Financing components

The Company does not expect to have any contracts where the period between the transfer of the promised goods or services to the customer, and the payment by the customer, exceeds one year. As a consequence, the Company does not adjust any of the transaction prices for the time value of money.

(q) Government grants

A government grant is recognized in profit or loss only when there is reasonable assurance that the Company will comply with the conditions associated with the grant and that the grant will be received.

A government grant is recognized in profit or loss in the period in which it becomes receivable as compensation for expenses or losses already incurred or for the purpose of giving immediate financial support to the Company without future related costs.

(Continued)

23

QISDA CORPORATION Notes to the Parent-Company-Only Financial Statements

Loans from financial institutions with a guarantee from the government are recognized at fair value using the market interest rate. The difference between the fair value of the loan and the amount received is recorded as deferred income and recognized in non-operating income-other income on a systematic basis over the period of the loan.

(r) Employee benefits

(i) Defined contribution plans

Obligations for contributions to defined contribution pension plans are expensed during the year in which employees render services.

(ii) Defined benefit plans

The liability recognized in respect of defined benefit pension plans is the present value of the defined benefit obligation at the reporting date, less, the fair value of plan assets. The discount rate for calculating the present value of the defined benefit obligation refers to the interest rate of high-quality government bonds that are denominated in the currency in which the benefits will be paid, and that have terms to maturity approximating the term of the related pension obligation. The defined benefit obligation is calculated annually by qualified actuaries using the projected unit credit method.

When the benefits of a plan are improved, the expense related to the increased obligations resulting from the services rendered by employees in the past years are recognized in profit or loss immediately.

The remeasurements of the net defined benefit liability (asset) comprise 1) actuarial gains and losses; 2) return on plan assets, excluding amounts included in net interest on the net defined benefit liability (asset); and 3) any change in the effect of the asset ceiling, excluding amounts included in net interest on the net defined benefit liability (asset). The remeasurements of the net defined benefit liabilities (asset) are recognized in other comprehensive income and then transferred to other equity.

The Company recognizes gains or losses on the curtailment or settlement of a defined benefit plan when the curtailment or settlement occurs. The gain or loss on curtailment or settlement comprises any resulting change in the fair value of plan assets and any change in the present value of the defined benefit obligation.

(iii) Short-term employee benefits

Short-term employee benefit obligations are measured on an undiscounted basis and are expensed during the period in which employees render services. A liability is recognized for the amount expected to be paid under short-term cash bonus or profit-sharing plans if the Company has a present legal or constructive obligation to make such payments as a result of past service provided by the employees, and the obligation can be estimated reliably.

(s) Income taxes

Income taxes comprise current taxes and deferred taxes. Current and deferred taxes are recognized in profit or loss unless they relate to business combinations or items recognized directly in equity or other comprehensive income.

(Continued)

24

QISDA CORPORATION Notes to the Parent-Company-Only Financial Statements

The Company has determined that the global minimum top-up tax which it is required to pay under Pillar Two legislation is an income tax in the scope of IAS 12. The Company has applied a temporary mandatory relief from deferred tax accounting for the impacts of the top-up tax and accounts for it as a current tax when it is incurred.

Current taxes comprise the expected tax payable or receivables on the taxable profits (losses) for the year and any adjustment to the tax payable or receivable in respect of previous years. The amount of current tax payables or receivables are the best estimate of the tax amount expected to be paid or received that reflects uncertainty related to income taxes, if any. It is measured using tax rates enacted or substantively enacted at the reporting date.

Deferred income taxes are recognized in respect of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for taxation purposes. Deferred taxes are not recognized for:

• (i) Temporary differences on the initial recognition of assets and liabilities in a transaction that is not a business combination and at the time of the transaction 1) affects neither accounting nor taxable profits (losses) and 2) does not give rise to equal taxable and deductible temporary differences;

• (ii) Temporary differences related to investments in subsidiaries, associates and joint arrangements to the extent that the Company is able to control the timing of the reversal of the temporary differences and it is probable that they will not reverse in the foreseeable future; and

(iii) Taxable temporary differences arising on the initial recognition of goodwill.

Deferred tax assets are recognized for unused tax losses, tax credits, and deductible temporary differences to the extent that it is probable that future taxable profits will be available against which they can be utilized. Deferred tax assets are reviewed at each reporting date and reduced to the extent that it is no longer probable that the related tax benefit will be realized; such reductions are reversed when the probability of future taxable profits improves.

Deferred taxes are measured at tax rates that are expected to be applied to temporary differences when they reserve, using tax rates enacted or substantively enacted at the reporting date, and reflect uncertainty related to income taxes, if any.

Deferred tax assets and liabilities are offset if the following criteria are met:

• (i) the Company has a legally enforceable right to set off current tax assets against current tax liabilities; and

• (ii) the deferred tax assets and the deferred tax liabilities relate to income taxes levied by the same taxation authority on either:

• 1) the same taxable entity; or

• 2) different taxable entities which intend to settle current tax assets and liabilities on a net basis, or to realize the assets and liabilities simultaneously, in each future period in which significant amounts of deferred tax liabilities or assets are expected to be settled or recovered.

(Continued)

25

QISDA CORPORATION Notes to the Parent-Company-Only Financial Statements

(t) Business combinations

The Company uses acquisition method for acquisitions of new subsidiaries. Goodwill is measured as the excess of the acquisition-date fair value of the consideration transferred (including any noncontrolling interest in the acquiree) over the net of the acquisition-date amounts of the identifiable assets acquired and liabilities assumed (generally at fair value). If the residual balance is negative, the Company shall re-assess whether it has correctly identified all of the assets acquired and liabilities assumed and recognize any additional assets or liabilities that are identified in that review, and shall recognize a gain on the bargain purchase thereafter.

Acquisition-related costs are expensed as incurred except for the costs related to issuance of debt or equity instruments.

In a business combination achieved in stages, the Company shall re-measure its previously held equity interest in the acquiree at its acquisition-date fair value and recognize the resulting gain or loss in profit or loss. The amount previously recognized in other comprehensive income in relation to the changes in the value of the Company’s equity interest should be reclassified to profit or loss on the same basis as would be required if the Company had disposed directly of the previously held equity interest.

If the initial accounting for a business combination is incomplete by the end of the reporting period in which the combination occurs, the provisional amounts for the items for which the accounting is incomplete are reported in the financial statements. During the measurement period, the provisional amounts recognized at the acquisition date are retrospectively adjusted to reflect new information obtained about facts and circumstances that existed as of the acquisition date. The measurement period shall not exceed one year from the acquisition date.

Contingent consideration as part of the consideration transferred is measured at the acquisition date fair value. Any fluctuation of the fair value during the measurement period after acquisition date is retrospectively adjusted to the acquisition cost and goodwill. The adjustments are to reflect new information obtained about facts and circumstances that existed as of the acquisition date. The measurement period shall not exceed one year from the acquisition date. For the fair value adjustments of the contingent consideration that occurred not during the measurement period, the accounting treatment will be based on the classification of contingent consideration. Contingent consideration classified as equity cannot be re-measured and has to be adjusted under owner’ s equity. Other contingent consideration should be subsequently measured at fair value at the end of each reporting period, and recognized in profit or loss.

(u) Earnings per share (“EPS”)

The basic and diluted EPS attributable to stockholders of the Company are disclosed in the financial statements. Basic EPS is calculated by dividing net income attributable to stockholders of the Company by the weighted-average number of common shares outstanding during the year. In calculating diluted EPS, the net income attributable to stockholders of the Company and weightedaverage number of common shares outstanding during the year are adjusted for the effects of dilutive potential common shares. The Company’s dilutive potential common shares are profit sharing for employees to be settled in the form of common stock.

(Continued)

26

QISDA CORPORATION Notes to the Parent-Company-Only Financial Statements

(v) Operating segments

The Company discloses the operating segment information in the consolidated financial statements. Therefore, the Company does not disclose the operating segment information in the parent-companyonly financial statements.

5. Critical accounting judgments and key sources of estimation uncertainty

The preparation of the parent-company-only financial statements in conformity with the Regulations Governing the Preparation of Financial Reports requires management to make judgments and estimates about the future, including climate-related risks and opportunities, which affect the application of the accounting policies and the reported amount of assets, liabilities, income and expenses. Actual results may differ from these estimates.

Estimates and underlying assumptions are reviewed on an ongoing basis and are consistent with the Company’s risk management and climate-related commitments where appropriate. Revisions to estimates are recognized prospectively in the period of the change and future periods.

Information about judgments made in applying the accounting policies that have significant effects on the amounts recognized in the parent-company-only financial statements is as follows:

Judgment regarding whether the Company has substantial control over the investee. Please refer to consolidated financial statements for the year ended December 31, 2024.

Information about assumptions and estimation uncertainties that have a significant risk of resulting in a material adjustment within the next financial year is included as follows:

(a) Valuation of inventories

Inventories are measured at the lower of cost and net realizable value. Due to the rapid technological innovations and highly competitive environments in the electronic industry, the life cycle of certain products of the Company are short and their market prices fluctuate rapidly, which could possibly result in a price decline and obsolescence of inventory, wherein the inventory cost may exceed its net realizable value. The net realizable value of the inventory is mainly determined based on assumptions of future demand within a specific time horizon, which could result in significant adjustments.

• (b) Assessment of impairment of goodwill from investments in subsidiaries

The assessment of impairment of goodwill requires the Company to make subjective judgments to identify cash-generating units, allocate the goodwill to relevant cash-generating units, and estimate the recoverable amount of relevant cash-generating units. Any changes in these estimates based on changed economic conditions or business strategies could result in significant adjustments in future years.

(Continued)

27

QISDA CORPORATION

Notes to the Parent-Company-Only Financial Statements

6. Significant account disclosures

(a) Cash and cash equivalents

Cash and cash equivalents
Demand deposits Foreign currency deposits	December 31, 2024 $ 385,759 1,476,146 $ 1,861,905	December 31, 2023
		180,482 2,352,474
		2,532,956

(b) Financial instruments measured at fair value through profit or loss

Financial assets at fair value through profit or loss－current: Foreign currency forward contracts Foreign exchange swaps Domestic listed stocks Privately held equity securities Financial assets at fair value through profit or loss－non-current: Privately held equity securities Financial liabilities at fair value through profit or loss－current: Foreign currency forward contracts	December 31, 2024 $ 3,755 1,608 164,400 - $ 169,763 $ 351,041 $ 9,344	December 31, 2023
		37,360 - - 96,126
		133,486
		-
		-

Please refer to note 6(x) for the amounts of gain (loss) recognized related to financial assets measured at fair value.

The Company entered into derivative contracts to manage foreign currency exchange risk resulting from its operating and financing activities. At each reporting date, the outstanding derivative financial instruments which did not conform to the criteria for hedge accounting consisted of the following:

• (i) Foreign currency forward contracts

CNY Buy / USD Sell JPY Buy / USD Sell	December 31, 2024
	Contract amount (in thousands) Maturity period USD 50,000 2025/03 JPY 4,500,000 2025/03

(Continued)

28

QISDA CORPORATION Notes to the Parent-Company-Only Financial Statements

CNY Buy / USD Sell (ii) Foreign exchange swaps Swap in USD / Swap out NTD	December 31, 2023
	Contract amount (in thousands) Maturity period USD 46,550 2024/01~2024/02 December 31, 2024
	Contract amount (in thousands) Maturity period USD 13,000 2025/01

－ (c) Financial assets at fair value through other comprehensive income non-current

Equity investments at fair value through other comprehensive income: Domestic listed stocks Privately held equity securities	December 31, 2024 $ 7,777,376 40,000 $ 7,817,376	December 31, 2023
		9,707,602 2,134
		9,709,736

The Company designated the equity investments shown above as financial assets at fair value through other comprehensive income because these investments are held for long-term for strategic purposes and not for trading.

The Company’ s subsidiary, DFI Inc., increased its investment in APLEX Technology Inc. (“ APLEX” ) in 2024 and gained significant influence over APLEX, resulting in the Company to － reclassify its investment and other equity unrealized gain on financial assets at fair value through other comprehensive of $71,595 and $42,220 in APLEX to investments accounted for using equity method and retained earnings, respectively.

No strategic investments were disposed for the year ended December 31, 2023, and there were no transfers of any cumulative gain or loss within equity relating to these investments.

(d) Notes and accounts receivable

Notes and accounts receivable Notes and accounts receivable from related parties Less: loss allowance	December 31, 2024 $ 10,983,017 16,872,354 27,855,371 (15,703) $ 27,839,668	December 31, 2023 8,967,138 14,112,765 23,079,903 (47,079) 23,032,824

(Continued)

29

QISDA CORPORATION Notes to the Parent-Company-Only Financial Statements

• (i) The Company applies the simplified approach to provide for its expected credit losses, i.e. the use of lifetime expected loss provision for all receivables (including receivables from related parties). Forward-looking information is taken into consideration as well. Analysis of expected credit losses on notes and accounts receivable (including receivables from related parties) was as follows:

Current Past due 1-90 days Past due over 91 days Current Past due 1-90 days Past due over 91 days	December 31, 2024	December 31, 2024
	Gross carrying amount Weighted- average loss rate $ 20,592,292 0.02% 7,254,700 0.04% 8,379 100% $ 27,855,371 December 31, 2023		Loss allowance
			4,397 2,927 8,379
			15,703
		Weighted- average loss rate 0.04% 0.73% 100%	Loss allowance
			6,589 36,533 3,957
			47,079

• (ii) Movements of the loss allowance for notes and accounts receivable (including receivables from related parties) were as follows:

Balance at January 1 Gain on reversal of impairment loss Balance at December 31 (e) Other receivables Other receivables－others Other receivables from related parties	2024 $ 47,079 (31,376) $ 15,703 December 31, 2024 $ - 6,850 $ 6,850	2023 60,060 (12,981) 47,079 December 31, 2023 5,160 6,717
		11,877

As of December 31, 2024 and 2023, no loss allowance was provided for other receivables after management’s assessment.

(Continued)

30

QISDA CORPORATION Notes to the Parent-Company-Only Financial Statements

(f) Inventories

Raw materials Work in process Finished goods Work in process－outsourced Inventories in transit	December 31, 2024 $ 1,023,478 174,184 5,522,270 356,532 43,780 $ 7,120,244	December 31, 2023
		851,305 141,245 4,687,098 469,966 49,658
		6,199,272

For the years ended December 31, 2024 and 2023, the cost of inventories sold amounted to $73,142,847 and $71,761,378, respectively, of which the write-downs of inventories to net realizable value amounted to $46,114, and $12,090, respectively.

(g) Investments accounted for using the equity method

A summary of the Company’s investments accounted for using the equity method at the reporting date was as follows:

Subsidiaries Associates	December 31, 2024 $ 55,321,471 3,750,239 $ 59,071,710	December 31, 2023
		50,189,425 5,509,523
		55,698,948

(i) Subsidiaries

Please refer to consolidated financial statements for the year ended December 31, 2024.

For the year ended December 31, 2023, the Company acquired additional 24.74% ownership of BBHC from CDH Medical Services Limited for a cash consideration of $5,656,725 and an investment payable of $628,958, wherein the difference between the decrease in noncontrolling interests and consideration paid amounting to $4,732,601 was recognized as － deductions to capital surplus difference between consideration and carrying amount arising from acquisition or disposal of shares of subsidiaries and retained earnings.

－ (ii) Acquisition of subsidiary Norbel Baby Co., Ltd.

1) Consideration transferred

On November 13, 2024 (the acquisition date), the Company acquired 13.94% equity ownership of Norbel Baby Co., Ltd. (“Norbel”) for a cash consideration of $913,500. As a result, the equity interest in Norbel increased from 26.72% to 40.66%, resulting in the Company to obtain control over Norbel, who has been included in the consolidated entities thereafter. Norbel is engaged in the retail and wholesale of maternity and infant products, medical care products, dietary supplement, and cosmetics.

(Continued)

31

QISDA CORPORATION

Notes to the Parent-Company-Only Financial Statements

The acquisition of Norbel enables the Company to strengthen its business deployment in the medical retail market, seize the opportunities in the senior market and expand its business in medical retail channel.

• 2) Identifiable net assets acquired in a business combination and goodwill

On November 13, 2024 (the acquisition date), the fair value of identifiable assets acquired and liabilities assumed from the acquisition, as well as goodwill arising from the acquisition, were as follows:

the acquisition, were as follows:
Consideration transferred:
Cash			$	913,500
Add: The fair value of the acquirer’s previously held				1,571,500
equity interest in the acquiree
Add: Non-controlling interests (measured at non-controlling				2,723,738
interest’s proportionate share of the fair value of
Norbel’s identifiable net assets)
Less: Identifiable net assets acquired at fair value:
Cash and cash equivalents	$	932,402
Notes and accounts receivable, net		22,460
Other receivables		37,226
Inventories		822,933
Other financial assets－current		964,802
Other current assets		9,836
Financial assets at fair value through profit or loss
－non-current		20,000
Property, plant and equipment		1,224,359
Right-of-use assets		1,009,288
Intangible assets－trademarks		1,321,806
Intangible assets－computer software		3,690
Deferred income tax assets		9,796
Other financial assets－non-current		27,229
Other non-current assets		49,322
Notes and accounts payable		(336,094)
Other payables and other current liabilities		(154,953)
Current income tax liabilities		(4,952)
Lease liabilities (including current and non-current)		(1,075,258)
Deferred income tax liabilities		(276,219)
Other non-current liabilities		(17,289)		4,590,384
Goodwill			$	618,354

(Continued)

32

QISDA CORPORATION Notes to the Parent-Company-Only Financial Statements

The Company’s previously held 26.72% equity interest in Norbel was remeasured to fair value at the acquisition date, and a loss on disposal of investments of $74,365 was recognized in other gains and losses.

(iii) Impairment test on goodwill

The excess of acquisition over the Company’s share of the net fair value of the identifiable assets acquired and liabilities assumed at the date of acquisition is recognized as goodwill, and any impairment of goodwill should be recognized as a deduction from the carrying amount of the investments accounted for using equity method. The carrying amounts of goodwill arising from business combinations of Alpha Networks Inc. (“Alpha”), DFI Inc. (“DFI”) and Partner Tech Corp. (“ PTT” ) and the respective CGUs to which the goodwill were allocated for impairment test purpose as of December 31, 2024 and 2023 were as follows:

impairment test purpose as of December 31, 2024 and 2023	were as follows:
Alpha DFI PTT	December 31, 2024 $ 1,730,813 $ 1,427,555 $ 810,579	December 31, 2023
		1,730,813
		1,427,555
		810,579

Each CGU or group of CGUs to which the goodwill is allocated represents the lowest level within the group, at which the goodwill is monitored for internal management purpose. Based on the results of impairment tests conducted by the Company, no impairment loss was recognized as of December 31, 2024 and 2023. The recoverable amount of a CGU was determined based on the value in use, and the related key assumptions were as follows:

Alpha: Revenue growth rate Discount rates DFI: Revenue growth rate Discount rates PTT: Revenue growth rate Discount rates	December 31, 2024 December 31, 2023 6%~11% 13%~15% 13.72% 18.44% December 31, 2024 December 31, 2023 8%~10% 7%~17% 14.90% 16.80% December 31, 2024 December 31, 2023 6% 6% 15.57% 15.65%

(Continued)

33

QISDA CORPORATION Notes to the Parent-Company-Only Financial Statements

• 1) The cash flow projections were based on future financial budgets, covering a period of 5 years, approved by management. Cash flows beyond that 5-year period have been extrapolated using 0% to 2.45% growth rate.

• 2) The estimation of discount rate is based on the weighted average cost of capital.

(iv) Investments in associates

Name of Associates Darfon Electronics Corp. (“DFN”) Norbel Baby Co., Ltd. (“Norbel”) TCI GENE INC (“TCI Gene”) Topview Optronics Corporation (“Topview”) Others	Main Business	Location Taiwan Taiwan Mainland China Taiwan	December	31, 2024 Carrying amount $ 2,399,797 - 499,824 551,732 298,886 $ 3,750,239	December 31, 2023	December 31, 2023
			Percentage of voting rights		Percentage of voting rights % 20.87 % 28.54 % 17.84 % 20.00 -	Carrying amount
	Manufacture and sale of computer peripheral products, power devices, green energy products and passive components Retail and wholesale of maternity and infant products, medical care products, dietary supplement, and cosmetics Genetic testing and wholesale of nutritional supplement Manufacture, sales and import and export of video surveillance cameras		% 21.02 - % 17.84 % 20.00 -			2,546,239 1,710,470 514,309 530,708 207,797
						5,509,523

In the second quarter of 2023, the Company acquired 28.54% ownership of Norbel for a cash consideration of 1,800,000. The equity-method was used to account for the investments as the Company has significant influence over Norbel. On November 13, 2024, the Company acquired an additional equity ownership of Norbel through public tender offer and obtained control over Norbel, who has been included in the consolidated entities thereafter. Please refer to note 6(g)(ii) for the related information.

In June 2023, the Company’ s subsidiaries disposed parts of its ownership in Topview and thereafter, three of its representative directors resigned, failing to own the majority of the board seats of Topview as of June 30, 2023, resulting in the Company to lose control over Topview and its subsidiaries, who were then no longer a subsidiary of the Company. Investments in Topview were reclassified to investments accounted for using the equity － method associates, resulting in a gain on disposal of investment of $273,124, which was included in other gains and losses.

For the years ended December 31, 2024 and 2023, the Company’ s shares of profits of associates amounted to $143,488 and $336,818, respectively.

The fair value of the investment in associates which are publicly traded was as follows:

DFN	December 31, 2024 $ 2,526,118	December 31, 2023
		3,143,871

(Continued)

34

QISDA CORPORATION Notes to the Parent-Company-Only Financial Statements

The summarized financial information in respect of each of the Company’s material associates is set out below:

• 1) The summarized financial information of DFN:

Current assets Non-current assets Current liabilities Non-current liabilities Equity Equity attributable to non-controlling interests of DFN Equity attributable to shareholders of DFN Net sales Net income Other comprehensive income (loss) Total comprehensive income Total comprehensive income (loss) attributable to non-controlling interests of DFN Total comprehensive income attributable to shareholders of DFN The Company’s share of equity of associates at January 1 Net income attributable to the Company Other comprehensive income (loss) attributable to the Company Capital surplus attributable to the Company and other adjustments Dividends received from associates The carrying amount of investments in the associates at December 313	December 31, 2024 $ 20,894,990 13,339,521 (14,928,752) (4,841,836) $ 14,463,923 $ 3,047,188 $ 11,416,735 2024 $ 21,700,226 $ 518,414 (281,319) $ 237,095 $ (147,100) $ 384,195 2024 $ 2,546,239 127,484 (49,347) 7,440 (232,019) $ 2,399,797	December 31, 2023 21,637,187 13,244,407 (14,592,995) (4,519,500) 15,769,099 3,564,494 12,204,605 2023 25,791,522 1,897,101 945,051 2,842,152 289,781 2,552,371 2023 2,187,968 334,479 184,264 13,542 (174,014) 2,546,239

(Continued)

35

QISDA CORPORATION Notes to the Parent-Company-Only Financial Statements

• 2) The summarized financial information of Norbel:

								December 31,	December 31,
									2023
	Current assets							$	2,549,818
	Non-current assets								4,060,643
	Current liabilities								(716,744)
	Non-current liabilities								(1,103,134)
	Equity							$	4,790,583
							From		From
							January 1,		April 26,
							2024 to		2023 to
						November 12,		December 31,
							2024		2023
	Net sales					$	2,820,080		2,361,669
	Net income		(loss)			$	(10,344)		37,798
	Other comprehensive loss						-		(1,108)
	Total comprehensive income (loss)					$	(10,344)		36,690
							From		From
							January 1,		April 26,
							2024 to		2023 to
						November 12,			December 31,
							2024		2023
	The Company’s share of equity of associates					$	1,710,470		-
	at January 1
	Increase in investments						-		1,800,000
	Net income		(loss) attributable to the Company				(3,637)		10,786
	Other comprehensive loss attributable to the Company						-		(316)
	Capital surplus attributable to the			Company			12,288		-
	Dividends received from associates						(60,968)		(100,000)
	Reclassification to consolidated entities						(1,658,153)		-
	The carrying amount of investments in				the associates
	at December 31					$	-		1,710,470
3)	Aggregate financial information of associates that were						not individually		material to the
	Company was summarized as follows. The financial information was								included in the
	Company’s		parent-company-only	financial statements.
						December 31,			December 31,
							2024		2023
	The aggregate carrying amount of			associates that
	were not individually material to the				Company	$	1,350,442		1,252,814
									(Continued)

36

QISDA CORPORATION Notes to the Parent-Company-Only Financial Statements

Attributable to the Company: Net income (loss) Other comprehensive income (loss) Total comprehensive income (loss)	2024 $ 19,641 (7,103) $ 12,538	2023 (8,447) 1,362 (7,085)

(h) Property, plant and equipment

Cost: Balance at January 1, 2024 Additions Disposals Reclassification Balance at December 31, 2024 Balance at January 1, 2023 Additions Disposals Reclassification Balance at December 31, 2023 Accumulated depreciation: Balance at January 1, 2024 Depreciation Disposals Balance at December 31, 2024 Balance at January 1, 2023 Depreciation Disposals Balance at December 31, 2023 Carrying amounts: Balance at December 31, 2024 Balance at December 31, 2023	Land $ 805,484 - - - $ 805,484 $ 805,484 - - - $ 805,484 $ - - - $ - $ - - - $ - $ 805,484 $ 805,484	Buildings 1,849,105 10,598 - - 1,859,703 1,830,220 13,681 - 5,204 1,849,105 1,342,418 45,749 - 1,388,167 1,296,478 45,940 - 1,342,418 471,536 506,687	Machinery 1,328,466 55,875 (15,456) 27,596 1,396,481 1,072,081 85,717 (10,588) 181,256 1,328,466 769,568 136,629 (14,531) 891,666 662,089 118,067 (10,588) 769,568 504,815 558,898	Other equipment 248,135 1,583 (52,462) - 197,256 244,690 986 (14,374) 16,833 248,135 194,410 26,388 (52,221) 168,577 176,146 31,758 (13,494) 194,410 28,679 53,725	Construction in progress and equipment to be inspected 96,685 27,564 - (106,838) 17,411 288,339 56,695 - (248,349) 96,685 - - - - - - - - 17,411 96,685	Total
						4,327,875 95,620 (67,918 (79,242
						4,276,335
						4,240,814 157,079 (24,962 (45,056
						4,327,875
						2,306,396 208,766 (66,752
						2,448,410
						2,134,713 195,765 (24,082
						2,306,396
						1,827,925
						2,021,479

The Company has obtained a parcel of land located at Yilan County for a period of time, at the amount of $104,324. Because of certain legal restrictions, this land was not registered under the name of the Company. In order to protect the Company’s rights to this land, the Company entered into an agreement with the registered owner. The contract specified that the Company retain all rights and obligations of the land.

Please refer to note 8 for a description of the Company’s property, plant and equipment pledged as collateral for long-term debt.

(Continued)

37

QISDA CORPORATION

Notes to the Parent-Company-Only Financial Statements

(i) Right-of-use assets

Cost: Balance at January 1, 2024 (balance at December 31, 2024) Balance at January 1, 2023 Additions Disposals Reclassification to investment property Balance at December 31, 2023 Accumulated depreciation: Balance at January 1, 2024 Depreciation Balance at December 31, 2024 Balance at January 1, 2023 Depreciation Disposals Reclassification to investment property Balance at December 31, 2023 Carrying amounts: Balance at December 31, 2024 Balance at December 31, 2023 Investment property Cost: Balance at January 1, 2024 (balance at December 31, 2024) Balance at January 1, 2023 Reclassification from right-of-use assets Balance at December 31, 2023 Accumulated depreciation: Balance at January 1, 2024 Depreciation Balance at December 31, 2024 Balance at January 1, 2023 Depreciation Reclassification from right-of-use assets Balance at December 31, 2023

Buildings $ 942,409 $ 950,424 9,901 (10,021) (7,895) $ 942,409 $ 598,772 98,201 $ 696,973 $ 514,813 98,256 (10,021) (4,276) $ 598,772 $ 245,436 $ 343,637 Right-of-use assets －buildings $ 295,631 $ 287,736 7,895 $ 295,631 $ 189,697 29,563 $ 219,260 $ 155,857 29,564 4,276 $ 189,697

(j) Investment property

(Continued)

38

QISDA CORPORATION Notes to the Parent-Company-Only Financial Statements

Carrying amounts: Balance at December 31, 2024 Balance at December 31, 2023 Fair value: Balance at December 31, 2024 Balance at December 31, 2023	Right-of-use assets －buildings
	$ 76,371 $ 105,934 $ 155,406 $ 158,653

Investment property comprises a number of commercial properties that the Company leased to third parties. The fair value of the investment property is determined by considering the discounted value of the cash flow that the Company expects to receive the sub-lease rent. The inputs, which are used in the fair value measurement, were classified to Level 3.

As of December 31, 2024 and 2023, investment property was not pledged as collateral for bank loans.

(k) Intangible assets

(i) The movements of cost and accumulated amortization of intangible assets were as follows:

Cost: Balance at January 1, 2024 Additions Reclassification Balance at December 31, 2024 Balance at January 1, 2023 Additions Reclassification Balance at December 31, 2023 Accumulated amortization: Balance at January 1, 2024 Amortization Balance at December 31, 2024 Balance at January 1, 2023 Amortization Balance at December 31, 2023 Carrying amounts: Balance at December 31, 2024 Balance at December 31, 2023	Computer software $ 350,014 - - $ 350,014 $ 349,774 240 - $ 350,014 $ 197,184 58,541 $ 255,725 $ 138,288 58,896 $ 197,184 $ 94,289 $ 152,830	Others 65,122 260 78,232 143,614 13,008 15,666 36,448 65,122 20,177 12,321 32,498 11,299 8,878 20,177 111,116 44,945	Total
			415,136 260 78,232
			493,628
			362,782 15,906 36,448
			415,136
			217,361 70,862
			288,223
			149,587 67,774
			217,361
			205,405
			197,775

(Continued)

39

QISDA CORPORATION Notes to the Parent-Company-Only Financial Statements

(ii) Amortization

The amortization of intangible assets is included in the following line items of the statement of comprehensive income:

Cost of sales Operating expenses Short-term borrowings Unsecured bank loans Unused credit facilities Interest rate interval	2024 $ 46,102 24,760 $ 70,862 December 31, 2024 $ 8,294,550 $ 16,704,650 0.68%~1.99%	2023
		44,720 23,054
		67,774
		December 31, 2023 6,500,000
		14,575,750
		1.63%~1.7059%

• (l) Short-term borrowings

• (m) Long-term debt

Unsecured bank loans Less: current portion of long-term debt Unused credit facilities Interest rate interval Maturity year	December 31, 2024 $ 26,540,471 (3,055,306) $ 23,485,165 $ 28,518,121 1.77%~2.1838% 2025~ 2029	December 31, 2023 21,930,804 (525,193)
		21,405,611
		22,183,839
		1.3%~2.023% 2024~ 2028

• (i) Collateral for bank borrowings

Please refer to note 8 for a description of the Company’s assets pledged as collateral to secure the bank loans.

• (ii) Low interest rate loan from government assistance

In early 2020, the Company has obtained the low interest rate loans from banks in accordance with “ Guidelines of Project Loans for Returning Overseas Taiwanese Businesses” . The preferential interest rate ranged from 1.30% to 1.425%. The difference between the related loan amount and the estimated fair value of the loan using the prevailing market interest rate ranged from 1.77% to 1.99% was recognized as deferred government grant. The deferred income was transferred to other income when the loan was paid off.

(Continued)

40

QISDA CORPORATION Notes to the Parent-Company-Only Financial Statements

(iii) Compliance with loan agreement

According to the syndicated loan agreement signed between the Company and the banks, the Company has promised to maintain certain financial ratios based on the Company’ s semiannual reviewed consolidated financial statements and annual audited consolidated financial statements. If the Company violates any of the related financial ratios, the Company should mend it in a specific period, and then the failure to maintain the required financial ratios during the amendment period would not be considered a default.

For the years ended December 31, 2024 and 2023, the Company’ s financial ratio was in compliance with the syndicated loan agreement.

(n) Bonds payable

The details of the Company’s secured corporate bonds were as follows:

Total secured corporate bonds issued Less: unamortized bond issuance cost Bonds payable－non-current	December 31, 2024 $ 3,000,000 (2,815) $ 2,997,185	December 31, 2023 3,000,000 (3,910) 2,996,090

On June 28, 2022, the Company issued $3,000,000 of secured corporate bonds at par value. The bonds have 5-year term and are repayable on maturity, with a fixed interest rate of 1.80% per annum, with simple interest and interest payable annually.

(o) Lease liabilities

The carrying amounts of lease liabilities were as follows:

The carrying amounts of lease liabilities were as follows:
Current Non-current Please refer to note 6(z) for the maturity analysis. The amounts recognized in profit or loss were as follows: Expenses relating to short-term leases Income from sub-leasing right-of-use assets Interest expense on lease liabilities	December 31, 2024 $ 143,029 $ 227,019 2024 $ 1,325 $ 155,312 $ 8,048	December 31, 2023
		139,704
		370,048
		2023
		3,784
		153,534
		10,326

The amounts recognized in the statement of cash flows for the Company were as follows:

Total cash outflow for leases	2024 $ 149,077	2023
		151,536

(Continued)

41

QISDA CORPORATION Notes to the Parent-Company-Only Financial Statements

(i) Real estate leases

The Company leases buildings for its office and factory. These leases typically run for a period of 2 to 10 years. The Company has to negotiate the new leased term and recognize relevant right-of-use assets and lease liabilities when the lease expires. Some of the leases include an option to renew the lease for an additional period of the same duration after the end of the contract term.

(ii) Other leases

The Company leases some transportation equipment with contract terms within one year. These leases are short-term and the Company has elected to apply exemption and not to recognize right-of-use assets and lease liabilities.

(p) Provisions

Balance at January 1 Provisions made Amount utilized Amount reversed Balance at December 31 Current Non-current	2024 $ 99,420 28,894 (15,805) (25,098) $ 87,411 $ 15,806 $ 71,605	2023 107,570 34,248 (16,426) (25,972) 99,420 16,426 82,994

Warranty provision is estimated based on historical warranty data associated with similar products and services. The Company expects to settle most of the warranty liability within three years from the date of the sale of the product.

(q) Operating lease —the Company acts as a lessor

The Company leased its land and buildings under operating leases. The future minimum lease payments under operating leases are as follows:

payments under operating leases are as follows:
Not later than 1 year Later than 1 year but not later than 5 years Later than 5 years	December 31, 2024 $ 142,968 583,744 145,936 $ 872,648	December 31, 2023
		141,814 359,234 19,112
		520,160

In 2024 and 2023, the related rental income amounted to $155,312 and $153,534, respectively, and － was recognized under non-operating income and loss other income.

(Continued)

42

QISDA CORPORATION Notes to the Parent-Company-Only Financial Statements

(r) Employee benefits

(i) Defined benefit plans

The reconciliation between the present value of defined benefit obligations and the net defined benefit liabilities (assets) for defined benefit plans was as follows:

Present value of defined benefit obligations Fair value of plan assets Net defined benefit liabilities	December 31, 2024 $ 598,249 (400,530) $ 197,719	December 31, 2023 647,327 (380,166) 267,161

The Company makes defined benefit plan contributions to the pension fund account at Bank of Taiwan that provides pension benefits for employees upon retirement. The plans (covered by the Labor Standards Law) entitle a retired employee to receive a payment based on years of service and average salary for the six months prior to the employee’s retirement.

1) Composition of plan assets

The pension fund (the “Fund”) contributed by the Company is managed and administered by the Bureau of Labor Funds of the Ministry of Labor (the Bureau of Labor Funds). According to the Regulations for Revenues, Expenditures, Safeguard and Utilization of the Labor Retirement Fund, with regard to the utilization of the Fund, minimum earnings shall be no less than the earnings attainable from two-year time deposits with interest rates offered by local banks.

As of December 31, 2024 and 2023, the Company’s labor pension fund account balance at Bank of Taiwan amounted to $400,530 and $380,166, respectively. Please refer to the website of the Bureau of Labor Funds for information on the labor pension fund assets including the asset portfolio and yield of the fund.

• 2) Movements in present value of defined benefit obligations

Defined benefit obligations at January 1 Current service costs and interest expense Remeasurement on the net defined benefit liabilities: －Actuarial gains arising from experience adjustments －Actuarial losses (gains) arising from changes in financial assumptions Benefits paid by the plan Benefits paid by employer Defined benefit obligations at December 31	2024 $ 647,327 11,402 (6,940) (21,037) (32,503) - $ 598,249	2023 716,938 12,804 (8,181) 8,145 (81,537) (842) 647,327

(Continued)

43

QISDA CORPORATION Notes to the Parent-Company-Only Financial Statements

3) Movements of fair value of plan assets

Fair value of plan assets at January 1 Interest income Remeasurement on the net defined benefit liabilities (assets) －Actuarial gains Contributions by the employer Benefits paid by the plan Fair value of plan assets at December 31	2024 $ 380,166 6,167 35,190 11,510 (32,503) $ 400,530	2023 439,897 7,523 1,804 12,479 (81,537) 380,166

• 4) Changes in the effect of the asset ceiling

In 2024 and 2023, there was no effect of the asset ceiling.

• 5) Expenses recognized in profit or loss

Current service costs Net interest expense on the net defined benefit liabilities Cost of sales Selling expenses Administrative expenses Research and development expenses	2024 $ 991 4,244 $ 5,235 $ 847 831 637 2,920 $ 5,235	2023
		541 4,740
		5,281
		907 814 654 2,906
		5,281

6) Actuarial assumptions

The principal assumptions of the actuarial valuation were as follows:

Discount rate Future salary increases rate	December 31, 2024 December 31, 2023 % 2.000 % 1.625 % 3.000 % 3.000

The Company expects to make contribution of $11,473 to the defined benefit plans in the year following December 31, 2024.

The weighted average duration of the defined benefit plans is 12.22 years.

(Continued)

44

QISDA CORPORATION Notes to the Parent-Company-Only Financial Statements

7) Sensitivity analysis

The following table summarizes the impact of a change in the assumptions on the present value of the defined benefit obligation on December 31, 2024 and 2023.

December 31, 2024 Discount rate Future salary change December 31, 2023 Discount rate Future salary change	Increase (decrease) in present value of defined benefit obligations 0.25% Increase 0.25% Decrease (13,468) 13,913 13,458 (13,101) (16,153) 16,698 16,129 (15,678)

Each sensitivity analysis considers the change in one assumption at a time, leaving the other assumptions unchanged. This approach shows the isolated effect of changing one individual assumption but does not take into account that some assumptions are related. The method used to carry out the sensitivity analysis is the same as the calculation of the net defined benefit liabilities recognized in the balance sheets.

(ii) Defined contribution plans

The Company contributes monthly an amount equal to 6% of each employee’s monthly wages to the employee’ s individual pension fund account at the Bureau of Labor Insurance in accordance with the provisions of the Labor Pension Act. Under this defined contribution plan, the Company has no legal or constructive obligation to pay additional amounts after contributing a fixed amount to the Bureau of Labor Insurance.

For the years ended December 31, 2024 and 2023, the Company recognized pension expenses of $90,132 and $92,713, respectively, in relation to the defined contribution plans.

(s) Income taxes

(i) The components of income tax expense were as follows:

Current income tax expense (benefit) Deferred income tax expense (benefit) Origination and reversal of temporary differences Changes in unrecognized deductible temporary differences and tax losses Deferred income tax expense Income tax expense	2024 $ 149,586 429,924 (414,799) 15,125 $ 164,711	2023 (44,735) (716,559) 767,261 50,702 5,967

(Continued)

45

QISDA CORPORATION Notes to the Parent-Company-Only Financial Statements

In 2024 and 2023, there was no income tax recognized directly in equity or other comprehensive income.

Reconciliation of income tax expense and income before income tax for 2024 and 2023 was as follows:

Income before income tax Income tax using the Company’s statutory tax rate Investment income recorded under equity method Gains (losses) on disposal of investments Surtax on undistributed earnings Tax-exempt dividend income Changes in unrecognized temporary differences and tax losses Others Income tax expense	2024 $ 2,328,664 $ 465,733 (334,988) 14,873 128,020 (96,928) (414,799) 402,800 $ 164,711	2023 2,981,700 596,340 (572,472) (54,625) - (87,572) 767,261 (642,965) 5,967

(ii) Deferred income tax assets and liabilities

• 1) Unrecognized deferred income tax assets and liabilities

Unrecognized deferred income tax assets:

Aggregate amount of temporary differences related to investments in subsidiaries Deductible temporary differences Unrecognized deferred income tax liabilities: Aggregate amount of temporary differences related to investments in subsidiaries	December 31, 2024 $ 1,210,375 1,557,601 $ 2,767,976 December 31, 2024 $ 2,967,955	December 31, 2023
		1,268,550 1,558,577
		2,827,127
		December 31, 2023
		2,612,307

As the Company is able to control the timing of the reversal of the temporary differences associated with investments in subsidiaries as of December 31, 2024 and 2023, and management considers that it is probable that the temporary differences will not reverse in the foreseeable future, such temporary differences are not recognized as deferred income tax assets and liabilities. In addition, as the Company determined that it is not probable that future taxable profits will be available against which the temporary differences and tax losses can be utilized, these items were not recognized as deferred income tax assets.

(Continued)

46

QISDA CORPORATION

Notes to the Parent-Company-Only Financial Statements

• 2) Recognized deferred income tax assets and liabilities

Changes in the amount of deferred income tax assets and liabilities for 2024 and 2023 were as follows:

Deferred income tax assets:

In 2024 Unrealized inter-company profits Deferred revenue Allowance for sales discounts Unrealized accrued expenses Others In 2023 Unrealized inter-company profits Deferred revenue Allowance for sales discounts Unrealized accrued expenses Others Deferred income tax liabilities: In 2024 Unrealized foreign exchange gains In 2023 Unrealized foreign exchange gains	Balance at January 1, 2024 $ 68,754 10,903 297,986 14,989 74,727 $ 467,359 Balance at January 1, 2023 $ 61,336 9,491 335,504 14,989 81,193 $ 502,513 Balance at January 1, 2024 $ (15,548) Balance at January 1, 2023 $ -	Recognized in profit or loss (25,202) 1,646 (31,399) - 34,994 (19,961) Recognized in profit or loss 7,418 1,412 (37,518) - (6,466) (35,154) Recognized in profit or loss 4,836 Recognized in profit or loss (15,548)	Balance at December 31, 2024 43,552 12,549 266,587 14,989 109,721 447,398 Balance at December 31, 2023 68,754 10,903 297,986 14,989 74,727 467,359 Balance at December 31, 2024 (10,712) Balance at December 31, 2023 (15,548)

(Continued)

47

QISDA CORPORATION Notes to the Parent-Company-Only Financial Statements

• (iii) The Company’ s income tax returns for the years through 2022 have been assessed by the R.O.C. tax authorities.

(iv) Global minimum top-up tax

The Company has applied a temporary mandatory relief from deferred tax accounting for the impacts of the top-up tax and accounts for it as a current tax when it is incurred. Please refer to note 4(s).

(t) Capital and other equity

(i) Common stock

As of December 31, 2024 and 2023, the Company’ s authorized shares of common stock consisted of 5,000,000 thousand shares, of which 1,927,447 thousand and 1,966,782 thousand shares were issued and outstanding, respectively. The par value of the Company’s common stock is NTD 10 per share.

The movements in outstanding shares of common stock were as follows (in thousands of shares):

Balance at January 1 Purchase of treasury stock Balance at December 31	Common stock	Common stock
	2024 1,966,782 (39,335) 1,927,447	2023
		1,966,782 -
		1,966,782

As of December 31, 2024 and 2023, the Company had issued 285 thousand units of global depository receipts (GDRs). The GDRs were listed on the Luxemburg Stock Exchange, and each GDR represents five common shares.

(ii) Treasury stock

On August 30, 2024, in order to maintain the Company’s credit and shareholders’ rights and interests, the Company’s Board of Directors resolved to repurchase its own common shares of 39,335 thousand shares as treasury stock, constituting 2% of the Company’s issued common stock. As of the completion date, October 24, 2024, a total of 39,335 thousand shares of treasury stock, amounting to $1,470,293, were repurchased.

On November 5, 2024, the Company’s Board of Directors resolved to retire 39,335 thousand shares of treasury stock, with the effective date of capital reduction set on November 20, 2024. All related registration process has since been completed.

(Continued)

48

QISDA CORPORATION

Notes to the Parent-Company-Only Financial Statements

(iii) Capital surplus

Share of changes in equity of associates Changes in ownership interests in subsidiaries Proceeds from disposal of forfeited employee stock managed by an employee stock ownership trust Claim for the disagreement right Difference between consideration and carrying amount arising from acquisition or disposal of shares of subsidiaries	December 31, 2024 $ 170,602 1,979,595 13,260 75 76,227 $ 2,239,759	December 31, 2023
		161,235 1,815,016 7,648 75 1
		1,983,975

Pursuant to the Company Act, any realized capital surplus is initially used to cover an accumulated deficit, and the balance, if any, could be transferred to common stock as stock dividends based on the original shareholding ratio or distributed as cash dividends based on a resolution approved by the stockholders. Realized capital surplus includes the premium derived from the issuance of shares of stock in excess of par value and donations from stockholders received by the Company. In accordance with the Regulations Governing the Offering and Issuance of Securities by Securities Issuers, distribution of stock dividends from capital surplus in any one year shall not exceed 10% of paid-in capital.

(iv) Unappropriated earnings and dividend policy

The Company’s articles of incorporation stipulate that at least 10% of annual earnings after deducting an accumulated deficit, if any, must be retained as a legal reserve until such retention equals the amount of paid-in capital. In addition, a special reserve should be set aside or reversed in accordance with applicable laws and regulations. The remaining balance of the annual net income, together with unappropriated earnings from previous years, if any, can be distributed as dividends after the earnings distribution plan proposed by the Board of Directors and approved during the stockholders’ meeting. The abovementioned distribution of earnings by way of cash dividends should be approved by the Company’s Board of Directors and then reported to the Company’s shareholders in its meeting.

The Company may distribute its legal reserve or capital surplus to shareholders by issuing new shares or by distributing cash according to article 241 of the Company Act. The abovementioned distribution of earnings by way of cash dividends could be approved by the Company’s Board of Directors and then reported to the Company’s shareholders in its meeting.

As the Company is a technology- and capital-intensive enterprise in its growing phase, the Company has adopted a remaining earnings appropriation method as its dividend policy in order to meet long-term capital needs and cash requirements of stockholders, and thereby maintain continuous development and steady growth.

The Company’s requirements for future expansion and cash flow are the primary factors that the Company considers when appropriating its earnings. The distribution ratio for cash dividends shall not be less than 10% of the total distribution.

(Continued)

49

QISDA CORPORATION Notes to the Parent-Company-Only Financial Statements

1) Legal reserve

If a company has no accumulated deficit, it may, pursuant to a resolution approved by the stockholders, distribute its legal reserve to shareholders by issuing new shares or by distributing cash for the portion in excess of 25% of the paid-in capital.

2) Special reserve

In accordance with the requirements issued by the FSC, a portion of earnings shall be allocated as special reserve during earnings distribution. The Company shall make allocation of special reserve for the amount of the current-period total net reduction of other shareholders’ equity. An equivalent amount of special reserve shall be allocated from the after-tax net profit in the period, plus items other than the after-tax net profit in the period that are included in the undistributed current-period earnings and the undistributed prior-period earnings. A portion of the undistributed prior-period earnings shall be reclassified to special earnings reserve (which does not qualify for earnings distribution) to account for cumulative changes to the net reduction of other shareholders’ equity pertaining to prior periods. The amounts of subsequent reversals pertaining to the net reduction of other shareholders’ equity shall qualify for additional distributions.

3) Earnings distribution

The appropriations of cash dividends of 2023 and 2022 earnings were approved by the Company’s Board of Directors on March 5, 2024 and March 6, 2023, respectively. Other appropriations of 2023 and 2022 earnings were approved by the shareholders during their meetings on May 29, 2024 and May 29, 2023, respectively. The resolved appropriations were as follows:

were as follows:
			2023 earnings					2022 earnings
		Dividends					Dividends
		per share					per share
		(in NTD)			Amount		(in NTD)		Amount
Legal reserve				$		-			832,491
Appropriation (reversal) of				$	(1,688,634)				4,243,165
special reserve
Dividends per share:
Cash dividends	$		1.20		2,360,139			2.00	3,933,564

On March 5, 2025, the appropriation of cash dividends of 2024 earnings was approved by the Company’s Board of Directors were as follows:

Dividends per share: Cash dividends	2024 earnings	2024 earnings
	Dividends per share (in NTD) $ 1.11	Amount
		2,139,466

(Continued)

50

QISDA CORPORATION Notes to the Parent-Company-Only Financial Statements

(v) Other equity items (net after tax)

1) Foreign currency translation differences

1)	Foreign currency translation differences
			2024	2023
	Balance at January 1	$	676,646	875,030
	Foreign exchange differences arising from translation
	of foreign operations		2,009,036	(198,384)
	Balance at December 31	$	2,685,682	676,646
2)	Unrealized gains (losses) on financial assets at fair value		through other	comprehensive
	income
			2024	2023
	Balance at January 1	$	(3,781,260)	(5,663,889)
	Unrealized gains (losses) from investments in
	equity instruments at fair value through
	other comprehensive income		(1,860,765)	1,466,613
	Disposal of financial assets at fair value through
	other comprehensive income		(137,343)	(256,167)
	Share of other comprehensive income (loss)
	of subsidiaries and associates		(177,357)	672,183
	Balance at December 31	$	(5,956,725)	(3,781,260)
3)	Remeasurement of defined benefit plans
			2024	2023
	Balance at January 1	$	(283,140)	(287,528)
	Remeasurement of the defined benefit plans		63,167	1,840
	Shares of remeasurement of the defined benefit plans
	of subsidiaries and associates accounted for using
	the equity method		53,425	2,548
	Balance at December 31	$	(166,548)	(283,140)

(u) Earnings per share (“EPS”)

• (i) Basic earnings per share

The basic earnings per share were calculated as the profit attributable to shareholders of the Company divided by the weighted-average number of ordinary shares outstanding as follows:

Profit attributable to shareholders of the Company Weighted-average number of common shares outstanding (in thousands) Basic earnings per share (in New Taiwan Dollar)	2024 $ 2,163,953 1,955,328 $ 1.11	2023
		2,975,733
		1,966,782
		1.51

(Continued)

51

QISDA CORPORATION Notes to the Parent-Company-Only Financial Statements

(ii) Diluted earnings per share 2024 Profit attributable to shareholders of the Company $ 2,163,953 Weighted-average number of common shares outstanding (in thousands) 1,955,328 Effect of dilutive potential common shares (in thousands): Remuneration to employee 6,743 Weighted-average number of common shares outstanding (including effect of dilutive potential common shares) (in thousands) 1,962,071 Diluted earnings per share (in New Taiwan Dollar) $ 1.10 (v) Revenue from contracts with customers (i) Disaggregation of revenue 2024 Primary geographical markets: Asia $ 42,342,535 Europe 7,450,774 Americas 26,740,506 Others 169,698 $ 76,703,513 Major products/services lines: Electronic products $ 75,634,781 Other design and development service 1,068,732 $ 76,703,513 (ii) Contract balances December 31, 2024 December 31, 2023 Notes and accounts receivable (including related parties) $ 27,855,371 23,079,903 Less: loss allowance (15,703) (47,079) $ 27,839,668 23,032,824 Contract liabilities $ 565,404 781,653

2023 2,975,733 1,966,782 9,059 1,975,841 1.51 2023 43,072,678 7,988,172 24,168,482 196,147 75,425,479 74,266,997 1,158,482 75,425,479 January 1, 2023 21,725,709 (60,060) 21,665,649 702,353

For details on notes and accounts receivable and related loss allowance, please refer to note 6(d).

The amounts of revenue recognized for the years ended December 31, 2024 and 2023 that was included in the contract liability balances at January 1, 2024 and 2023 were $162,624 and $182,070, respectively.

(Continued)

52

QISDA CORPORATION Notes to the Parent-Company-Only Financial Statements

(w) Remuneration to employees and directors

The Company’s Article of Incorporation requires that earnings shall first to be offset against any deficit, then, a range from 5% to 20% will be distributed as remuneration to its employees and no more than 1% to its directors. Employees who are entitled to receive the abovementioned employee remuneration, in shares or cash, include the employees of the subsidiaries of the Company who meet certain specific requirement.

For the years ended December 31, 2024 and 2023, the Company estimated its remuneration to employees amounting to $185,212 and $245,716, respectively, and the remuneration to directors amounting to $5,664 and $6,800, respectively. The abovementioned estimated amounts are calculated based on the net profits before tax of each period (excluding the remuneration to employees and directors), multiplied by a certain percentage of the remuneration to employees and directors. The estimations are recognized as cost of sales or operating expenses. If the actual amounts differ from the estimated amounts, the differences shall be accounted as changes in accounting estimates and recognized as profit or loss in next year.

The estimated remuneration to employees and directors for 2024 and 2023 were the same as the amount approved by the Company’ s Board of Directors on March 5, 2025 and March 5, 2024, respectively, and paid in cash. Related information is available on the Market Observation Post System website of the Taiwan Stock Exchange.

(x) Non-operating income and loss

• (i) Interest income

Interest income from bank deposits (ii) Other income Rental income Dividend income Government grants income (iii) Other gains and losses, net Gains (losses) on disposal of property, plant and equipment Gains (losses) on disposal of investments (note 6(g)) Foreign currency exchange gains (losses) Losses on financial assets and liabilities at fair value through profit or loss Others	2024 $ 77,788 2024 $ 155,312 484,639 13,219 $ 653,170 2024 $ (573) (74,365) (124,071) (145,990) 31,140 $ (313,859)	2023 99,692 2023 153,534 437,858 7,282 598,674 2023 2,379 273,124 16,124 (34,954) 28,148 284,821

(Continued)

53

QISDA CORPORATION Notes to the Parent-Company-Only Financial Statements

(iv) Finance costs Interest expense of bank loans and corporate bonds Interest expense on lease liabilities	2024 $ (699,484) (8,048) $ (707,532)	2023 (657,732) (10,326) (668,058)

(y) Financial instruments (i) Categories of financial instruments 1) Financial assets December 31, 2024 Financial assets at fair value through profit or loss $ 520,804 Financial assets at fair value through other comprehensive income 7,817,376 Financial assets measured at amortized cost: Cash and cash equivalents 1,861,905 Notes and accounts receivable and other receivables (including related parties) 27,846,518 Other financial assets－non-current 48,931 Subtotal 29,757,354 Total $ 38,095,534 2) Financial liabilities December 31, 2024 Financial liabilities at fair value through profit or loss $ 9,344 Financial liabilities measured at amortized cost: Short-term borrowings 8,294,550 Notes and accounts payable and other payables (including related parties) 30,847,831 Lease liabilities (including current portion and related parties) 370,048 Bonds payable 2,997,185 Long-term debt (including current portion) 26,540,471 Other non-current liabilities－guarantee deposits 9,972 Subtotal 69,060,057 Total $ 69,069,401	December 31, 2023
	133,486
	9,709,736
	2,532,956 23,044,701 38,566
	25,616,223
	35,459,445
	December 31, 2023
	-
	6,500,000 28,729,237 509,752 2,996,090 21,930,804 9,781
	60,675,664
	60,675,664

(Continued)

54

QISDA CORPORATION Notes to the Parent-Company-Only Financial Statements

(ii) Fair value information

• 1) Financial instruments not measured at fair value

The Company considers that the carrying amounts of financial assets and financial liabilities measured at amortized cost approximate their fair values.

• 2) Financial instruments measured at fair value

The financial department of the Company evaluates the fair value of financial instrument and utilizes the assistance from external experts or financial institutions for the evaluation of fair value when necessary, and regularly revises the inputs and makes essential adjustments on the fair value to confirm the evaluation results are reasonable.

The financial instruments at fair value through profit and loss and financial assets at fair value through other comprehensive income are measured at fair value on a recurring basis. The table below analyzes financial instruments that are measured at fair value subsequent to initial recognition, grouped into Levels 1 to 3 based on the degree to which the fair value is observable. The different levels have been defined as follows:

• a) Level 1: quoted prices (unadjusted) in active markets for identified assets or liabilities.

• b) Level 2: inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly (i.e., as prices) or indirectly (i.e., derived from prices).

• c) Level 3: inputs for the assets or liabilities that are not based on observable market data (unobservable inputs).

Level 1 Financial assets at fair value through profit and loss: Derivative instruments－foreign currency forward contracts $ - Derivative instruments－foreign exchange swaps - Domestic listed stocks 164,400 Privately held equity securities - $ 164,400 Financial assets at fair value through other comprehensive income: Domestic listed stocks $ 7,777,376 Privately held equity securities - $ 7,777,376 Financial liabilities at fair value through profit and loss: Derivative instruments－foreign currency forward contracts $ -		December 31, 2024	December 31, 2024
		Fair Value
		Level 2 3,755 1,608 - - 5,363 - - - 9,344	Level 3 - - - 351,041 351,041 - 40,000 40,000 -	Total 3,755 1,608 164,400 351,041
				520,804
				7,777,376 40,000
				7,817,376
				9,344

(Continued)

55

QISDA CORPORATION Notes to the Parent-Company-Only Financial Statements

Financial assets at fair value through profit and loss: Derivative instruments－foreign currency forward contracts Privately held equity securities Financial assets at fair value through other comprehensive income: Domestic listed stocks Privately held equity securities		December 31, 2023	December 31, 2023
		Fair Value
	Level 1 $ - - $ - $ 9,707,602 - $ 9,707,602	Level 2 37,360 - 37,360 - - -	Level 3 - 96,126 96,126 - 2,134 2,134	Total 37,360 96,126
				133,486
				9,707,602 2,134
				9,709,736

• 3) Valuation techniques and assumptions used in fair value measurement

• a) Non-derivative financial instruments

The fair value of financial instruments traded in active liquid markets is determined with reference to quoted market prices.

For listed stock with standard terms and conditions and traded in active markets. The fair value is based on quoted market prices.

The fair value of privately held equity securities is estimated by using the market approach and is determined by reference to valuations of similar companies, net worth and recent operating activities. The significant unobservable inputs is primarily the liquidity discounts. No quantitative information is disclosed due to that the possible changes in liquidity discounts would not cause significant potential financial impact.

• b) Derivative financial instruments

The fair value of derivative financial instruments is determined using a valuation technique generally accepted by market participants. The fair value of foreign currency forward contracts and foreign exchange swaps is usually determined by the forward exchange rate.

• 4) Transfer between levels of the fair value hierarchy

The equity securities of ITH CORP. which has been classified to financial assets at fair value through profit or loss, were transferred from Level 3 to Level 1 in 2024 as ITH CORP. became a listed company on Taiwan Stock Exchange beginning on November 26, 2024.

There was no transfer among fair value hierarchies for the year ended December 31, 2023.

(Continued)

56

QISDA CORPORATION Notes to the Parent-Company-Only Financial Statements

• 5) Movement in financial assets included in Level 3 fair value hierarchy

Financial assets at fair value through profit or loss:

Financial assets at fair value through profit or loss:
Balance at January 1 Additions Transferred out from Level 3 Recognized in changes in profit or loss Balance at December 31	2024 $ 96,126 355,000 (96,126) (3,959) $ 351,041	2023
		- 96,126 - -
		96,126

Financial assets at fair value through other comprehensive income:

Balance at January 1 Additions Recognized in other comprehensive loss Balance at December 31	2024 $ 2,134 40,000 (2,134) $ 40,000	2023 155,170 60,528 (213,564) 2,134

(z) Financial risk management

The Company is exposed to credit risk, liquidity risk, and market risk (including currency risk, interest rate risk, and other market price risk). The Company has disclosed the information on exposure to the aforementioned risks and the Company’s policies and procedures to measure and manage those risks as well as the quantitative information below.

The Company’s Board of Directors is responsible for developing and monitoring the Company’s risk management policies. The Company’ s risk management policies are established to identify and analyze the risks faced by the Company, to set appropriate risk limits and controls, and to monitor adherence to the controls. Risk management policies and systems are reviewed regularly to reflect changes in market conditions and the Company’s operations.

The Company’ s management monitors and reviews financial activities in accordance with procedures required by relevant regulations and internal controls. Internal auditors undertake both regular and ad hoc reviews of risk management controls and procedures, the results of which are reported to the Company’s Board of Directors.

(i) Credit risk

Credit risk is the risk of financial loss to the Company if a customer or counterparty of a financial instrument fails to meet its contractual obligations, and arises principally from the Company’s cash and cash equivalents, derivative instruments, receivables from customers, and other receivables. The maximum exposure to credit risk is equal to the carrying amount of the Company’s financial assets.

The Company maintains cash and enters into derivative transactions with various reputable financial institutions; therefore, the exposure related to potential default by those counterparties is not considered significant.

(Continued)

57

QISDA CORPORATION Notes to the Parent-Company-Only Financial Statements

The majority of the Company’s customers are well-known international companies with high financial transparency in the electronics industry. As of December 31, 2024 and 2023, 83% and 74%, respectively, of the Company’s notes and accounts receivable were concentrated in the top five customers. In order to reduce credit risk of accounts receivable, the Company has established a credit policy under which each customer is analyzed individually for creditworthiness for the purpose of setting the credit limit. Additionally, the Company continuously evaluates the credit quality of customers and utilizes insurance to minimize the risk.

The Company’s policy provides financial guarantees only to wholly owned subsidiaries. As of December 31, 2024 and 2023, except for its subsidiaries, the Company did not provide any other guarantees and endorsements.

(ii) Liquidity risk

Liquidity risk is the risk that the Company will encounter difficulty in settling its financial liabilities by delivering cash or other financial assets. The Company manages liquidity risk by monitoring regularly the current and mid- to long-term cash demand, maintaining adequate cash and banking facilities, and ensuring compliance with the terms of the loan agreements. As of December 31, 2024 and 2023, the Company had unused credit facilities of $45,222,771 and $35,837,089, respectively.

The table below summarizes the maturity profile of the Company’s financial liabilities based on contractual undiscounted payments, including principal and interest.

December 31, 2024 Non-derivative financial liabilities: Short-term borrowings with floating interest rates Notes and accounts payable Other payables Lease liabilities Bonds payable with fixed interest rates Long-term debt with floating interest rates Guarantee deposits Derivative financial instruments: Foreign currency forward contracts: Outflow Inflow Foreign exchange swaps: Outflow Inflow December 31, 2023 Non-derivative financial liabilities: Short-term borrowings with floating interest rates Notes and accounts payable Other payables Lease liabilities Bonds payable with fixed interest rates Long-term debt with floating interest rates Guarantee deposits Derivative financial instruments: Foreign currency forward contracts: Outflow Inflow	Contractual cash flows $ 8,328,684 29,346,838 1,500,993 378,953 3,135,000 28,141,480 9,972 $ 70,841,920 $ 2,589,389 (2,583,800) 424,597 (426,205) $ 3,981 $ 6,510,098 26,328,292 2,400,945 526,705 3,189,000 23,452,483 9,781 $ 62,417,304 $ 1,394,053 (1,431,413) $ (37,360)	Within 6 months 7,728,654 29,346,838 1,500,993 73,876 27,000 3,231,808 - 41,909,169 2,589,389 (2,583,800) - - 5,589 6,510,098 26,328,292 2,400,945 73,876 27,000 499,090 - 35,839,301 1,394,053 (1,431,413) (37,360)	6-12 months 600,030 - - 74,643 27,000 315,313 - 1,016,986 - - 424,597 (426,205) (1,608) - - - 73,876 27,000 435,507 - 536,383 - - -	1-2 years - - - 145,537 54,000 8,919,872 3,291 9,122,700 - - - - - - - - 148,519 54,000 6,205,116 3,101 6,410,736 - - -	2-5 years More than 5 years - - - - - - 84,897 - 3,027,000 - 15,674,487 - 125 6,556 18,786,509 6,556 - - - - - - - - - - - - - - - - 230,434 - 3,081,000 - 16,312,770 - 125 6,555 19,624,329 6,555 - - - - - - (Continued)	More than 5 years - - - - - - 6,556
						6,556
						- - - -
						-
						- - - - - - 6,555
						6,555
						- -
						-

58

QISDA CORPORATION Notes to the Parent-Company-Only Financial Statements

The Company does not expect that the cash flows included in the maturity analysis would occur significantly earlier or at significantly different amounts.

• (iii) Market risk

Market risk is the risk that changes in market prices, such as foreign exchange rates, interest rates, and equity prices, will affect the Company’ s income or the value of its financial instruments. The objective of market risk management is to manage and control market risk exposures within acceptable parameters, while optimizing the return.

The Company utilizes derivative financial instruments to manage market risk and the volatility of profit or loss. All such transactions are carried out within the guidelines set by the Company’s Board of Directors.

1) Foreign currency risk

The Company utilizes foreign currency forward contracts and foreign exchange swaps to hedge its foreign currency exposure with respect to its sales and purchases. These financial instruments help to reduce, but do not eliminate, the impact of foreign currency exchange rate movements.

The Company’s exposure to foreign currency risk arises from cash and cash equivalents, notes and accounts receivable (including related-party transactions), notes and accounts payable (including related-party transactions), other receivables (including related-party transactions), other payables (including related-party transactions), and loans and borrowings that are denominated in a currency other than the functional currency of Company. At the reporting date, the carrying amounts of the Company’ s significant monetary assets and liabilities denominated in a currency other than the functional currency of the Company and the sensitivity analysis were as follows:

Financial assets USD Financial liabilities		December 31, 2024	December 31, 2024	December 31, 2024
	Foreign currency (in thousands) $ 888,520 893,517 4,507,600	Exchange rate 32.785 32.785 0.2099	NTD (in thousands) 29,130,128 29,293,955 946,145	Change in magnitude Pre-tax effect on profit or loss % 1 291,301 % 1 292,940 % 1 9,461
USD JPY

Financial assets USD Financial liabilities		December 31, 2023	December 31, 2023	December 31, 2023
	Foreign currency (in thousands) $ 816,760 860,117	Exchange rate 30.750 30.750	NTD (in thousands) 25,115,370 26,448,598	Change in magnitude Pre-tax effect on profit or loss % 1 251,154 % 1 264,486
USD

(Continued)

59

QISDA CORPORATION Notes to the Parent-Company-Only Financial Statements

As the Company deals in diverse foreign currencies, gains and losses on foreign exchange were summarized as a single amount. Please refers to note 6(x) for the aggregate of realized and unrealized foreign exchange gains for the years ended December 31, 2024 and 2023.

2) Interest rate risk

The Company’s short-term borrowings and long-term debt carried floating interest rates. To manage the interest rate risk, the Company periodically assesses the interest rates of bank loans and maintains good relationships with financial institutions to obtain lower financing costs. The Company also strengthens the management of working capital to reduce the dependence on bank loans as well as the risk arising from fluctuation of interest rates.

The following sensitivity analysis is based on the risk exposure to floating-interest-rate liabilities on the reporting date. The sensitivity analysis assumes the liabilities recorded at the reporting date had been outstanding for the entire period.

If interest rates had been 100 basis points (1%) higher/lower, with all other variables held constant, pre-tax income for the years ended December 31, 2024 and 2023 would have been $348,350 and $284,308, respectively, lower/higher, which mainly resulted from the borrowings with floating interest rates.

3) Other market price risk

The Company is exposed to the risk of price fluctuation in the securities market due to the equity investment. The Company supervises the equity price risk actively and manages the risk based on fair value.

Assuming a hypothetical increase or decrease of 5% in equity prices of the equity investments at each reporting date, the other comprehensive income for the years ended December 31, 2024 and 2023, would have increased or decreased by $390,869 and $485,487, respectively.

(aa) Capital management

In consideration of the industry dynamics and future developments, as well as external environment factors, the Company maintains an optimal capital structure to enhance long-term shareholder value by managing its capital in a manner to ensure that it has sufficient and necessary financial resources to fund its working capital needs, capital expenditures, repayment of debts, dividend payments, and other business requirements for continuing operations and to reward shareholders and take into consideration the interests of other stakeholders. The Company monitors its capital through reviewing the liability-to-equity ratio periodically.

The Company’s liability-to-equity ratio at the end of each reporting period was as follows:

Total liabilities Total equity Liability-to-equity ratio	December 31, 2024 $ 71,614,558 $ 35,562,019 % 201.38	December 31, 2023 63,507,616 37,057,358 % 171.38 (Continued)

60

QISDA CORPORATION Notes to the Parent-Company-Only Financial Statements

(ab) Investing and financing activities not affecting current cash flow

• (i) Please refer to note 6(i) for a description of acquisition of right-of-use assets under lease for the year ended December 31, 2023.

• (ii) Reconciliation of liabilities arising from financing activities was as follows:

Short-term borrowings Long-term debt Bonds payable Lease liabilities Total liabilities from financing activities Short-term borrowings Long-term debt Bonds payable Lease liabilities Total liabilities from financing activities	January 1, 2024 $ 6,500,000 21,930,804 2,996,090 509,752 $ 31,936,646 January 1, 2023 $ 1,870,000 27,499,908 2,995,015 637,277 $ 33,002,200	Cash flows 1,794,550 4,613,924 - (139,704) 6,268,770 Cash flows 4,630,000 (5,559,986) - (137,426) (1,067,412)	Non-cash	changes Others - (4,257) 1,095 - (3,162) changes Others - (9,118) 1,075 - (8,043)	December 31, 2024
			Additions - - - - - Non-cash
					8,294,550 26,540,471 2,997,185 370,048
					38,202,254
					December 31, 2023
			Additions - - - 9,901 9,901
					6,500,000 21,930,804 2,996,090 509,752
					31,936,646

7. Related-party transactions

• (a) Name and relationship with related parties

The followings are subsidiaries and related parties that have had transactions with the Company during the reporting periods.

Name of related party Relationship with the Company Qisda Sdn. Bhd. (“QLPG”) The Company’s subsidiary Qisda America Corp. (“QALA”) The Company’s subsidiary Qisda Japan Co., Ltd. (“QJTO”) The Company’s subsidiary BenQ Corp. (“BenQ”) The Company’s subsidiary BenQ Material Corp. (“BMC”) The Company’s subsidiary BenQ Dialysis Technology Corp. (“BDT”) The Company’s subsidiary Qisda Optronics Corp. (“QTOS”) The Company’s subsidiary Qisda (L) Corp. (“QLLB”) The Company’s subsidiary Darly Venture (L) Ltd. (“Darly”) The Company’s subsidiary

(Continued)

61

QISDA CORPORATION Notes to the Parent-Company-Only Financial Statements

Name of related party

Darly Venture Inc. (“APV”) BenQ BM Holding Cayman Corp. (“BBHC”) BenQ Biotech (Shanghai) Co., Ltd. (“BBC”) Guangxi Youshan Medical Technology Co., Ltd. (“Youshan”) Wangcheng Medical Technology(Chengdu) Co., Ltd. (“Wangcheng”) Shanghai Filter Technology Co., Ltd. (“Filter”) Shanghai Zhenglang Medical Equipment Co., Ltd. (“Zhenglang”) Shanghai Perfusion Medical Technology Co., Ltd. (“Perfusion”) Qisda Vietnam Co., Ltd. (“QVH”) Qisda (Suzhou) Co., Ltd. (“QCSZ”) Qisda (Hong Kong) Limited (“QCHK”) BenQ Medical (Shanghai) Co., LTD. (“BMSH”) Qisda (Shanghai) Co., Ltd. (“QCSH”) Qisda Electronics (Suzhou) Co., Ltd. (“QCES”) Qisda Optronics (Suzhou) Co., Ltd. (“QCOS”) Qisda Precision Industry (Suzhou) Co., Ltd. (“QCPS”) ACE Energy Co., Ltd. (“AEG”) BenQ Europe B.V. (“BQE”) BenQ Asia Pacific Corp. (“BQP”) BenQ America Corporation (“BQA”) BenQ Latin America Corp. (“BQL”) Mainteq Europe B.V. (“MQE”) Darly2 Venture Co., Ltd. (“Darly 2”) BenQ Intelligent Technology (Hong Kong) Co., Ltd. (“BQHK_HLD”) BenQ INFTY Lab Ltd. (“INF”) BenQ Guru Holding Limited (“GSH”) BenQ Medical Technology Corp. (“BMTC”) PT BenQ Teknologi Indonesia (“BQid”) BenQ Korea Co., Ltd. (“BQkr”) BenQ Japan Co., Ltd. (“BQjp”) BenQ Australia Pty Ltd. (“BQau”) BenQ (M.E.) FZE (“BQme”) BenQ India Private Ltd. (“BQin”) BenQ Singapore Pte Ltd. (“BQsg”) BenQ Service & Marketing (M) Sdn. Bhd (“BQmy”) BenQ (Thailand) Co., Ltd. (“BQth”)

Relationship with the Company The Company’s subsidiary The Company’s subsidiary The Company’s subsidiary The Company’s subsidiary The Company’s subsidiary

The Company’s subsidiary The Company’s subsidiary

The Company’s subsidiary

The Company’s subsidiary The Company’s subsidiary The Company’s subsidiary The Company’s subsidiary The Company’s subsidiary The Company’s subsidiary The Company’s subsidiary The Company’s subsidiary The Company’s subsidiary The Company’s subsidiary The Company’s subsidiary The Company’s subsidiary The Company’s subsidiary The Company’s subsidiary The Company’s subsidiary The Company’s subsidiary

The Company’s subsidiary The Company’s subsidiary The Company’s subsidiary The Company’s subsidiary The Company’s subsidiary The Company’s subsidiary The Company’s subsidiary The Company’s subsidiary The Company’s subsidiary The Company’s subsidiary The Company’s subsidiary The Company’s subsidiary

(Continued)

62

QISDA CORPORATION Notes to the Parent-Company-Only Financial Statements

Name of related party

BenQ Vietnam Co., Ltd. (BQvn) BenQ Technology (Shanghai) Co., Ltd. (“BQls”) ShengCheng Trading (Shanghai) Co., Ltd. (“BQsha_EC2”) BenQ Intelligent Technology (Shanghai) Co., Ltd. (“BQC_RO”) BenQ Guru Software Co., Ltd. (“GSS”) Metaguru Corporation (“MRU”) BenQ Canada Corp. (“BQca”) BenQ Mexico S. de R.L. de C.V. (“BQmx”) Joytech LLC. (“Joytech”) Vividtech LLC. (“Vividtech”) MaxGen Comercio Industrial Imp E Exp Ltda. (“MaxGen”) BenQ Service de Mexico S. de R.L. de C.V. (“BQsm”) BenQ UK Limited (“BQuk”) BenQ Deutschland GmbH (“BQde”) BenQ Iberica S.L. Unipersonal (“BQib”) BenQ Austria GmbH (“BQat”) BenQ Benelux B.V. (“BQnl”) BenQ Italy S.R.L. (“BQit”) BenQ France SAS (“BQfr”) BenQ Nordic A.B. (“BQse”) BenQ LLC. (“BQru”) BenQ BM Holding Corp. (“BBM”) Darly Consulting Corporation (“Darly C”) Highview Investments Limited (“Highview”) Asiaconnect International Company (“Asiaconnect”) LILY Medical Corporation (“LILY”) BenQ AB Dentcare Corporation (“BABD”) BenQ HealthCare Corporation (“BHS”) EASTECH CO., LTD. (“EASTECH“) BenQ Medical Technology (Shanghai) Ltd. (“BMTS”) Concord Medical Co., Ltd. (“Concord”) BenQ Intelligent (Shanghai) Medical Co., LTD. (“BQSH”) (formerly LILY Medical (Suzhou) Co., Ltd. (“ALS”)) New Best Hearing International Trade Co., Ltd. (“NBHIT”) Concord Healthcare Co., Ltd. (“CCHC”) CKCARE Co., Ltd. (“CKCARE”) BenQ Materials (L) Co. (“BMLB”) Sigma Medical Supplies Corp. (“SGM”)

Relationship with the Company The Company’s subsidiary The Company’s subsidiary The Company’s subsidiary The Company’s subsidiary

The Company’s subsidiary The Company’s subsidiary The Company’s subsidiary The Company’s subsidiary The Company’s subsidiary The Company’s subsidiary The Company’s subsidiary The Company’s subsidiary The Company’s subsidiary The Company’s subsidiary The Company’s subsidiary The Company’s subsidiary The Company’s subsidiary The Company’s subsidiary The Company’s subsidiary The Company’s subsidiary The Company’s subsidiary The Company’s subsidiary The Company’s subsidiary The Company’s subsidiary The Company’s subsidiary The Company’s subsidiary The Company’s subsidiary The Company’s subsidiary The Company’s subsidiary The Company’s subsidiary The Company’s subsidiary The Company’s subsidiary

The Company’s subsidiary The Company’s subsidiary The Company’s subsidiary The Company’s subsidiary The Company’s subsidiary

(Continued)

63

QISDA CORPORATION Notes to the Parent-Company-Only Financial Statements

Relationship with the Company The Company’s subsidiary The Company’s subsidiary The Company’s subsidiary The Company’s subsidiary The Company’s subsidiary The Company’s subsidiary The Company’s subsidiary The Company’s subsidiary

Name of related party

Suzhou Sigma Medical Supplies Co., Ltd. (“SMSZ”) The Company’s subsidiary Genejet Biotech Co., Ltd. (“GJB”) The Company’s subsidiary Cenefom Corp. (“CENEFOM”) The Company’s subsidiary BenQ Material (Suzhou) Co., Ltd. (“BMS”) The Company’s subsidiary Daxon Biomedical (Suzhou) Co., Ltd. (“DTB”) The Company’s subsidiary BenQ Materials Medical Supplies (Suzhou) Co., Ltd. (“BMM”) The Company’s subsidiary BenQ Materials (Wuhu) Co., Ltd. (“BMW”) The Company’s subsidiary

BenQ Medical Aesthetics Materials Technology (Wuhu) Co., Ltd. (“BME”)

WEB-PRO Corporation (“WPC”) Beyond Top Pte. Ltd. (“WPSG”) Web-Pro (Vietnam) Co., Ltd. (“WPVN”) Nanjing BenQ Hospital Co., Ltd. (“NMH”) Suzhou BenQ Hospital Co., Ltd. (“SMH”) BenQ Hospital Management Consulting (Nanjing) Co., Ltd. (“NMHC”)

The Company’s subsidiary The Company’s subsidiary The Company’s subsidiary The Company’s subsidiary The Company’s subsidiary The Company’s subsidiary

BenQ Healthcare Consulting Corporation (“BHCC”) The Company’s subsidiary Suzhou BenQ Investment Co., Ltd. (“BIC”) The Company’s subsidiary Partner Tech Corp. (“PTT”) The Company’s subsidiary Partner-Tech Europe GmbH (“PTE”) The Company’s subsidiary Partner Tech Middle East FZCO (“PTME”) The Company’s subsidiary Partner Tech France (“PTF”) The Company’s subsidiary Partner Tech UK Corp., Ltd. (“PTUK”) The Company’s subsidiary P&S Investment Holding Co., Ltd. (B.V.I.) The Company’s subsidiary Partner Tech (Shanghai) Co., Ltd. (“PTCM”) The Company’s subsidiary Partner Tech USA Inc. (“PTU”) The Company’s subsidiary Webest Solution Corporation (“WEBEST”) The Company’s subsidiary Mace Digital Corporation (“PTMG”) The Company’s subsidiary Sloga Team D.o.o. (“Sloga”) The Company’s subsidiary Retail Solution & System S.L. (“RSS”) The Company’s subsidiary E-POS International LLC (“E-POS”) The Company’s subsidiary Epoint Systems Pte. Ltd. (“PTSE”) The Company’s subsidiary Epoint Systems Sdn. Bhd. (“PTMY”) The Company’s subsidiary Cresson Inc. (“PTJP”) The Company’s subsidiary Partner Tech Africa Pacific Corp. The Company’s subsidiary WiXtar Corporation (“WiXtar”) The Company’s subsidiary Corex (Pty) Ltd. (“Corex”) The Company’s subsidiary Ace Pillar Co., Ltd. (“ACE”) The Company’s subsidiary Cyber South Management Ltd. (“Cyber South”) The Company’s subsidiary

(Continued)

64

QISDA CORPORATION Notes to the Parent-Company-Only Financial Statements

Name of related party

Tianjin Ace Pillar Co., Ltd. Hong Kong Ace Pillar Enterprise Company Limited BlueWalker GmbH (“BWA”) Standard Technology Corp. (“STC”) Standard Technology Corp. (“STCBVI”) Standard International Trading (Shanghai) Co., Ltd. Proton Inc. (“Proton”) Ace Tek (HK) Holding Co., Ltd. (“Ace Tek”) Suzhou Super Pillar Automation Equipment Co., Ltd. Grace Transmission (Tianjin) Co., Ltd. Advancedtek Ace (TJ) Inc. Transpak Equipment Corporation (“TEKPAK”) DFI Inc. (“DFI”) DFI AMERICA, LLC DFI Co., Ltd. Yan Tong Technology Ltd. (“Yan Tong”) Diamond Flower Information (NL) B.V. Brainstorm Corporation (“Brainstorm”) Yan Ying Hao Trading (ShenZhen) Co., Ltd. (“DYTH”) Aewin Technologies Co., Ltd (“AEWIN”) Wise Way Aewin Tech Inc. Bright Profit Aewin Beijing Technologies Co., Ltd. (“Aewin Beijing”) Aewin (Shenzhen) Technologies Co., Ltd. K2 International Medical Inc. (“K2”) K2 Medical (Thailand) Co., Ltd. K2 (Shanghai) International Medical Inc. (“K2SH”) PT. Frismed Hoslab Indonesia (“K2 Indonesia”) ERA Bioteq Enterprise Co., Ltd. (“ERA”) Data Image Corporation (“DIC”) Data Image (Mauritius) Corporation (“DICMR”) Data Image (Suzhou) Corporation DIVA Laboratories. Ltd. (“DIVA”) DIVA Laboratories GmbH DIVA Laboratories U.S., LLC Panoramic Imaging Solutions Inc. Diva Capital Inc. Diva Holding Inc.

Relationship with the Company

The Company’s subsidiary The Company’s subsidiary The Company’s subsidiary The Company’s subsidiary The Company’s subsidiary The Company’s subsidiary The Company’s subsidiary The Company’s subsidiary The Company’s subsidiary The Company’s subsidiary The Company’s subsidiary The Company’s subsidiary The Company’s subsidiary The Company’s subsidiary The Company’s subsidiary The Company’s subsidiary The Company’s subsidiary The Company’s subsidiary The Company’s subsidiary The Company’s subsidiary The Company’s subsidiary The Company’s subsidiary The Company’s subsidiary The Company’s subsidiary The Company’s subsidiary The Company’s subsidiary The Company’s subsidiary The Company’s subsidiary The Company’s subsidiary The Company’s subsidiary The Company’s subsidiary The Company’s subsidiary The Company’s subsidiary The Company’s subsidiary The Company’s subsidiary The Company’s subsidiary The Company’s subsidiary The Company’s subsidiary The Company’s subsidiary

(Continued)

65

QISDA CORPORATION Notes to the Parent-Company-Only Financial Statements

Relationship with the Company The Company’s subsidiary The Company’s subsidiary

Name of related party

Suzhou Diva Lab. Inc. Expert Alliance Systems & Consultancy (HK) Co., Ltd. (“EASC”) Expert Alliance Smart Technology Co., Ltd. Topview Optronics Corporation (“Topview”)

Expert Alliance Smart Technology Co., Ltd. The Company’s subsidiary Topview Optronics Corporation (“Topview”) Prior to June 30, 2023, Topview was a subsidiary of the Company. Starting June 30, 2023, Topview became an associate of the Company. Messoa Technologies Inc. (“Messoa”) Prior to June 30, 2023, Messoa was a subsidiary of the Company. Starting June 30, 2023, Messoa became an associate of the Company. Messoa Technologies Inc. (“Messoa USA”) Prior to June 30, 2023, Messoa USA was a subsidiary of the Company. Starting June 30, 2023, Messoa USA became an associate of the Company. Metaage Corporation (“MTG”) The Company’s subsidiary Global Intelligence Network Co., Ltd. (“Ginnet”) The Company’s subsidiary Epic Cloud Co., Ltd. (“Epic Cloud”) The Company’s subsidiary Grandsys Inc. (“Grandsys”) The Company’s subsidiary Grandsys Technology & Service Corp. The Company’s subsidiary SYSAGE TECHNOLOG (SHANGHAI) CO., LTD. The Company’s subsidiary AdvancedTEK International Corp. (“AdvancedTEK”) The Company’s subsidiary DSI Group Co., Ltd. (“Statinc”) The Company’s subsidiary APEO Human Capital Services Corp. (“APEO”) The Company’s subsidiary DKABio Co., Ltd. (“Datta”) The Company’s subsidiary Owl Consulting Co., Ltd. (“Owl”) The Company’s subsidiary Golden Spirit Co., Ltd. (“GSC”) The Company’s subsidiary Chan Guare Industry Co., Ltd. (“CGI”) The Company’s subsidiary Naisen Kelin Industry Co., Ltd. (“NKI”) The Company’s subsidiary Bigmin Bio-Tech Company Ltd. The Company’s subsidiary E-Strong Medical Technology Co., Ltd. (“ESM”) The Company’s subsidiary Simula Technology Inc. (“Simula”) The Company’s subsidiary Aspire Asia Inc. The Company’s subsidiary Simula Technology Corp. The Company’s subsidiary Action Star Technology Co., Ltd. (“AST”) The Company’s subsidiary Simula Company Limited The Company’s subsidiary Aspire Electronics Corp. The Company’s subsidiary Simula Technology (ShenZhen) Co., Ltd. The Company’s subsidiary Alpha Networks Inc. (“Alpha”) The Company’s subsidiary Alpha Solutions Co., Ltd. (“Alpha Solutions”) The Company’s subsidiary

(Continued)

66

QISDA CORPORATION Notes to the Parent-Company-Only Financial Statements

Name of related party

Alpha Networks Inc. (“Alpha USA”) Alpha Technical Services Inc. (“ATS”) Alpha Networks (Hong Kong) Limited (“Alpha HK”) Alpha Networks Vietnam Company Limited “(Alpha VN”) Indialpha Technet Private Limited “(Indialpha”) Enrich Investment Corporation (“Enrich Investment”) Hitron Technologies Inc. (“Hitron”) D-Link Asia Investment Pte, Ltd. (“D-Link Asia”) Alpha Networks (Dongguan) Co., Ltd. (“Alpha DGF“) Alpha Networks (Chengdu) Co., Ltd. (“Alpha CD”) Alpha Networks (Changshu) Co., Ltd. (“Alpha CSF”) Mirac Networks (Dongguan) Co., Ltd. (“Mirac”) Alpha Networks (Changshu) Trading Co., Ltd. (“Alpha CST”) Hitron Technologies (Samoa) Inc. (“HSM”) Interactive Digital Technologies Inc. (“IDT”) Hitron Technologies Europe Holding B.V. (“HBV”) Hitron Technologies (Americas) Inc. (“HUS”) Innoauto Technologies Inc. (“HTG”) Hitron Technologies (Vietnam) Inc. (“HVN”) Hitron Technologies (SIP) Inc. (“HSZ”) Jietech Trading (Suzhou) Inc. (“HJT”) Hwa Chi Technologies (Shanghai) Inc. (“IHC”) Transnet Corporation (“Transnet”) Aespula Technologies Inc. (“APL”) Fiber Logic Communications, Inc. (“Fiber Logic”) Norbel Baby Co., Ltd. (“Norbel”)

AU Optronics Corp. (“AU”)

Darfon Electronics Corp. (“DFN”) Visco Vision Inc. (“Visco Vision”) Q.S.Control Corp. (“Q.S.C”) Rapidtek Technologies Inc. (“Rapidtek”) Marketop Smart Solutions Co., Ltd. (“Marketop Smart”) APLEX Technology Inc. (“APLEX”)

Darwin Precisions Corporation (“Darwin Precisions”) AUO (Xiamen) Co., Ltd. (“AUOXM”)

Relationship with the Company The Company’s subsidiary The Company’s subsidiary The Company’s subsidiary The Company’s subsidiary

The Company’s subsidiary The Company’s subsidiary The Company’s subsidiary The Company’s subsidiary The Company’s subsidiary The Company’s subsidiary The Company’s subsidiary The Company’s subsidiary The Company’s subsidiary The Company’s subsidiary The Company’s subsidiary The Company’s subsidiary The Company’s subsidiary The Company’s subsidiary The Company’s subsidiary The Company’s subsidiary The Company’s subsidiary The Company’s subsidiary The Company’s subsidiary The Company’s subsidiary Prior to November 13, 2024, Norbel was an associate of the Company. Starting November 13, 2024, Norbel became a subsidiary of the Company. AU accounted for its shareholder in the Company using the equity method. The Company’s associate The Company’s associate The Company’s associate The Company’s associate The Company’s associate Starting December 24, 2024, APLEX became an associate of the Company. AU’s subsidiary AU’s subsidiary

(Continued)

67

QISDA CORPORATION Notes to the Parent-Company-Only Financial Statements

Name of related party Relationship with the Company AUO (Kunshan) Co., Ltd. (“AUOKS”) AU’s subsidiary AUO (Suzhou) Co., Ltd. (“AUOSZ”) AU’s subsidiary AU Optronics (Slovakia) s.r.o. (“AUOSK”) AU’s subsidiary AUO Crystal Corp. (“ACTW”) AU’s subsidiary AUO Display Plus Corporation (“ADP”) AU’s subsidiary AUO Education Service Corp. AU’s subsidiary Darad Innovation Corporation DFN’s subsidiary Unictron Technologies Corporation DFN’s subsidiary TD HiTech Energy Inc. DFN’s subsidiary Darfon Energy Technology Corp. (“DET”) DFN’s subsidiary BenQ Foundation Substantive related party

(b) Significant related-party transactions

(i) Revenue

2024 Subsidiaries: QALA $ 21,182,002 BenQ 3,058,766 QJTO 3,218,911 Other subsidiaries 441,105 27,900,784 Associates 1,806 The entity who has significant influence over the Company: AU 1,854,827 AUOSZ 1,588,606 Others 413,656 3,857,089 $ 31,759,679	2023
	18,995,649 4,053,493 2,733,421 535,162
	26,317,725
	13,500
	2,259,226 1,305,361 334,971
	3,899,558
	30,230,783

There were no significant differences between the sales prices for related parties and those for third-party customers. The payment terms of 30~120 days showed no significant difference between related parties and third-party customers, which were subject to payment extension taking into account the market conditions for subsidiaries.

The Company sold raw materials and work in process to its subsidiaries for reprocessing, and the related finished goods were resold back to the Company. For this reason, the Company offset the recognized revenues and costs from these transactions, which amounted to $6,309,090 and $9,072,799, for the years ended December 31, 2024 and 2023, respectively.

(Continued)

68

QISDA CORPORATION Notes to the Parent-Company-Only Financial Statements

(ii) Purchases

Subsidiaries: QCSZ QCOS Other subsidiaries Associates The entity who has significant influence over the Company	2024 $ 47,574,921 11,126,838 516,027 59,217,786 27,631 515,535 $ 59,760,952	2023
		50,122,958 11,684,637 1,402,706
		63,210,301 4,915 131,906
		63,347,122

There were no significant differences between the purchase prices for related parties and those for third-party vendors. The payment terms of 30~120 days showed no significant difference between related parties and third-party vendors.

(iii) Lease

The Company leased its office and plant to its related parties. In 2024 and 2023, the related rental income from subsidiaries amounted to $118,311 and $116,624, respectively, and from associates amounted to $3,540 and $3,608, respectively, recognized as the non-operating － income and loss other income. The related receivables were classified as other receivables from related parties.

The Company leased factory from AU, and the rent is paid monthly with reference to the nearby office rental rates. Additions to right-of-use assets amounted to $9,901 in 2023. For the years ended December 31, 2024 and 2023, the related interest expense on lease liabilities amounted to $166 and $44, respectively. As of December 31, 2024 and 2023, the balances of the lease liabilities amounted to $4,594 and $9,497, respectively.

(iv) Repair service

The Company’ s subsidiaries provided repair service to the Company. These subsidiaries charged the Company for their repair service based on the actual costs of services rendered. For the years ended December 31, 2024 and 2023, the repair service fees amounted to $12,548 and $12,780, respectively, recognized as operating costs. The related payables were fully paid.

(v) Donation

For the year ended December 31, 2023, the Company made a donation to a substantive related party, BenQ Foundation, amounting to $6,500.

(vi) Property transactions

In 2023, the Company bought machinery from subsidiaries at a price of $2,380.

(vii) Guarantees

For the years ended December 31, 2024 and 2023, the Company provided guarantees in order to apply for foreign exchange credit line for its subsidiaries amounting to $3,475,210 and $2,337,000, respectively.

(Continued)

69

QISDA CORPORATION Notes to the Parent-Company-Only Financial Statements

(viii) Processing costs

For the years ended December 31, 2024 and 2023, manufacturing overhead incurred for reprocessing by subsidiaries amounted to $852,922 and $426,060, respectively, wherein the related outstanding payables were included in accounts payable to related parties.

(ix) Receivables from related parties

Account Accounts receivable from related parties Other receivables from related parties	Related-party categories Subsidiaries: QALA BenQ QJTO Other subsidiaries Associates The entity who has significant influence over the Company: AU AUOSZ Others Subsidiaries The entity who has significant influence over the Company	December 31, 2024 $ 11,177,981 2,916,707 1,441,487 140,304 15,676,479 944 314,229 674,553 206,149 1,194,931 $ 16,872,354 $ 5,803 1,047 $ 6,850	December 31, 2023
			10,528,447 1,469,264 1,103,506 85,667
			13,186,884
			881
			176,694 556,578 191,728
			925,000
			14,112,765
			5,675 1,042
			6,717

(x) Payables to related parties

Account Accounts payable to related parties	Related party categories Subsidiaries: QCSZ QCES QCOS Other subsidiaries Associates The entity who has significant influence over the Company	December 31, 2024 $ 20,081,040 1,714,119 5,084,858 398,546 27,278,563 15,525 143 $ 27,294,231	December 31, 2023
			16,925,223 1,973,219 5,535,436 126,160
			10,975
			10,975 149
			24,571,162

(Continued)

70

QISDA CORPORATION Notes to the Parent-Company-Only Financial Statements

(c) Compensation for key management personnel

Short-term employee benefits Post-employment benefits	2024 $ 177,649 972 $ 178,621	2023 256,768 1,080 257,848

8. Pledged assets

The carrying amounts of the assets pledged as collateral are detailed below:

Pledged assets Land and buildings	Pledged to secure Credit lines of bank loans	December 31, 2024 $ -	December 31, 2023 1,207,760

9. Significant commitments and contingencies

In addition to those in note 7, the Company had the following commitments and contingencies:

(a) Significant unrecognized commitments

Unused letters of credit	December 31, 2024 $ 950,765	December 31, 2023 492,000

10. Significant loss from disaster: None.

11. Significant subsequent events: None.

12. Others

A summary of employee benefits, depreciation, and amortization, categorized by function, is as follows:

	2024	2024	2024	2023	2023	2023
	Cost of sales	Operating expenses	Total	Cost of sales	Operating expenses	Total
Employee benefits: Salaries Insurance Pension Remuneration to directors Others Depreciation Amortization	386,330 31,370 13,866 - 42,246 139,584 46,102	1,991,803 139,462 81,501 33,964 145,615 196,946 24,760	2,378,133 170,832 95,367 33,964 187,861 336,530 70,862	443,769 32,750 14,352 - 33,192 119,940 44,720	2,469,314 155,507 83,642 34,348 137,772 203,645 23,054	2,913,083 188,257 97,994 34,348 170,964 323,585 67,774

(Continued)

71

QISDA CORPORATION Notes to the Parent-Company-Only Financial Statements

The number of employees The number of non-employee directors Average employee benefits Average employee salaries Average employee salaries adjustment rate Supervisors’ remuneration

The Company’s salary and remuneration policies (including directors, managers and employees) were as follows:

(a) Directors:

• (i) The remuneration to directors is stipulated and distributed according to the Company’ s Articles of Incorporation, authorizing the Board of Directors to determine the remuneration based on the participation and contribution of each director, as well as “Remuneration Policy to the Directors and Functional Committee Members” which is in reference to domestic and overseas industry norms. If there is earnings, the remunerations to directors is approved by the Board of Directors according to the Company's Articles of Incorporation.

• (ii) The remunerations to directors is in accordance with the Company’s Articles of Incorporation and Remuneration Policy, and is reviewed by the Remuneration Committee and approved by the Board of Directors.

(b) Managers:

The remuneration to managers is in accordance with the Company’s personnel rules with reference to the industry norms, individual performance and the Company’s overall operating performance, and is reviewed by the Salary and Remuneration Committee and approved by the Board of Directors.

• (c) Employees:

• (i) The Company provides diversified and competitive overall remuneration and career development opportunities. Apart from basic salary (including principal salary, meal allowance, etc.), various allowances and rewards, such as work allowances, duty allowances, performance bonuses, incentive bonuses and remuneration to employees based on the Company’s annual profit, are designed for difference job nature and reward purpose.

• (ii) The Company annually participates in the international market salary surveys, wherein it adjust the salary based on the salary benchmark of each job and individual performance to sustain its market competitiveness. Under the premise of enhancing the Company's overall operations and performance through teamwork and individual effort, the Company designs various short term or long term reward plans and profit sharing with employees to achieve the purpose of talent attraction, retention, motivation and programmatic cultivation of high quality talents.

• (iii) The salary and bonus for employees is in accordance with the Company’s personnel rules. The remuneration to employees is in accordance with Company’s Articles of Incorporation, and is approved by the Board of Directors and reported to shareholders meeting.

(Continued)

72

QISDA CORPORATION Notes to the Parent-Company-Only Financial Statements

13. Additional disclosures

• (a) Information on significant transactions:

• (i) Financing provided to other parties: Table 1 (attached)

• (ii) Guarantees and endorsements provided to other parties: Table 2 (attached)

• (iii) Marketable securities held at the reporting date (excluding investments in subsidiaries, associates, and joint ventures): Table 3 (attached)

• (iv) Marketable securities for which the accumulated purchase or sale amounts for the year exceed $300 million or 20% of the paid-in capital: Table 4 (attached)

• (v) Acquisition of real estate which exceeds $300 million or 20% of the paid-in capital: None

• (vi) Disposal of real estate which exceeds $300 million or 20% of the paid-in capital: None

• (vii) Total purchases from and sales to related parties which exceed $100 million or 20% of the paid-in capital: Table 5 (attached)

• (viii) Receivables from related parties which exceed $100 million or 20% of the paid-in capital: Table 6 (attached)

• (ix) Transactions about derivative instruments: Please refer to note 6(b)

• (b) Information on investees: Table 7 (attached)

• (c) Information on investment in Mainland China: Table 8 (attached)

• (d) Major shareholders:

Major shareholders:
Shareholding Shareholder’s Name	Shares	Percentage
AU Optronics Corp.	235,230,510	% 12.20

14. Segment information

Please refer to the consolidated financial statements for the year ended December 31, 2024.

QISDA CORPORATION

Financing provided to other parties For the year ended December 31, 2024

(Amounts in thousands of New Taiwan dollars and other currencies)

Table 1

Table 1
No.	Name of Lender	Name of Borrower	Financial Statement Account	Is a Related Party	Highest Balance of Financing to Other Parties During the Period	Ending Balance	Actual Usage Amount During the Period	Range of Interest Rates During the Period	Purpose of Fund Financing for the Borrower	Transaction Amounts	Reasons for Short- term Financing	Allowance for Bad Debt	Collateral		Finanacing Limits for Each Borrowing Company	Financing Company's Total Financing Amounts Limits
													Item	Value
17 15 18 16 14 15 13 12 11 9 12 10 9 8 8 8 7 7 6 5 4 3 2 1 1	Alpha Alpha HK Enrich Alpha CD AEWIN Alpha HK Suzhou Super Pillar Automation Equipment Co., Ltd. ACE Darshin Materials Medical Supplies (Suzhou) Co., Ltd. BMS ACE WPC BMS QCOS QCOS QCOS BQC_RO BQC_RO NMHC BIC BBM QLLB Darly 2 BenQ BenQ	Alpha VN Enrich Transnet Corporation Alpha CSF Aewin Beijing Technologies Co., Ltd Suzhou Super Pillar Automation Equipment Co., Ltd. Alpha CSF Tianjin Ace Pillar Co., Ltd. BenQ Materials Medical Supplies (Suzhou) Co., Ltd BenQ Materials Medical Supplies (Suzhou) Co., Ltd. Tianjin Ace Pillar Co., Ltd. Web-Pro(Vietnam)Co.,Ltd BenQ Meterials (Wuhu) Co., Ltd. BenQ Biotech (Shanghai) Co., Ltd. (“BBC”) BenQ Medical (Shanghai) Co., Ltd.(“BMSH”) Qisda (Shanghai) Co., Ltd.(“QCSH”) BenQ Biotech (Shanghai) Co., Ltd. (“BBC”) Qisda (Shanghai) Co., Ltd.(“QCSH”) Nanjing BenQ Hospital Co., Ltd.(“NMH”) Suzhou BenQ Hospital Co., Ltd. (“SMH”) Nanjing BenQ Hospital Co., Ltd.(“NMH”) Qisda (Shanghai) Co., Ltd.(“QCSH”) APV Darly Venture (L) Ltd BQL	Other receivables from related parties Other receivables from related parties Other receivables from related parties Other receivables from related parties Other receivables from related parties Other receivables from related parties Other receivables from related parties Other receivables from related parties Other receivables from related parties Other receivables from related parties Other receivables from related parties Other receivables from related parties Other receivables from related parties Other receivables from related parties Other receivables from related parties Other receivables from related parties Other receivables from related parties Other receivables from related parties Other receivables from related parties Other receivables from related parties Other receivables from related parties Other receivables from related parties Other receivables from related parties Other receivables from related parties Other receivables from related parties	Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes	295,515 164,175 100,000 1,904,430 221,060 22,734 21,369 1,895,586 112,288 153,643 45,133 224,565 1,204,876 454,670 229,845 36,374 246,032 87,796 45,467 237,676 1,127,582 6,557 272,802 328,350 15,000	295,065 163,925 - - - 22,458 20,212 1,886,430 112,288 40,424 22,458 112,288 1,190,248 449,150 229,495 35,932 89,830 - 44,915 230,311 - 6,557 269,490 327,850 -	295,065 163,925 - - - 22,458 20,212 1,886,430 - 40,424 22,458 112,288 821,046 71,864 163,925 33,686 - - 44,915 230,311 - 6,557 269,490 327,850 -	1.65% 1.25%~1.75% 5.50% - - - - 3.00% 0%~2.00% 1.85%~2.87% 1.30% 1.30% 1.30% 3.30% 2.00%~3.30% 2.00% 3.30% 2.00% 1.00% 1.00% - - 0.75% 0.50% 4.55%	2 2 2 2 2 1 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2	- - - - - 250,359 - - - - - - - - - - - - - - - - - - -	Operating requirements Operating requirements Operating requirements Business transaction Operating requirements Operating requirements Operating requirements Operating requirements Operating requirements Operating requirements Operating requirements Operating requirements Operating requirements Operating requirements Operating requirements Operating requirements Operating requirements Operating requirements Operating requirements Operating requirements Operating requirements Operating requirements Operating requirements Operating requirements Operating requirements	- - - - - - - - - - - - - - - - - - - - - - - - -	- - - - - - - - - - - - - - - - - - - - - - - - -	- - - - - - - - - - - - - - - - - - - - - - - - -	257,581 1,982,982 496,289 55,659 280,222 1,287,903 118,611 417,793 1,976,081 43,742 495,851 417,793 1,939,743 1,976,081 3,556,202 3,556,202 1,214,461 7,112,404 22,045 347,335 2,907,965 7,445,047 3,686,438 2,009,612 3,686,438	515,161 3,965,963 111,318 496,289 560,444 1,287,903 118,611 835,586 1,976,081 43,742 835,586 991,702 1,939,743 1,976,081 35,562,019 35,562,019 1,214,461 14,224,807 22,045 347,335 2,907,965 7,445,047 3,686,438 2,009,612 3,686,438

～ 73 ～

No.	Name of Lender	Name of Borrower	Financial Statement Account	Is a Related Party	Highest Balance of Financing to Other Parties During the Period	Ending Balance	Actual Usage Amount During the Period	Range of Interest Rates During the Period	Purpose of Fund Financing for the Borrower	Transaction Amounts	Reasons for Short- term Financing	Allowance for Bad Debt	Collateral	Collateral	Finanacing Limits for Each Borrowing Company	Financing Company's Total Financing Amounts Limits
													Item	Value
22 21 20 19	MTG K2 International Medical Inc Proton Cyber South	Tianjin Ace Pillar Co., Ltd. Corex K2 Medical (Thailand) Co. Ltd Tianjin Ace Pillar Co., Ltd.	Other receivables from related parties Other receivables from related parties Other receivables from related parties Other receivables from related parties	Yes Yes Yes Yes	22,985 13,134 107,399 262,680	22,950 13,114 3,279 29,284	22,950 13,114 - -	3.00% - 6.22%~6.30% -	2 2 2 2	- - - -	Operating requirements Operating requirements Operating requirements Operating requirements	- - - -	- - - -	- - - -	814,764 130,868 389,016 519,280	1,629,528 261,735 389,016 519,280

• (Note 1)The aggregate financing amount and the individual financing amount of BenQ to subsidiaries shall not exceed 40% of the most recent net worth of BenQ.

• (Note 2)The aggregate financing amount and the individual financing amount of Darly 2 to subsidiaries shall not exceed 40% of the most recent net worth of Darly 2.

• (Note 3)The aggregate financing amount and the individual financing amount of QLLB to subsidiaries shall not exceed 40% of the most recent net worth of QLLB.

• (Note 4)The aggregate financing amount and the individual financing amount of BBM to subsidiaries shall not exceed 40% of the most recent net worth of BBM.

• (Note 5)The aggregate financing amount and the individual financing amount of BIC to subsidiaries shall not exceed 40% of the most recent net worth of BIC.

• (Note 6)The aggregate financing amount and the individual financing amount of NMHC to subsidiaries shall not exceed 100% of the most recent net worth of NMHC.

• (Note 7)The aggregate financing amount to subsidiaries wholly owned by the Company and the individual financing amount of BQC_RO shall not exceed 40% and 20%, respectively, of the most recent net worth of the Company.

The financing amount to the subsidiaries not wholly owned by the Company and the individual financing amount of BQC_RO shall not exceed 40% of the most recent net worth of BQC_RO.

• (Note 8)The aggregate financing amount to subsidiaries wholly owned by the Company and the individual financing amount of QCOS shall not exceed 100% and 10%, respectively, of the most recent net worth of the Company. The financing amount to the subsidiaries not wholly owned by the Company and the individual financing amount of QCOS shall not exceed 40% of the most recent net worth of QCOS.

• (Note 9)The aggregate financing amount to subsidiaries wholly owned by BMC and the individual financing amount of BMS shall not exceed 100% of the most recent audited and reviewed net worth of BMS.

• (Note 10)The aggregate financing amount and the individual financing amount of WPC to subsidiaries shall not exceed 40% and 20%, respectively, of the most recent audited and reviewed net worth of WPC.

• (Note 11)The aggregate financing amount to subsidiaries wholly owned by DTB and the individual financing amount of DTB shall not exceed 100% of the most recent audited and reviewed net worth of DTB.

(Note 12)The aggregate financing amount and the individual financing amount of ACE to subsidiaries shall not exceed 40% and 20%, respectively, of the most recent net worth of Tianjin Ace Pillar Co., Ltd..

• (Note 13)The aggregate financing amount and the individual financing amount of Suzhou Super Pillar Automation Equipment Co., Ltd. to subsidiaries shall not exceed 40% and 20%, respectively, of the most recent net worth of Suzhou Super Pillar Automation Equipment Co., Ltd.. For financing among foreign subsidaries which wholly owned by parent company because of financing purpose,the aggregate financing amount and the individual financing amount shall not exceed 100% of most recent net worth of Suzhou Super Pillar Automation Equipment Co., Ltd.

(Note 14)The aggregate financing amount and the individual financing amount of AEWIN to subsidiaries shall not exceed 40% and 20%, respectively, of the most recent net worth of AEWIN.

• (Note 15)The aggregate financing amount to foreign subsidiaries wholly owned by Alpha and the individual financing amount of Alpha HK shall not exceed 100% of the most recent net worth of Alpha HK. (Note 16)The aggregate financing amount to foreign subsidiaries wholly owned by Alpha and the individual financing amount of Alpha CD shall not exceed 100% of the most recent net worth of Alpha CD.

(Note 17)The aggregate financing amount and the individual financing amount of Alpha to subsidiaries shall not exceed 40% and 20%, respectively, of the most recent net worth of Alpha.

(Note 18)The aggregate financing amount and the individual financing amount of Enrich to subsidiaries shall not exceed 40% and 20%, respectively, of the most recent net worth of Enrich.

(Note 19)The aggregate financing amount and the individual financing amount of Cyber South to subsidiaries shall not exceed 10% and 5%, respectively, of the most recent net worth of Cyber South.

For financing among foreign subsidaries which wholly owned by ACE because of financing purpose,the aggregate financing amount and the individual financing amount shall not exceed 100% of most recent net worth of Cyber South.

(Note 20)The aggeregate financing amount and the individual financing amount of Proton to subsidiaries shall not exceed 10% and 5%, respectively, of the most recent net worth of Proton.

For financing among foreign subsidaries which wholly owned by ACE because of financing purpose,the aggregate financing amount and the individual financing amount shall not exceed 100% of most recent net worth of Proton. (Note 21)The aggregate financing amount and the individual financing amount of K2 to subsidiaries shall not exceed 40% and 20%, respectively, of the most recent net worth of K2.

(Note 22)The aggregate financing amount and the individual financing amount of MTG to subsidiaries shall not exceed 40% and 20%, respectively, of the most recent net worth of MTG.

(Note 23)Purpose of Fund Financing: 1.Business transaction purpose. 2. Short-term financing purpose.

～ 74 ～

QISDA CORPORATION

Guarantees and endorsements provided to other parties

For the year ended December 31, 2024

(Amounts in thousands of New Taiwan dollars and other currencies)

		QISDA CORPORATION Guarantees and endorsements provided to other parties For the year ended December 31, 2024 (Amounts in thousands of New Taiwan dollars and other currencies)	QISDA CORPORATION Guarantees and endorsements provided to other parties For the year ended December 31, 2024 (Amounts in thousands of New Taiwan dollars and other currencies)	QISDA CORPORATION Guarantees and endorsements provided to other parties For the year ended December 31, 2024 (Amounts in thousands of New Taiwan dollars and other currencies)	QISDA CORPORATION Guarantees and endorsements provided to other parties For the year ended December 31, 2024 (Amounts in thousands of New Taiwan dollars and other currencies)	QISDA CORPORATION Guarantees and endorsements provided to other parties For the year ended December 31, 2024 (Amounts in thousands of New Taiwan dollars and other currencies)	QISDA CORPORATION Guarantees and endorsements provided to other parties For the year ended December 31, 2024 (Amounts in thousands of New Taiwan dollars and other currencies)	QISDA CORPORATION Guarantees and endorsements provided to other parties For the year ended December 31, 2024 (Amounts in thousands of New Taiwan dollars and other currencies)	QISDA CORPORATION Guarantees and endorsements provided to other parties For the year ended December 31, 2024 (Amounts in thousands of New Taiwan dollars and other currencies)	QISDA CORPORATION Guarantees and endorsements provided to other parties For the year ended December 31, 2024 (Amounts in thousands of New Taiwan dollars and other currencies)	QISDA CORPORATION Guarantees and endorsements provided to other parties For the year ended December 31, 2024 (Amounts in thousands of New Taiwan dollars and other currencies)	QISDA CORPORATION Guarantees and endorsements provided to other parties For the year ended December 31, 2024 (Amounts in thousands of New Taiwan dollars and other currencies)	QISDA CORPORATION Guarantees and endorsements provided to other parties For the year ended December 31, 2024 (Amounts in thousands of New Taiwan dollars and other currencies)
Table 2
No.	Endorsements / Guarantee Provider	Counter-party of Guarantee and Endorsement		Limits on Amount of Guarantees and Endorsements Provided to Each Guaranteed Party	Highest Balance of Guarantees and Endorsements During the Period	Balance of Guarantees and Endorsements as of Reporting Date	Actual Usage Amount During the Period	Property Pledged for Guarantees and Endorsements	Ratio of Accumulated Amounts of Guarantees and Endorsements to Net Worth of the Latest Financial Statements	Maximum Amounts for Guarantees and Endorsements	Gaurantee Provided by Parent Company	Gaurantee Provided by A Subsidiary	Endorsements / Guarantees Provided to Subsidiaries in Mainland China
		Name	Relationship with the Company
5 4 3 4 2 2 2 2 2 2 1 0	MTG Alpha DIC Alpha PTT PTT PTT PTT PTT PTT BenQ The Company	Corex Alpha CSF Data Image (Suzhou) Corporation Alpha DGF Partner Tech Asia Pacific Corp. Webest Solution Corporation Partner Tech (Shanghai) Co., Ltd. Partner Tech USA Inc. Partner Tech Middle East FZCO Partner-Tech Europe GmbH MaxGen QLLB	Parent/Subsidiary Parent/Subsidiary Parent/Subsidiary Parent/Subsidiary Parent/Subsidiary Parent/Subsidiary Parent/Subsidiary Parent/Subsidiary Parent/Subsidiary Parent/Subsidiary Parent/Subsidiary Parent/Subsidiary	814,764 4,957,454 390,350 4,957,454 245,287 245,287 245,287 245,287 245,287 245,287 1,843,219 7,112,404	5,378,400 101,894 197,010 130,180 32,545 64,940 10,000 60,000 64,940 65,090 229,845 631,600	3,475,210 84,734 98,355 65,570 - 32,785 - 60,000 32,785 - 229,495 597,850	3,475,210 84,734 98,355 65,570 - 32,785 - 60,000 - - 12,171 209,123	#VALUE! #VALUE! #VALUE! #VALUE! #VALUE! #VALUE! #VALUE! #VALUE! #VALUE! #VALUE! #VALUE! #VALUE!	14.68% 2.31% - 1.68% 4.90% - 2.68% - 5.36% 8.04% 0.92% 9.77%	2,036,910 9,914,908 9,914,908 975,875 613,218 613,218 613,218 613,218 613,218 613,218 9,216,094 17,781,010	N N N N N N N N N N N Y	- - - - - - - - - - - -	- Y Y Y - - - Y - - - -

(Note 1)The aggregate endorsement/guarantee amount provided by the Company to QLLB and the endorsement/guarantee amount provided to individual party shall not exceed 50% and 20%, respectively, of the most recent audited or reviewed net worth of the Company.

(Note 2)The aggregate endorsement/guarantee amount provided by BenQ to MaxGen and the endorsement/guarantee amount provided to individual party shall not exceed 100% and 20%, respectively, of the most recent net worth of BenQ.

(Note 3)The aggregate endorsement/guarantee amount provided by PTT to PTT 's subsidiaries and the endorsement/guarantee amount provided to individual party shall not exceed 50% and 20%, respectively, of the most recent net worth of PTT.

(Note 4)The aggregate endorsement/guarantee amount provided by DIC to Data Image (Suzhou) Corporation and the endorsement/guarantee amount provided to individual party shall not exceed 50% and 20%, respectively, of the most recent net worth of DIC.

(Note 5)The aggregate endorsement/guarantee amount provided by Alpha to Alpha's subsidiaries and the endorsement/guarantee amount provided to individual party shall not exceed 100% and 50%, respectively, of the most recent net worth of Alpha.

(Note 6)The aggregate endorsement/guarantee amount provided by MTG to Corex and the endorsement/guarantee amount provided to individual party shall not exceed 50% and 20%, respectively, of the most recent net worth of MTG.

～ 75 ～

QISDA CORPORATION

Marketable securities held (excluding investments in subsidiaries, associates, and joint ventures)

For the year ended December 31, 2024

(Amounts in thousands of New Taiwan dollars, unless specified otherwise)

Table 3

Investing Company	Marketable Securities Type and Name	Relationship with the Securities Issuer	Financial Statement Account	December 31, 2024	December 31, 2024	December 31, 2024	December 31, 2024
				Shares/Units	Carrying Value	Percentage of Ownership	Fair Value	Note
The Company The Company The Company The Company The Company The Company The Company The Company QLLB BMC BMC BMC BMC APV APV APV APV APV APV APV APV APV APV APV APV Darly 2 Darly 2 Darly 2 Darly 2 Darly 2 Darly 2 Darly 2 Darly 2 Darly 2 Darly 2 Darly 2 PTAP Darly C Darly C Darly C Darly C BenQ	Stock: AU Stock: TXOne Networks Inc. SCT Holding,LTD. Stock: DRAGONFLY UNMANNED AIRCRAFT SYSTEMS CO., ITH CORP. Stock: Fong Huang 6 Innovation Corporation Dunpin No.1 Innovation Investment Co., Ltd. Dunpin No.2 Innovation Investment Co., Ltd. CPEC Huachuang Private Equity Fund (Fujian) Co., Ltd. Fund Stock: Lagis Enterprise Co., Ltd. Stock: YiLeLaFa Corporation Stock: Biodenta Corporation Stock: CUUMed Catheter Medical Co., Ltd. Stock: Hi-Clearance Inc. Stock: Joymaster Inc. Stock: Crystalvue Medical Corp. Stock: Gigastone Corporation Stock: Athena Capital Management Stock: CDIB Capital Innovation Advisors Corporation Stock: D8AI , Inc. Stock: Raydium Semiconductor Corporation Stock: PlayNitride Inc. Stock: JiaTech International Investment Co., Ltd. Stock: Digitimes Inc. Stock: Digital Idea Multi-Media Co., Ltd. Stock: Crystalvue Medical Corp. Stock: Raydium Semiconductor Corporation Stock: Fong Huang Innovation Corporation Stock: Fong Huang 2 Innovation Corporation Stock: Fong Huang 3 Innovation Corporation Stock: Fong Huang 4 Innovation Corporation Affinity Health Fund One, L.P. JAFCO Taiwan II Venture Capital Limited Partnership Affinity Health Fund Two, L.P. Stock: InnoFund V Co., Ltd. Stock: Cyberbiz Corporation Stock: Cyberbiz Corporation Stock: Crystalvue Medical Corp. Stock: Athena Capital Management Stock: Anqing Innovation Stock: Visco Vision Inc. Stock: GT Booster Corp.	- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -	Financial assets at fair value through other comprehensive income-non-current Financial assets at fair value through other comprehensive income-non-current Financial assets at fair value through other comprehensive income-non-current Financial assets at fair value through other comprehensive income-non-current Financial assets at fair value through profit or loss-current Financial assets at fair value through profit or loss-non-current Financial assets at fair value through profit or loss-non-current Financial assets at fair value through profit or loss-non-current Financial assets at fair value through other comprehensive income-non-current Financial assets at fair value through other comprehensive income-current Financial assets at fair value through other comprehensive income-non-current Financial assets at fair value through profit or loss-non-current Financial assets at fair value through other comprehensive income-non-current Financial assets at fair value through other comprehensive income-current Financial assets at fair value through other comprehensive income-non-current Financial assets at fair value through other comprehensive income-non-current Financial assets at fair value through other comprehensive income-non-current Financial assets at fair value through other comprehensive income-non-current Financial assets at fair value through other comprehensive income-non-current Financial assets at fair value through other comprehensive income-non-current Financial assets at fair value through other comprehensive income-non-current Financial assets at fair value through other comprehensive income-non-current Financial assets at fair value through other comprehensive income-non-current Financial assets at fair value through profit or loss-non-current Financial assets at fair value through profit or loss-non-current Financial assets at fair value through other comprehensive income-non-current Financial assets at fair value through other comprehensive income-non-current Financial assets at fair value through other comprehensive income-non-current Financial assets at fair value through other comprehensive income-non-current Financial assets at fair value through other comprehensive income-non-current Financial assets at fair value through other comprehensive income-non-current Financial assets at fair value through other comprehensive income-non-current Financial assets at fair value through other comprehensive income-non-current Financial assets at fair value through profit or loss-non-current Financial assets at fair value through profit or loss-non-current Financial assets at fair value through profit or loss-non-current Financial assets at fair value through profit or loss-non-current Financial assets at fair value through other comprehensive income-non-current Financial assets at fair value through other comprehensive income-non-current Financial assets at fair value through other comprehensive income-non-current Financial assets at fair value through other comprehensive income-non-current Financial assets at fair value through other comprehensive income-non-current	530,879 909 800 1,000 3,000 29,500 3,000 3,000 - 1,680 300 23 3,429 340 619 706 31 2,000 2,717 19,500 2,300 100 5,000 1,000 1,000 494 993 6,000 3,000 3,000 3,000 (Note 2&3) (Note 2&3) (Note 2) 3,000 71 142 36 1,000 1,033 285 63	7,777,376 (Note 1) (Note 1) 40,000 164,400 287,871 31,598 31,572 38,959 64,764 2,101 (Note 1) 94,650 47,442 (Note 1) 59,905 1,125 14,421 11,940 7,554 906,107 20,000 39,898 62,159 82,182 41,898 391,064 84,487 41,331 40,474 42,344 33,387 20,755 29,068 40,501 3,625 23,484 3,031 7,211 7,471 51,004 18,721	6.92% 1.37% 2.44% 19.29% 0.61% 14.99% 7.96% 7.59% 2.50% 5.25% 2.73% 2.50% 8.76% 0.76% 6.19% 2.77% 0.06% 6.17% 3.33% 10.76% 3.03% 0.09% 8.12% 3.60% 7.14% 1.94% 1.31% 18.75% 7.01% 13.04% 12.77% 2.00% 2.81% 1.38% 7.03% 0.73% 1.46% 0.14% 3.09% 2.24% 0.45% 8.00%	7,777,376 - - 40,000 164,400 287,871 31,598 31,572 38,959 64,764 2,101 - 94,650 47,442 - 59,905 1,125 14,421 11,940 7,554 906,107 20,000 39,898 62,159 82,182 41,898 391,064 84,487 41,331 40,474 42,344 33,387 20,755 29,068 40,501 3,625 23,484 3,031 7,211 7,471 51,004 18,721	- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

～ 76 ～

Investing Company	Marketable Securities Type and Name	Relationship with the Securities Issuer	Financial Statement Account	December 31, 2024	December 31, 2024	December 31, 2024	December 31, 2024
				Shares/Units	Carrying Value	Percentage of Ownership	Fair Value	Note
PTT PTUK PTU PTJP DFI AEWIN AEWIN STC STC ACE MTG MTG MTG MTG MTG MTG MTG Statinc Grandsys MTG MTG Simula GSC Alpha Enrich Hitron Hitron Hitron Hitron Hitron Hitron Hitron Hitron DIVA DIVA DIVA CKCARE Norbel Concord	Stock: D8AI , Inc. Stock: APEX EVOLUTION SERVICES LTD Stock: SBM TECHNOLOGY CORPORATION Stock:AC Network Co., Ltd. Fund: Cathay No 1 REIT Stock: Aewin Korea Technologies Co., Ltd Stock: AuthenTrend Technology Inc. Stock: Intelligent fluids GmbH Stock: COMPITEK CORP PTE LTD. (CPL) Stock: Blade Hydrogen Green Technology Co., Ltd. Stock: Dynasafe Technologies, Inc. Stock: CDS Holdings Limited Stock: Yobon Technologies, Inc. Stock: Touch Cloud, Inc. Stock: Gemini Data, Inc. Stock: Kingtel Corporation Stock: High Performance Information Co., Ltd. Stock: Taiwan Innovation Centre Aging Inc. Stock: Remotek Corporation Limited Partnership Equity: Taiwania Capital Buffalo Fund V ,LP. Limited Partnership Equity: New Economy Ventures L.P. Stock: Taiwan Competition Co., Ltd. Stock: New Image Medical Co.,Ltd. Stock: TGC, Inc. Dunpin No.2 Innovation Investment Co., Ltd. Stock: Senao International Co., Ltd. Stock: Chao Long Motor Parts Corp. Stock: Imagetech Co., Ltd. Stock: Tsunami Visual Technologies, Inc. Stock: Pivot Technology Corp. Stock: Cardtek Technology Co., Ltd. Stock: Yesmobile Holdings Company Ltd. Preferred Stock: Codent Networks (Cayman) Ltd. Stock: Insight Genomics Inc. Stock: Renown Information Technology Corp. Stock: Pharmally International Holding Co. Ltd. Stock: Pchain Biotechnology Corp. Stock: Fong Huang 8 Innovation Corporation Stock: Fong Huang 8 Innovation Corporation	- - - - - Substantive related party - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -	Financial assets at fair value through other comprehensive income-non-current Financial assets at fair value through other comprehensive income-non-current Financial assets at fair value through other comprehensive income-non-current Financial assets at fair value through other comprehensive income-non-current Financial assets at fair value through profit or loss-current Financial assets at fair value through other comprehensive income-non-current Financial assets at fair value through profit or loss-non-current Financial assets at fair value through other comprehensive income-non-current Financial assets at fair value through other comprehensive income-non-current Financial assets at fair value through other comprehensive income-non-current Financial assets at fair value through profit or loss-non-current Financial assets at fair value through profit or loss-non-current Financial assets at fair value through profit or loss-non-current Financial assets at fair value through profit or loss-non-current Financial assets at fair value through profit or loss-non-current Financial assets at fair value through profit or loss-non-current Financial assets at fair value through other comprehensive income-non-current Financial assets at fair value through other comprehensive income-non-current Financial assets at fair value through other comprehensive income-non-current Financial assets at fair value through profit or loss-non-current Financial assets at fair value through profit or loss-non-current Financial assets at fair value through other comprehensive income-non-current Financial assets at fair value through other comprehensive income-non-current Financial assets at fair value through profit or loss-non-current Financial assets at fair value through profit or loss-non-current Financial assets at fair value through profit or loss-current Financial assets at fair value through other comprehensive income-non-current Financial assets at fair value through other comprehensive income-non-current Financial assets at fair value through other comprehensive income-non-current Financial assets at fair value through other comprehensive income-non-current Financial assets at fair value through other comprehensive income-non-current Financial assets at fair value through other comprehensive income-non-current Financial assets at fair value through other comprehensive income-non-current Financial assets at fair value through other comprehensive income-non-current Financial assets at fair value through other comprehensive income-non-current Financial assets at fair value through profit or loss-current Financial assets at fair value through other comprehensive income-non-current Financial assets at fair value through profit or loss-non-current Financial assets at fair value through other comprehensive income-non-current	4,200 - 8 1 1,442 10 300 27 36 10,000 4,404 600 3 200 2,706 443 2,138 200 114 (Note 2) (Note 2) 500 200 500 5,000 152 668 120 1,220 198 1,000 294 1,570 600 240 150 9 2,000 2,000	2,756 617 4,918 1,146 22,135 740 (Note 1) (Note 1) 9,214 50,018 586,489 (Note 1) (Note 1) (Note 1) (Note 1) (Note 1) 123,149 1,970 (Note 1) 179,041 35,378 1,447 2,960 (Note 1) 52,620 4,902 34,142 (Note 1) (Note 1) (Note 1) (Note 1) (Note 1) (Note 1) 2,856 2,176 (Note 1) 122 19,680 20,000	2.32% 10.00% 10.00% 20.00% - 16.67% 1.08% 1.36% 6.28% 9.31% 19.15% 1.08% 0.42% 1.50% 1.12% 18.09% 8.04% 7.14% 0.17% 12.78% 7.36% 16.67% 0.74% 1.83% 12.66% 0.06% 1.79% 1.20% 9.34% 10.94% 6.45% 0.75% - 6.40% 4.80% - 0.10% 9.76% 9.76%	2,756 617 4,918 1,146 22,135 740 - - 9,214 50,018 586,489 - - - - - 123,149 1,970 - 179,041 35,378 1,447 2,960 - 52,620 4,902 34,142 - - - - - - 2,856 2,176 - 122 19,680 20,000	- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

(Note 1)The impairment loss was fully recognized.

(Note 2)There was no shares as the company is a limited partnership.

(Note 3)In accordance with the Q&A of the FSC , the accounting treatment need not be applied retrocactively to investments in limited partnerships prior to June 30, 2023 in accordance with the IFRS Q&A released by Accounting Research and Development Foundation on June 15, 2023. Therefore, the Group continues to measure its investments in limited partnerships as financial assets at fair value through other comprehensive income.

～ 77 ～

QISDA CORPORATION

Marketable securities for which the accumulated purchase or sale amount for the year exceed NT$300 million or 20% of the paid-in capital

For the year ended December 31, 2024

(Amounts in thousands of New Taiwan dollars, unless specified otherwise)

Table 4	Table 4	Table 4	Table 4	Table 4
Company name	Marketable Securities Type and Name	Financial Statement Account	Counter-Party	Name of Relationship	Beginning Balance		Purchase		Disposal				Ending Balance
					Shares	Amount	Shares	Amount	Shares	Amount	Carrying Value	Gain (Loss) on Disposal	Shares	Amount (Note 1)
The Company Alpha Alpha DFI ACE NMH	Norbel D-Link Asia Fiber Logic TEKPAK TEKPAK Guigang Donghui Medical Investment Co., Ltd.	Investment accounted for using equity method Non-current assets classified as held for sale Investment accounted for using equity method Investment accounted for using equity method Investment accounted for using equity method Investment accounted for using equity method	- NEWSTART INVESTMENT COMPANY LIMITED Tai Tung Communication Co., Ltd. and other shareholders - - Beijing Xing Ai Jiacheng Investment Management Co., Ltd. and capital increase in cash	- - - - - -	10,000 - - - - -	1,710,740 - - - - 364,384	5,220 - 7,127 373 460 -	913,500 - 511,688 560,000 690,000 597,046	- - - - - -	- 568,606 - - - -	- 113,055 - - - -	- 223,285 - - - -	15,220 - 7,127 373 460 -	2,489,442 - 506,666 597,914 736,719 899,236

(Note 1) The ending balance includes shares of profits/losses of investees and other related adjustment.

～ 78 ～

QISDA CORPORATION

Total purchases from and sales to related parties which exceed NT$100 million or 20% of the paid-in capital For the year ended December 31, 2024

(Amounts in thousands of New Taiwan dollars, unless specified otherwise)

Table 5

Table 5
Company Name	Related Party	Nature of Relationship	Transaction Detail				Transactions with Terms Different from Others		Notes/Accounts Receivable or (Payable)		Note
			Purchases/ (Sales)	Amount	% of Total Purchases/ (Sales)	Payment Terms	Unit Price	Payment Terms	Ending Balance	~~% of Total Note/~~ Accounts Receivable or ~~(Payable)~~
The Company The Company The Company The Company The Company The Company The Company The Company The Company The Company The Company The Company The Company QCSZ QCSZ QCSZ QCSZ QCES QCOS QCOS QCOS QCOS QCOS QCOS QCOS QCPS QCPS QALA QJTO QVH BenQ BenQ BenQ BenQ BenQ BenQ BenQ BQA BQA BQA BQC_RO BQC_RO BQC_RO BQC_RO BQE	BenQ QJTO QALA AU AUOXM AU AUOSZ AUOKS DFI DFI QCSZ QCOS QVH The Company BQC_RO QCPS AU QCOS The Company BQC_RO AUOXM QCES QCPS AU AU QCSZ QCOS The Company The Company The Company BQA BQC_RO BQE BQL BQP The Company AU BQCA INF BenQ BQsha_EC2 QCOS QCSZ BenQ BQDE	Parent/Subsidiary Parent/Subsidiary Parent/Subsidiary The entity who has significant influence over the Group The entity who has significant influence over the Group The entity who has significant influence over the Group The entity who has significant influence over the Group The entity who has significant influence over the Group Parent/Subsidiary Parent/Subsidiary Parent/Subsidiary Parent/Subsidiary Parent/Subsidiary Parent/Subsidiary Affiliates Affiliates The entity who has significant influence over the Group Affiliates Parent/Subsidiary Affiliates The entity who has significant influence over the Group Affiliates Affiliates Affiliates The entity who has significant influence over the Group Affiliates Affiliates Parent/Subsidiary Parent/Subsidiary Parent/Subsidiary Affiliates Affiliates Affiliates Affiliates Affiliates Parent/Subsidiary The entity who has significant influence over the Group Affiliates Affiliates Affiliates Affiliates Affiliates Affiliates Affiliates Affiliates	(Sales) (Sales) (Sales) (Sales) (Sales) Purchases (Sales) (Sales) (Sales) Purchases Purchases Purchases Processing cost (Sales) (Sales) Purchases Purchases (Sales) (Sales) (Sales) (Sales) Purchases Purchases Purchases Purchases (Sales) (Sales) Purchases Purchases (Processing Revenue) (Sales) (Sales) (Sales) (Sales) (Sales) Purchases Purchases (Sales) (Sales) Purchases (Sales) Purchases Purchases Purchases (Sales)	(3,058,766) (3,218,911) (21,182,002) (1,854,827) (196,376) 515,535 (1,588,606) (216,662) (107,471) 115,635 47,574,921 11,126,838 852,922 (47,574,921) (3,122,202) 1,128,580 1,531,593 (349,278) (11,126,838) (423,182) (666,085) 349,278 162,598 103,312 411,976 (1,128,580) (162,598) 21,182,002 3,218,911 (852,922) (3,296,634) (345,989) (3,874,596) (733,676) (4,509,868) 3,058,766 2,218,843 (528,081) (1,320,196) 3,296,634 (363,474) 423,182 3,122,202 345,989 (737,560)	(4) (4) (28) (2) - 1 (2) - - - 63 15 1 (78) (5) 2 3 (6) (85) (3) (5) 3 1 1 3 (79) (11) 98 100 (94) (26) (3) (30) (6) (35) 26 19 (12) (30) 99 (6) 10 76 8 (17)	OA90 OA120 OA90 OA120 OA120 OA120 OA120 OA120 60~90 Days 60~90 Days OA120 OA120 OA60 OA120 OA120 OA60 EOM55 OA60 OA120 OA120 OA120 OA60 OA60 60~90 Days OA60 OA60 OA60 OA90 OA120 OA60 OA90 OA60 OA90 OA90 OA60 OA90 EOM55 OA60 OA60 OA90 OA60 OA120 OA120 OA60 OA30	- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -	- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -	2,916,707 1,441,487 11,177,981 314,229 97,242 - 674,553 108,897 50,864 (68,343) (20,081,040) (5,084,858) (204,853) 20,081,040 135,095 (515,703) (164,727) 17,264 5,084,858 8,810 415,122 (17,264) (23,918) (20,200) (23,968) 515,703 23,918 (11,177,981) (1,441,487) 204,853 225,491 31,835 933,942 309,350 1,287,504 (2,916,707) (626,567) 80,132 449,526 (225,491) 39,815 (8,810) (135,095) (31,835) 6,152	10 5 40 1 - - 2 - - - (67) (17) (1) 92 1 (4) (1) 1 90 - 7 (1) (1) (1) (1) 90 4 (100) (100) 69 7 1 29 9 39 (61) (13) 10 57 (100) 12 (2) (36) (8) 1	- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

～ 79 ～

Company Name	Related Party	Nature of Relationship	Transaction Detail	Transaction Detail	Transaction Detail	Transaction Detail	Transactions with Terms Different from Others	Transactions with Terms Different from Others	Notes/Accounts Receivable or (Payable)	Notes/Accounts Receivable or (Payable)	Note
			Purchases/ (Sales)	Amount	% of Total Purchases/ (Sales)	Payment Terms	Unit Price	Payment Terms	Ending Balance	~~% of Total Note/~~ Accounts Receivable or ~~(Payable)~~
BQE BQE BQE BQE BQE BQE BQE BQE BQE BQL BQL BQL BQP BQP BQP BQP BQP BQP BQP BQP BQAT BQAU BQCA BQCH BQDE BQFR BQIB BQID BQIN BQIT BQJP BQKR BQME BQMX BQNL BQSE BQsha_EC2 BQTH BQUK MaxGen ZGC Filter BBC NKI CGI ESM GSC GSC Bigmin Bio-Tech K2	BQFR BQIT BQUK BQAT BQSE BQIB BQNL BQCH BenQ BQMX MaxGen BenQ BQAU BQIN BQJP BQKR BQME BQTH BQID BenQ BQE BQP BQA BQE BQE BQE BQE BQP BQP BQE BQP BQP BQP BQL BQE BQE BQC_RO BQP BQE BQL BQA BBC Filter CGI NKI GSC ESM Bigmin Bio-Tech GSC K2SH	Affiliates Affiliates Affiliates Affiliates Affiliates Affiliates Affiliates Affiliates Affiliates Affiliates Affiliates Affiliates Affiliates Affiliates Affiliates Affiliates Affiliates Affiliates Affiliates Affiliates Affiliates Affiliates Affiliates Affiliates Affiliates Affiliates Affiliates Affiliates Affiliates Affiliates Affiliates Affiliates Affiliates Affiliates Affiliates Affiliates Affiliates Affiliates Affiliates Affiliates Affiliates Affiliates Affiliates Affiliates Affiliates Affiliates Affiliates Affiliates Affiliates Affiliates	(Sales) (Sales) (Sales) (Sales) (Sales) (Sales) (Sales) (Sales) Purchases (Sales) (Sales) Purchases (Sales) (Sales) (Sales) (Sales) (Sales) (Sales) (Sales) Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases (Sales) Purchases (Sales) Purchases (Sales) Purchases Purchases (Sales) (Sales)	(350,838) (142,393) (771,090) (579,883) (210,800) (166,412) (937,182) (113,990) 3,874,596 (502,094) (198,321) 733,676 (281,461) (1,274,269) (844,855) (366,968) (801,988) (118,599) (117,440) 4,509,868 579,883 281,461 528,081 113,990 737,560 350,838 166,412 117,440 1,274,269 142,393 844,855 366,968 801,988 502,094 937,182 210,800 363,474 118,599 771,090 198,321 1,320,196 (156,601) 156,601 (112,064) 112,064 (288,509) 288,509 140,884 (140,884) (315,041)	(8) (3) (18) (13) (5) (4) (22) (3) 100 (63) (25) 98 (5) (25) (16) (7) (15) (2) (2) 96 100 100 100 100 100 100 100 52 77 100 100 92 90 100 100 100 100 100 100 100 100 (100) 34 (67) 60 (66) 63 31 (96) (31)	OA30 OA30 OA30 OA45 OA30 OA30 OA30 OA30 OA90 OA90 OA90 OA90 OA60 OA60 OA60 OA60 OA60 OA60 OA60 OA60 OA45 OA60 OA60 OA30 OA30 OA30 OA30 OA60 OA60 OA30 OA60 OA60 OA60 OA90 OA30 OA30 OA60 OA60 OA30 OA90 OA60 OA60 OA60 OA30 OA30 OA60 OA60 OA60 OA60 OA90	- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -	- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -	173,588 - 34,206 25,868 - 11,013 145,911 1,502 (933,942) 200,005 636,041 (309,350) 17,170 503,175 151,868 16,201 108,339 103,222 4,300 (1,287,504) (25,868) (17,170) (80,132) (1,502) (6,152) (173,588) (11,013) (4,300) (503,175) - (151,868) (16,201) (108,339) (200,005) (145,911) - (39,815) (103,222) (34,206) (636,041) (449,526) 51,181 (51,181) 17,594 (17,594) 53,177 (53,177) (27,061) 27,061 66,110	41 - 8 6 - 3 35 - (95) 24 76 (91) 2 45 13 1 10 9 - (100) (100) (97) (100) (27) (97) (97) (96) (29) (100) - (94) (98) (90) (96) (99) - (85) (100) (95) (88) (98) 100 (44) 78 (54) 55 (65) (33) 100 33	- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

～ 80 ～

Company Name	Related Party	Nature of Relationship	Transaction Detail	Transaction Detail	Transaction Detail	Transaction Detail	Transactions with Terms Different from Others	Transactions with Terms Different from Others	Notes/Accounts Receivable or (Payable)	Notes/Accounts Receivable or (Payable)	Note
			Purchases/ (Sales)	Amount	% of Total Purchases/ (Sales)	Payment Terms	Unit Price	Payment Terms	Ending Balance	~~% of Total Note/~~ Accounts Receivable or ~~(Payable)~~
K2SH DIC Data Image (Suzhou) Corporation DIC DFI DFI AMERICA, LLC. DFI Diamond Flower Information (NL) B.V. DFI DFI Co., Ltd. AEWIN Aewin Beijing DFI DFI DFI AEWIN Aewin Tech Inc. Alpha Alpha Alpha Alpha Alpha HK Alpha VN Alpha HK Alpha HK Alpha HK Hitron Hitron HVN Alpha USA Alpha CSF Hitron Alpha VN Alpha CSF HUS HBV Alpha BMC BMC BMC BMC BMC BMC BMC BMC BMC BMM SGM BMS BMW	K2 Data Image (Suzhou) Corporation DIC AUO Display Plus Corporation DFI AMERICA, LLC. DFI Diamond Flower Information (NL) B.V. DFI DFI Co., Ltd. DFI Aewin Beijing AEWIN QCOS The Company The Company Aewin Tech Inc. AEWIN Alpha USA Alpha CSF Hitron Alpha HK Alpha VN Alpha HK Alpha VN Alpha Alpha CSF HUS HBV Hitron Alpha Alpha Alpha Alpha HK Alpha HK Hitron Hitron Alpha VN AU AUOSZ AUOXM BMM VVM SGM BMS VVT BMW BMC BMC BMC BMC	Affiliates Affiliates Affiliates The entity who has significant influence over the Group Affiliates Affiliates Affiliates Affiliates Affiliates Affiliates Affiliates Affiliates Affiliates Parent/Subsidiary Parent/Subsidiary Affiliates Affiliates Affiliates Affiliates Affiliates Affiliates Affiliates Affiliates Affiliates Affiliates Affiliates Affiliates Affiliates Affiliates Affiliates Affiliates Affiliates Affiliates Affiliates Affiliates Affiliates Affiliates The entity who has significant influence over the Group The entity who has significant influence over the Group The entity who has significant influence over the Group Affiliates Associate Affiliates Affiliates Associate Affiliates Affiliates Affiliates Affiliates Affiliates	Purchases Processing cost (Processing Revenue) Purchases (Sales) Purchases (Sales) Purchases (Sales) Purchases (Sales) Purchases (Sales) Purchases (Sales) (Sales) Purchases (Sales) Purchases (Sales) Purchases (Sales) (Sales) Purchases (Sales) (Sales) (Sales) (Sales) (Sales) Purchases (Sales) Purchases Purchases Purchases Purchases Purchases Purchases (Sales) (Sales) (Sales) (Sales) (Sales) (Sales) Purchases Purchases Purchases Purchases Purchases (Sales) (Sales)	315,041 974,711 (974,711) 125,340 (474,799) 474,799 (420,268) 420,268 (321,741) 321,741 (250,359) 250,359 (103,312) 107,471 (115,635) (421,787) 421,787 (4,165,372) 4,487,390 (1,969,145) 5,092,433 (5,584,453) (5,092,433) 5,092,433 (5,092,433) (2,641,867) (4,557,272) (155,587) (4,366,596) 4,165,372 (4,487,390) 1,969,145 5,584,453 2,641,867 4,557,272 155,587 4,366,596 (3,927,823) (868,678) (545,489) (574,396) (205,090) (297,855) 918,260 440,584 150,866 574,396 297,855 (918,260) (150,866)	100 49 (29) 6 (15) 96 (13) 96 (10) 99 (15) 38 (3) 5 (4) (25) 100 (31) 39 (15) 44 (42) (100) 100 (38) (20) (77) (3) (100) 89 (92) 26 100 55 96 100 61 (26) (6) (4) (4) (1) (2) 9 4 2 89 97 (95) (53)	OA90 Depends on its working capital status Depends on its working capital status EOM45 60~90 Days 60~90 Days 60~90 Days 60~90 Days 60~90 Days 60~90 Days After shipment 150 Days After shipment 150 Days 60~90 Days 60~90 Days 60~90 Days After shipment 120 Days After shipment 120 Days OA90 OA90 OA60 OA90 OA90 OA90 OA90 OA90 OA90 OA120 OA90 OA60 OA90 OA90 OA60 OA90 OA90 OA120 OA90 OA60 OA90 OA90 OA90 OA180 OA90 OA180 OA180 OA60 OA180 OA180 OA180 OA180 OA180	- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - (Note 1) (Note 1) (Note 1) (Note 1) (Note 1) (Note 1) (Note 2) (Note 2) (Note 2) (Note 2) (Note 2) (Note 2) (Note 2)	- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -	(66,110) (307,842) 307,842 (7,499) 83,994 (83,994) 1,361 (1,361) 23,387 (23,387) 239,388 (239,388) 20,200 (50,864) 68,343 125,484 (125,484) 896,523 (776,482) 1,006,398 (677,961) 1,522,114 640,311 (640,311) 677,961 297,756 2,173,774 18,413 1,154,580 (896,523) 776,482 (1,006,398) (1,522,114) (297,756) (2,173,774) (18,413) (1,154,580) 1,010,257 283,434 153,949 184,164 36,411 17,739 (672,700) (64,977) (75,213) (184,164) (17,739) 672,700 75,213	(97) (75) 43 (2) 14 (90) - (100) 4 (92) 45 (92) 3 (8) 11 24 (100) 29 (38) 33 (33) 62 100 (100) 28 12 85 1 100 (100) 100 (43) (69) (100) (100) (100) (51) 28 8 4 5 1 - (19) (2) (2) (94) (77) 99 66	- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

～ 81 ～

Company Name	Related Party	Nature of Relationship	Transaction Detail	Transaction Detail	Transaction Detail	Transaction Detail	Transactions with Terms Different from Others	Transactions with Terms Different from Others	Notes/Accounts Receivable or (Payable)	Notes/Accounts Receivable or (Payable)	Note
			Purchases/ (Sales)	Amount	% of Total Purchases/ (Sales)	Payment Terms	Unit Price	Payment Terms	Ending Balance	~~% of Total Note/~~ Accounts Receivable or ~~(Payable)~~
Simula Simula Technology (ShenZhen) Co., Ltd. Simula Simula Technology Corp. PTT PTT PTT PTT PTT PTE PTU PTUK PTAP PTME AST The Company	Simula Technology (ShenZhen) Co., Ltd. Simula Simula Technology Corp. Simula PTE PTU PTUK PTME PTAP PTT PTT PTT PTT PTT The Company AST	Affiliates Affiliates Affiliates Affiliates Affiliates Affiliates Affiliates Affiliates Affiliates Affiliates Affiliates Affiliates Affiliates Affiliates Affiliates Affiliates	Purchases (Sales) (Sales) Purchases (Sales) (Sales) (Sales) (Sales) (Sales) Purchases Purchases Purchases Purchases Purchases (Sales) Purchases	575,878 (575,878) (185,186) 185,186 (303,046) (318,675) (122,091) (136,084) (111,522) 303,046 318,675 122,091 111,522 136,084 (221,082) 221,082	89 (78) (21) 88 (29) (30) (12) (13) (11) 37 96 80 39 44 (31) -	EOM60 EOM60 EOM60 EOM60 OA90 OA90 OA90 OA90 OA30 OA90 OA90 OA90 OA90 OA90 EOM60 EOM60	(Note 4) (Note 4) - - (Note 3) (Note 3) (Note 3) (Note 3) (Note 3) - - - - - (Note 5) (Note 5)	- - - - - - - - - - - - - - - -	(61,711) 61,711 33,457 (33,457) 135,187 60,575 14,945 79,456 11,211 (135,187) (60,575) (14,945) (11,211) (79,456) 96,532 (96,532)	(65) 67 16 (73) 38 17 4 22 3 (48) (100) (85) (29) (97) 44 -	- - - - - - - - - - - - - - - -

(Note 1)The selling prices of BMC to related parties are not comparable to the sales prices for third-party customers as the specifications of products were different. For the other transaction, there were no significant differences between the sales for related parties and those for third-party customers.

• (Note 2)The purchase prices to related parties are not comparable to the purchase prices for third-party vendors as the specifications of products were different, and it is conducted under the agreed purchase price and conditions.

• (Note 3)The selling prices of PPT to related parties are not comparable to the sales prices for third-party customers as the specifications of products were different. For the other transaction, there were no significant differences between the sales for related parties and those for third-party customers. (Note 4)Simula seldom purchases the same products from other vendors. Therefore, the purchase prices are not comparable.

• (Note 5)AST did not sell the same products to third-party customers. Therefore, the sales prices are not comparable.

～ 82 ～

QISDA CORPORATION

Receivables from related parties which exceed NT$100 million or 20% of the paid-in capital

December 31, 2024

(Amounts in thousands of New Taiwan dollars, unless specified otherwise)

Table 6

Table 6
Company Name	Related Party	Nature of Relationship	Ending Balance	Turnover Rate	Overdue		Amount Received in Subsequent Period	Allowance for Bad Debts
					Amount	Action Taken
The Company The Company The Company The Company The Company The Company QCSZ QCSZ QCOS QCOS QCPS QCES QVH BenQ BenQ BenQ BenQ BenQ BQA BQE BQE BQL BQL BQP BQP BQP BQP PTT Data Image (Suzhou) Corporation AEWIN AEWIN Alpha Alpha Alpha CSF Alpha HK	BenQ QJTO QALA AU AUOSZ AUOKS The Company BQC_RO The Company AUOXM QCSZ The Company The Company BQA BQE BQL BQP QCSZ INF BQFR BQNL MaxGen BQMX BQIN BQJP BQME BQTH PTE DIC Aewin Tech Inc. Aewin Beijing Alpha USA Hitron Alpha Alpha	Parent/Subsidiary Parent/Subsidiary Parent/Subsidiary The entity who has significant influence over the Group The entity who has significant influence over the Group The entity who has significant influence over the Group Parent/Subsidiary Parent/Subsidiary Parent/Subsidiary The entity who has significant influence over the Group Affiliates Parent/Subsidiary Parent/Subsidiary Affiliates Affiliates Affiliates Affiliates Affiliates Affiliates Affiliates Affiliates Affiliates Affiliates Affiliates Affiliates Affiliates Affiliates Affiliates Affiliates Affiliates Affiliates Affiliates Affiliates Affiliates Affiliates	2,916,707 1,441,487 11,177,981 314,229 674,553 108,897 20,081,040 135,095 5,084,858 415,122 515,703 1,714,119 204,853 225,491 933,942 309,350 1,287,504 396,912 449,526 173,588 145,911 636,041 200,005 503,175 151,868 108,339 103,222 135,187 307,842 125,484 239,388 896,523 1,006,398 776,482 677,961	1.39 2.53 1.95 7.56 2.58 1.49 2.57 29.96 2.10 2.12 3.07 (Note 1) (Note 1) 22.53 5.26 2.99 2.89 (Note 1) 3.78 1.74 9.34 0.36 3.40 1.93 3.33 5.22 1.18 2.27 3.20 3.87 0.97 3.67 3.85 6.33 11.04	1,436,704 246,798 5,354,809 - - - 8,457,709 - 2,846,253 32,007 314,792 894,973 - - - 149,618 311,682 - - 139,093 42,365 - - 78,544 85,981 - 58,312 60,656 - - 71,292 - - 19,608 -	- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -	536,966 362,924 3,430,228 178,420 330,229 45,312 6,016,454 - 2,846,253 32,007 314,792 1,185,144 204,853 225,491 - 180,214 452,480 - 55,657 31,244 145,911 183,738 51,778 58,530 69,056 78,726 16,437 32,171 - - 13,680 - 481,922 158,643 627,999	- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

～ 83 ～

Company Name	Related Party	Nature of Relationship	Ending Balance	Turnover Rate	Overdue	Overdue	Amount Received in Subsequent Period	Allowance for Bad Debts
					Amount	Action Taken
Alpha HK Alpha HK Alpha VN Hitron HVN BMC BMC BMC BMC BMS	Alpha CSF Alpha VN Alpha HK HUS Hitron AU AUOSZ AUOXM BMM BMC	Affiliates Affiliates Affiliates Affiliates Affiliates The entity who has significant influence over the Group The entity who has significant influence over the Group The entity who has significant influence over the Group Affiliates Affiliates	297,756 1,522,114 640,311 2,173,774 1,154,580 1,010,257 283,434 153,949 184,164 672,700	5.25 4.58 11.52 2.47 3.06 4.41(Note 2) 3.32(Note 2) 3.19(Note 2) 2.74(Note 2) 1.55(Note 2)	17,150 43,680 - - - - - - - 184,376	- - - - - - - - - -	144,370 478,396 627,999 786,265 218,179 - - - - 81,706	- - - - - - - - - -

(Note 1)The sales from repurchasing after processing have been eliminated; therefore, calculation of turnover rate is not applicable.

(Note 2)The calculation of turnover rate includes the account receivable sold to financial institutions.

～ 84 ～

QISDA CORPORATION

Information of Investees (Excluding Information on investments in Mainland China)

For the year ended December 31, 2024

(Amounts in thousands of New Taiwan dollars / shares, unless specified otherwise)

Table 7

Table 7
Investor	Investee	Location	Main Businesses and Products	Original investment Amount		Balances as of December 31, 2024			Net Income (Loss) of the Investee	Investment Income (Loss)	Note
				December 31, 2024	December 31, 2023	Shares	Percentage of Ownership	Carrying Value
The Company The Company The Company The Company The Company The Company The Company The Company The Company The Company The Company The Company The Company The Company The Company The Company The Company The Company The Company The Company The Company The Company The Company The Company The Company The Company The Company The Company The Company BMC BMC BMC BMC	DFN BMC BenQ QALA QJTO QLPG QLLB APV Darly BBHC PTT BDT QTOS Q.S.Control Corp. DFI Alpha DIC EASCHK MTG Topview QVH Simula GSC TCI Gene Rapidtek Norbel H2 Energy Co., Ltd. Marketop Smart APLEX BMLB SGM Visco Vision Inc. CENEFOM	Taiwan Taiwan Taiwan USA Japan Malaysia Malaysia Taiwan Malaysia Cayman Taiwan Taiwan Taiwan Taiwan Taiwan Taiwan Taiwan Hong Kong Taiwan Taiwan Vietnam Taiwan Taiwan Taiwan Taiwan Taiwan Taiwan Taiwan Taiwan Malaysia Taiwan Taiwan Taiwan	Manufacture and sale of computer peripherals, power devices, green energy products and passive components R&D, manufacture and sale of optoelectronics film Sales of brand-name electronic products Sales of electronic products Sales and maintenance of electronic products in Japanese market Leasing and management services Investment and holding activity Investment and holding activity Investment and holding activity Investment and holding activity Manufacture, sales, and import and export of POS terminals and peripheral Manufacture and sale of medical consumable and equipment Sales of electronic products R&D, manufacture and sales of medical consumables and equipments Manufacture and sales of industrial motherboards and components R&D, manufacture and sale of LAN/MAN, wireless, mobile & broadband, and digital multimedia products Manufacture and sales of marine display modules Sales of electronic products Distributing and reselling software and hardware equipment of ICT infrastructures, computing & data utilization, and digitalization Manufacture and sales of video surveillance cameras Manufacture of monitors Manufacture and sales of electronic material Sale of alcohol and medical disinfectant Genetic testing and wholesale of nutritional supplement Antenna design and production and sales of RF testing products Retail and wholesale of maternity and infant products, medical care products, dietary supplement, and cosmetics Energy service AI healthcare R&D and manufacture of industrial computer products Investment and holding activity Sales of medical consumables and equipment Manufacture and sale of contact lenses R&D, manufacture and sales of medical consumables and equipments	662,195 507,883 4,963,435 32,800 2,701 578,128 3,687,539 850,016 165,000 7,789,187 1,475,978 280,000 1,000 63,000 3,154,750 8,135,810 543,534 78,338 3,202,856 172,500 1,212,849 600,000 254,000 545,160 163,850 2,713,500 7,500 29,400 29,375 499,790 231,727 168,771 272,968	662,195 507,883 4,963,435 32,800 2,701 578,128 3,687,539 570,016 165,000 7,789,187 1,475,978 280,000 1,000 63,000 3,154,750 8,135,810 260,000 78,338 3,202,856 172,500 1,212,849 600,000 254,000 545,160 163,850 1,800,000 1,500 - - 499,790 231,727 168,771 272,968	58,005 43,659 320,000 1,000 - 50,000 114,250 257,059 6,000 108,555 43,577 28,000 100 6,000 51,610 295,797 24,295 1 96,841 5,750 - 30,000 18,200 4,720 2,638 15,220 750 2,940 1,388 14,082 2,000 9,334 11,646	21.02% 13.61% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 44.32% 58.04% 100.00% 100.00% 20.00% 45.08% 54.60% 31.11% 54.00% 51.41% 20.00% 100.00% 37.51% 50.00% 17.84% 8.79% 40.66% 25.00% 49.00% 3.74% 100.00% 100.00% 14.82% 50.98%	2,399,797 707,418 9,239,160 96,949 65,805 390,438 18,011,224 4,323,576 313,880 3,149,461 1,347,951 28,534 1,020 74,571 2,794,992 7,469,767 585,089 93,673 2,540,719 551,732 334,056 518,724 336,884 499,824 117,434 2,489,442 6,822 28,464 71,595 1,821,997 45,024 495,853 201,720	618,567 199,206 1,209,457 21,340 21,088 (8,753) 1,222,406 175,159 29,487 507,384 119,847 (7,898) 15 29,082 396,611 218,627 223,194 (8,420) 113,561 257,121 10,537 (100,874) 40,371 56,311 (64,988) 111,578 (2,149) (1,911) 58,996 61,046 569 636,471 (18,464)	127,484 29,875 1,203,784 21,340 21,088 (8,753) 929,913 161,217 29,487 224,716 45,203 (8,027) 15 5,816 97,735 (82,611) 64,626 (4,547) 55,992 38,274 10,537 (53,543) 14,296 (3,346) (19,594) (746) (573) (936) - - - - -	Associate Parent/Subsidiary Parent/Subsidiary Parent/Subsidiary Parent/Subsidiary Parent/Subsidiary Parent/Subsidiary Parent/Subsidiary Parent/Subsidiary Parent/Subsidiary Parent/Subsidiary Parent/Subsidiary Parent/Subsidiary Associate Parent/Subsidiary Parent/Subsidiary Parent/Subsidiary Parent/Subsidiary Parent/Subsidiary Associate Parent/Subsidiary Parent/Subsidiary Parent/Subsidiary Associate Associate Parent/Subsidiary Associate Associate Associate Affiliates Affiliates Associate Affiliates

～ 85 ～

Investor	Investee	Location	Main Businesses and Products	Original investment Amount	Original investment Amount	Balances as of December 31, 2024	Balances as of December 31, 2024	Balances as of December 31, 2024	Net Income (Loss) of the Investee	Investment Income (Loss)	Note
				December 31, 2024	December 31, 2023	Shares	Percentage of Ownership	Carrying Value
BMC BMC BMC BMC WPC WPSG APV APV APV APV APV APV APV APV APV APV APV APV APV APV Darly C Darly Darly BenQ BenQ BenQ BenQ BenQ BenQ BenQ BenQ BenQ BenQ BenQ BenQ BenQ BenQ	GJB WPC MLK Bioscience Co., Ltd. Kangde Corp. WPSG WPVN Darly C BMC BMTC BBHC PTT DFI Alpha Topview DIC Simula GSC TCI Gene Rapidtek APLEX Alpha BenQ Guru Holding Ltd. (GSH) BBHC BQA BQL BQE BenQ Mexico S. de R.L. de C.V. BQP Darly 2 BenQ Guru Holding Ltd. (GSH) DFN BMC BBHC BMTC MQE INF BQHK_HLD	Taiwan Taiwan Taiwan Taiwan Singapore Vietnam Taiwan Taiwan Taiwan Cayman Taiwan Taiwan Taiwan Taiwan Taiwan Taiwan Taiwan Taiwan Taiwan Taiwan Taiwan Hong Kong Cayman USA USA The Netherlands Mexico Taiwan Taiwan Hong Kong Taiwan Taiwan Cayman Taiwan The Netherlands Taiwan Hong Kong	R&D, manufacture and sales of medical consumables and equipments R&D, manufacture and sale of medical supplies R&D and sale of medical consumable and equipment Sales of medical consumables and equipment Investment and holding activity Manufacture and sale of medical supplies Investment management consulting R&D, manufacture and sale of optoelectronics film Manufacture and sales of medical consumables and equipments Investment and holding activity Manufacture, sales, and import and export of POS terminals and peripheral Manufacture and sales of industrial motherboards and components R&D, manufacture and sale of LAN/MAN, wireless, mobile & broadband, and digital multimedia products Manufacture and sales of video surveillance cameras Manufacture and sales of marine display modules Manufacture and sales of electronic material Sale of alcohol and medical disinfectant Genetic testing and wholesale of nutritional supplement Antenna design and production and sales of RF testing products R&D and manufacture of industrial computer products R&D, manufacture and sale of LAN/MAN, wireless, mobile & broadband, and digital multimedia products Investment and holding activity Investment and holding activity Sales of brand-name electronic products in North America markets Sales of brand-name electronic products in Latin America markets Sales of electronic products in European markets Sales of electronic products Sales of brand-name electronic products in Asia markets Investment and holding activity Investment and holding activity Manufacture and sale of computer peripherals, power devices, green energy products and passive components R&D, manufacture and sale of optoelectronics film Investment and holding activity Manufacture and sales of medical consumables and equipments Maintenance of brand-name electronic monitors and projectors in European markets Assembly and sales of gaming electronic products Sales of brand-name electronic products in HK markets	50,460 3,161,999 6,000 5,980 895,139 926,053 77,933 221,786 42,584 904,102 112,080 149,096 284,143 - 104,735 201,673 150,000 189,516 42,050 55,765 273,445 30,456 471,516 114,553 342,589 960,568 - 950,000 2,641,132 74,021 233,491 946,731 719,088 235,069 90,912 117,987 118,282	47,860 3,161,999 6,000 5,980 895,139 926,053 77,933 221,786 42,584 904,102 112,080 149,096 284,143 11,806 88,222 201,673 150,000 189,516 42,050 - 273,445 30,456 471,516 114,553 342,589 960,568 - 950,000 2,361,132 74,021 233,491 946,731 719,088 235,069 90,912 117,987 118,282	4,270 35,700 217 598 30,000 - 12,105 15,182 3,549 25,000 6,006 2,294 12,236 - 3,857 5,390 18,200 1,480 677 2,144 12,710 7,800 14,158 200 9,350 5,009 - 20,000 294,367 23,400 14,017 80,848 20,000 19,353 82 6,947 4,000	79.35% 51.00% 20.00% 7.48% 100.00% 100.00% 45.11% 4.73% 7.96% 10.21% 8.00% 2.00% 2.26% - 4.94% 6.74% 50.00% 5.59% 2.26% 5.77% 2.35% 12.50% 5.77% 100.00% 100.00% 100.00% 0.03% 100.00% 100.00% 37.50% 5.07% 25.21% 8.17% 43.43% 100.00% 100.00% 100.00%	45,687 2,549,897 - 4,466 715,838 709,248 183,091 270,586 89,885 725,496 177,895 158,462 256,357 - 127,717 200,233 259,754 185,845 39,908 110,654 245,095 16,424 411,783 1,344,892 (1,219) 1,147,331 - 432,618 5,024,047 50,758 579,796 1,440,917 580,396 478,892 83,231 92,485 3,293,173	379 154,474 (862) (5,804) (61,183) (59,929) 5,966 199,206 104,831 507,384 119,847 396,611 218,627 257,121 223,194 (100,874) 40,371 56,311 (64,988) 58,996 218,627 (3,543) 507,384 124,051 (105,372) 87,644 (25,153) 191,109 227,854 (3,543) 618,567 199,206 507,384 104,831 1,260 5,327 921,620	- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -	Affiliates Affiliates Associate Associate Affiliates Affiliates Affiliates Affiliates Affiliates Affiliates Affiliates Affiliates Affiliates Associate Affiliates Affiliates Affiliates Associate Associate Associate Affiliates Affiliates Affiliates Affiliates Affiliates Affiliates Affiliates Affiliates Affiliates Affiliates Associate Affiliates Affiliates Affiliates Affiliates Affiliates Affiliates

～ 86 ～

Investor	Investee	Location	Main Businesses and Products	Original investment Amount	Original investment Amount	Balances as of December 31, 2024	Balances as of December 31, 2024	Balances as of December 31, 2024	Net Income (Loss) of the Investee	Investment Income (Loss)	Note
				December 31, 2024	December 31, 2023	Shares	Percentage of Ownership	Carrying Value
BenQ BenQ BQP BQP BQP BQP BQP BQP BQP BQP BQP BQP BQA BQL BQL BQL BQL Joytech LLC Vividtech LLC BQmx Darly 2 Darly 2 Darly 2 Darly 2 Darly 2 Darly 2 Darly 2 Darly 2 Darly 2 Darly 2 BQE BQE BQE BQE BQE BQE BQE BQE BQE BMTC BMTC BMTC BMTC	PT BenQ Teknologi Indonesia Alpha BenQ India Private Ltd. BenQ (M.E.) FZE BenQ Japan Co., Ltd. BenQ Singapore Pte Ltd. BenQ Australia Pte Ltd. BenQ Service & Marketing (M) Sdn Bhd BenQ (Thailand) Co., Ltd. BenQ Korea Co., Ltd. PT BenQ Teknologi Indonesia BenQ Vietnam Co., Ltd. BenQ Canada Corp. BenQ Mexico S. de R.L. de C.V. Joytech LLC Vividtech LLC BenQ Service de Mexico S. de R.L. de C.V. Maxgen Comércio Industrial imp E Exp Ltda. Maxgen Comércio Industrial imp E Exp Ltda. BenQ Service de Mexico S. de R.L. de C.V. Darly C BBHC BenQ Guru Holding Ltd. (GSH) BMTC PTT DFI Alpha DIC Topview Simula BenQ UK Limited BenQ Deutschland GmbH BenQ Benelux B.V. BenQ Austria GmbH BenQ Iberica S.L. Unipersonal BenQ Italy S.R.L BenQ France SAS BenQ Nordic A.B. BenQ LLC. Asiaconnect Highview LILY BABD	Indonesia Taiwan India United Arab Emirates Japan Singapore Australia Malaysia Thailand Korea Indonesia Vietnam Canada Mexico USA USA Mexico Brazil Brazil Mexico Taiwan Cayman Hong Kong Taiwan Taiwan Taiwan Taiwan Taiwan Taiwan Taiwan UK Germany The Netherlands Austria Spain Italy France Sweden Russia Taiwan Samoa Taiwan Taiwan	Sales of electronic products R&D, manufacture and sale of LAN/MAN, wireless, mobile & broadband, and digital multimedia products Sales of electronic products Sales of electronic products Sales of electronic products Sales of electronic products Sales of electronic products Sales of electronic products Sales of electronic products Providing administration and management services to affiliates Sales of electronic products Sales of electronic products Sales of electronic products Sales of electronic products Investment and holding activity Investment and holding activity Sales of electronic products Sales of electronic products Sales of electronic products Providing administration and management services to affiliates Investment management consulting Investment and holding activity Investment and holding activity Manufacture and sales of medical consumables and equipments Manufacture, sales, and import and export of POS terminals and peripheral Manufacture and sales of industrial motherboards and components R&D, manufacture and sale of LAN/MAN, wireless, mobile & broadband, and digital multimedia products Manufacture and sales of marine display modules Manufacture and sales of video surveillance cameras Manufacture and sales of electronic material Sales of electronic products Sales of electronic products Sales of electronic products Sales of electronic products Sales of electronic products Sales of electronic products Sales of electronic products Sales of electronic products Providing administration and management services to affiliates Sales of medical consumables and equipment and software Investment and holding activity Sales of medical consumables and equipment Sales of medical consumables and equipment	21 342 224,405 8,891 4,518 1,837 132,590 119,488 120,116 1,713 6,901 5,576 26 77,591 74,046 74,046 - 74,046 74,046 87 89,179 2,122,721 121,860 27,337 49,426 596,382 79,990 48,093 116,653 205,920 14,800 25,587 567 1,091 4,677 92,654 2,045 445 52 21,984 68,748 185,000 88,000	21 342 224,405 8,891 4,518 1,837 132,590 119,488 120,116 1,713 6,901 5,576 26 77,591 74,046 74,046 - 74,046 74,046 87 89,179 2,122,721 121,860 27,337 49,426 596,382 79,990 48,093 123,252 205,920 14,800 25,587 567 1,091 4,677 92,654 2,045 445 52 21,984 36,211 185,000 88,000	- 18 440,296 - - 500 2,191 100 12,000 10 6 - 1 3 1 1 - 1 1 3 14,728 65,024 31,200 1,590 1,648 9,175 4,185 3,005 2,475 5,500 - - - - - 50 - - - 1,995 2,062 10,000 8,800	0.31% 0.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 99.69% 100.00% 100.00% 99.97% 100.00% 100.00% 0.03% 50.00% 50.00% 99.97% 54.89% 26.55% 50.00% 3.57% 2.19% 8.01% 0.77% 3.85% 8.61% 6.88% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 99.75% 100.00% 100.00% 88.00%	92 351 177,176 175,910 204,480 9,381 106,601 3,957 (91,317) (471) 29,737 2,434 70,961 80,086 (68,295) (68,295) 1 (68,295) (68,295) 3,978 222,775 1,887,121 67,678 40,271 48,880 634,167 76,158 71,345 307,545 204,296 84,804 192,807 (14,809) 46,729 63,387 50,318 (99,735) 33,792 19,402 23,570 45,828 269,705 58,569	9,203 218,627 39,203 24,882 5,037 3,570 11,977 (4,238) 4,432 1,599 9,203 (2,036) 1,297 (25,153) (66,098) (66,098) 22 (132,196) (132,196) 22 5,966 507,384 (3,543) 104,831 119,847 396,611 218,627 223,194 257,121 (100,874) 6,047 5,453 7,516 5,429 21,047 (1,463) 3,146 3,252 4,372 937 (6,242) 36,223 (285)	- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -	Affiliates Affiliates Affiliates Affiliates Affiliates Affiliates Affiliates Affiliates Affiliates Affiliates Affiliates Affiliates Affiliates Affiliates Affiliates Affiliates Affiliates Affiliates Affiliates Affiliates Affiliates Affiliates Affiliates Affiliates Affiliates Affiliates Affiliates Affiliates Associate Affiliates Affiliates Affiliates Affiliates Affiliates Affiliates Affiliates Affiliates Affiliates Affiliates Affiliates Affiliates Affiliates Affiliates

～ 87 ～

Investor	Investee	Location	Main Businesses and Products	Original investment Amount	Original investment Amount	Balances as of December 31, 2024	Balances as of December 31, 2024	Balances as of December 31, 2024	Net Income (Loss) of the Investee	Investment Income (Loss)	Note
				December 31, 2024	December 31, 2023	Shares	Percentage of Ownership	Carrying Value
BMTC BMTC BMTC BMTC Concord BHS BHS K2 K2 K2 Asiaconnect PTT PTT PTT PTT PTT PTT PTT PTT WiXtar WiXtar WiXtar PTE PTE PTE PTE PTAP PTME PTSE PTAP DFI DFI DFI DFI DFI DFI DFI DFI AEWIN AEWIN Wise Way	BHS EASTECH Concord K2 CCHC NBHIT CKCARE K2 Medical (Thailand) Co., LTD PT Frismed Hoslab Indonesia ERA K2 PTUK PTAP PTE PTME PTSE WiXtar P&S PTU WEBEST PTMG PTSE PTUK Sloga RSS PTF PTME E-POS PTMY PTJP DFI AMERICA, LLC. Yan Tong Technology Ltd. DFI Co., Ltd. Diamond Flower Information (NL) B.V. AEWIN ACE TEKPAK APLEX Wise Way Aewin Tech Inc. Bright Profit	Taiwan Taiwan Taiwan Taiwan Taiwan Taiwan Taiwan Thailand Indonesia Taiwan Taiwan UK Taiwan Germany United Arab Emirates Singapore Taiwan British Virgin Islands USA Taiwan Taiwan Singapore UK Slovenia Spain France United Arab Emirates United Arab Emirates Malaysia Japan USA Mauritius Japan The Netherlands Taiwan Taiwan Taiwan Taiwan Anguilla USA Hong Kong	Sales of medical consumables and equipment Sales of medical consumables and equipment Sales and purchase of medical products, medical equipment leasing and management consulting Sales of medical consumables Sales of medical consumables and equipment, and management consulting Sales of medical consumables and equipment Sales of medical products, over-the-counter drugs, and health supplements Sales of medical consumables Medical devices for blood donation and consumables Sales of minimally invasive medical devices Sales of medical consumables Sales, import and export of electronic products Sales, import and export of electronic products Sales, import and export of electronic products Sales, import and export of electronic products Software development and sales of product Software development and sales of product Investment and holding activity Sales, import and export of electronic products Sales, import and export of electronic products Software development and sales of product Software development and sales of product Sales, import and export of electronic products Sales, import and export of electronic products Sales, import and export of electronic products Sales, import and export of electronic products Sales, import and export of electronic products Sales, import and export of electronic products Software development and sales of product Software development and sales of product Sales of industrial motherboards Investment and holding activity Sales of industrial motherboards Sales of industrial motherboards Manufacture and sale of industrial motherboards and component Tests, processing, sales, repairment and electromechanical integration of automatic control and mechanical transmission system Manufacture and sales of pallet strapping equipment R&D and manufacture of industrial computer products Investment and holding activity Wholesale of computer peripheral products and software Investment and holding activity	100,000 20,300 190,000 390,000 119,984 59,280 105,300 15,919 257,728 133,005 10,000 43,834 80,000 51,451 137,387 - 94,122 40,597 94,376 29,254 29,417 97,801 5,640 980 - 1,641 309 2,485 10,434 19,397 254,683 28,394 104,489 35,219 564,191 1,270,850 560,000 234,297 46,129 77,791 46,129	100,000 20,300 190,000 390,000 119,984 59,280 105,300 15,919 257,728 - 10,000 43,834 80,000 51,451 137,387 57,449 25,769 134,973 - 29,254 29,417 - 5,640 980 - 1,641 309 2,485 - - 254,683 107,198 104,489 35,219 564,191 1,301,359 - - 46,129 77,791 46,129	10,000 700 13,333 7,800 12,000 1,092 4,362 - 12.00 2,700 200 886 8,000 (Note 1) 0.099 - 9,275 1,372 3,188 2,500 2,100 318 114 (Note 1) (Note 1) (Note 1) 0.001 0.3 130.000 0.140 1,209.000 1,100 6 12 30,376 52,436 373 4,957 1,500 2,560 1,500	100.00% 70.00% 40.00% 39.00% 100.00% 52.00% 60.00% 49.00% 67.00% 60.00% 1.00% 88.60% 100.00% 50.02% 99.00% - 60.67% 100.00% 100.00% 100.00% 100.00% 100.00% 11.40% 90.00% 68.00% 70.00% 1.00% 100.00% 65.00% 100.00% 100.00% 100.00% 100.00% 100.00% 51.38% 46.71% 31.65% 13.36% 100.00% 100.00% 100.00%	195,416 35,595 293,128 292,443 122,188 80,209 106,240 49,057 315,842 132,172 7,499 72,115 72,527 138,659 28,598 - 124,084 59,645 139,100 31,739 23,989 98,042 10,056 (15,568) 11,584 675 298 (3,477) 11,093 18,760 470,216 32,939 166,403 182,604 722,711 1,062,595 597,914 272,944 78,776 23,995 112,478	52,347 12,783 49,570 82,354 1,430 40,183 7,177 28,798 53,113 3,481 82,354 32,692 4,481 19,008 (3,212) 4,029 (19,455) 376 21,583 4,195 16,823 4,029 32,692 26 3,851 (307) (3,212) (7,640) 689 29 16,545 17,090 19,224 24,865 52,874 67,390 207,087 58,996 (38,354) 11,547 (38,355)	- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -	Affiliates Affiliates Affiliates Affiliates Affiliates Affiliates Affiliates Affiliates Affiliates Affiliates Affiliates Affiliates Affiliates Affiliates Affiliates Affiliates Affiliates Affiliates Affiliates Affiliates Affiliates Affiliates Affiliates Affiliates Affiliates Affiliates Affiliates Affiliates Affiliates Affiliates Affiliates Affiliates Affiliates Affiliates Affiliates Affiliates Affiliates Associate Affiliates Affiliates Affiliates

～ 88 ～

Investor	Investee	Location	Main Businesses and Products	Original investment Amount	Original investment Amount	Balances as of December 31, 2024	Balances as of December 31, 2024	Balances as of December 31, 2024	Net Income (Loss) of the Investee	Investment Income (Loss)	Note
				December 31, 2024	December 31, 2023	Shares	Percentage of Ownership	Carrying Value
ACE ACE Cyber South Cyber South ACE STC AEG ACE ACE DIC DIC DIC DIVA DIVA DIVA DIVA DIVA Diva Capital lnc. EASCHK MTG MTG MTG MTG MTG MTG MTG MTG MTG Epic Cloud Epic Cloud AdvancedTEK Statnic Statnic Simula Simula Simula Simula Aspire Asia Inc. Aspire Asia Inc. GSC	Cyber South Hong Kong Ace Pillar Enterprise Company Limited Proton Inc. Ace Tek (HK) Holding Co., Ltd. STC Standard Technology Corp. Blue Walker GmbH AEG TEKPAK Data Image (Mauritius) Corporation DIVA DMC Components International, LLC DIVA Laboratories GmbH DIVA Laboratories U.S., LLC Panoramic Imaging Solutions Inc. Diva Capital lnc. The Linden Group Corp. Diva Holding lnc. Expert Alliance Smart Technology Co., Ltd Ginnet Epic Cloud Corex Statinc Grandsys Inc. AdvancedTEK Everlasting Digital ESG Co., Ltd. MRU Brainstorm Ginnet Statinc APEO Datta Owl Aspire Asia Inc. Simula Technology Corp. Simula Company Limited Action Star Technology Co.,Ltd. Aspire Electronics Corp. Simula Company Limited Bigmin Bio-Tech Company Ltd.	Samoa Hong Kong Samoa Hong Kong Taiwan British Virgin Islands Germany Taiwan Taiwan Mauritius Taiwan Orlando, USA Germany USA Taiwan Samoa USA Samoa Macao Taiwan Taiwan South Africa Taiwan Taiwan Taiwan Taiwan Taiwan USA Taiwan Taiwan Taiwan Taiwan Taiwan British Virgin Islands USA Hong Kong Taiwan Samoa Hong Kong Taiwan	Investment and holding activity Sales of automation mechanical transmission system and component Investment and holding activity Investment and holding activity Sales of semiconductor, optoelectronics and machinery equipment, and equipment repair Investment and holding activity Sales and service of energy management product Energy service Manufacture and sales of pallet strapping equipment Investment and holding activity Manufacture and sale of medical consumable and equipment Agency sales Sales of monitor Sales of monitor Sales of monitor Investments in Mainland China Sales of monitor Investments in Mainland China Sales of electronic products and smart services Sales of network and information and communication hardware and software Software and data processing services Sales, import and export of electronic products Market research, marketing consultant and data processing services Software and data processing services Applications implement services Sales and software development R&D and sales of computer information system Wholesale and retail of computers and peripherals product Sales of network and information and communication hardware and software Market research, marketing consultant and data processing services Implementation of application software services Market research, marketing consultant and data processing services Market research, marketing consultant and data processing services Investment and holding activity Sales in North America Investment and holding activity Manufacture of computer and periherals products Investment and holding activity Investment and holding activity Sale of alcohol and medical disinfectant	107,041 - 527,665 4,938 187,000 21,727 138,804 166,760 690,000 518,381 638,740 24,304 25,092 35,858 - 52,908 30,015 52,598 381 120,001 55,000 506,936 69,983 286,613 30,091 5,000 31,000 530,075 172 40 2,060 20,000 3,960 276,221 15,699 187,625 983,858 - 181,726 20,250	107,041 5,120 527,665 4,938 187,000 21,727 138,804 166,760 - 518,381 625,680 24,304 25,092 35,858 24,600 52,908 30,015 52,598 381 120,001 55,000 251,872 69,983 94,547 30,091 5,000 31,000 530,075 172 40 2,060 20,000 - 286,764 15,699 187,625 983,858 95,099 181,726 20,250	4,669 - 17,744 150 6,084 600 (Note 1) 4,993 460 20,215 21,273 300 - - - - - - 100 10,525 5,500 2 1,754 10,813 1,153 500 2,000 233 10 1 200 2,000 100 9,073 500 50,500 32,001 - 46,033 1,500	100.00% - 100.00% 100.00% 60.00% 100.00% 100.00% 99.86% 39.00% 100.00% 36.26% 30.00% 100.00% 100.00% - 100.00% 19.00% 100.00% 100.00% 79.73% 100.00% 100.00% 34.99% 40.15% 34.09% 29.41% 100.00% 35.09% 0.08% 0.02% 100.00% 100.00% 100.00% 100.00% 100.00% 52.31% 59.35% - 47.69% 100.00%	519,280 - 389,016 3,115 233,050 104,019 192,273 223,730 736,719 507,945 633,622 9,343 1,018 21,164 - 9,039 - 9,122 6,636 173,135 58,123 (14,453) 79,730 348,633 39,260 1,953 32,253 459,215 172 40 2,628 1,627 4,526 88,015 53,596 96,625 873,786 - 88,079 32,733	(32,134) - (43,250) 420 19,672 13,991 23,018 29,268 207,087 18,563 93,661 (2,923) (167) 5,578 1,511 (861) 9,004 (862) (3,024) 3,444 1,873 (453,610) (2,000) 30,977 10,915 (1,796) 6,369 (179,987) 3,444 (2,000) 88 (5,335) 1,571 (21,570) 5,583 (45,731) (72,390) 898 (45,731) 5,495	- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -	Affiliates Affiliates Affiliates Affiliates Affiliates Affiliates Affiliates Affiliates Affiliates Affiliates Affiliates Associate Affiliates Affiliates Affiliates Affiliates Associate Affiliates Affiliates Affiliates Affiliates Affiliates Affiliates Affiliates Affiliates Associate Affiliates Affiliates Affiliates Affiliates Affiliates Affiliates Affiliates Affiliates Affiliates Affiliates Affiliates Affiliates Affiliates Affiliates

～ 89 ～

Investor	Investee	Location	Main Businesses and Products	Original investment Amount	Original investment Amount	Balances as of December 31, 2024	Balances as of December 31, 2024	Balances as of December 31, 2024	Net Income (Loss) of the Investee	Investment Income (Loss)	Note
				December 31, 2024	December 31, 2023	Shares	Percentage of Ownership	Carrying Value
GSC GSC GSC Alpha Alpha Alpha Alpha Alpha Alpha Alpha Alpha Alpha Enrich Enrich Enrich Enrich Enrich Hitron Hitron Hitron Hitron Hitron Hitron IDT IDT	E-Strong Medical Technology Co., Ltd. Naisen Kelin Industry Co., Ltd. Chan Guare Industry Co., Ltd. Alpha Solutions Alpha USA Alpha HK ATS Enrich Hitron Alpha VN Indialpha Fiber Logic IDT Transnet APL Rapidtek Indialpha HSM IDT HVN HUS HBV HTG Transnet Fiber Logic	Taiwan Taiwan Taiwan Japan USA Hong Kong USA Taiwan Taiwan Vietnam India Taiwan Taiwan Taiwan Taiwan Taiwan India Samoa Taiwan Vietnam USA The Netherlands Taiwan Taiwan Taiwan	Manufacture of alcohol and dialysate Manufacture and sale of cleaning wipes and non-woven fabrics Sale of cleaning supplies, cleaning wipes and other dental care products Sale of network equipment, components and technical services Sale, marketing and procurement service in USA Investment and holding activity Post-sale service Investment and holding activity Marketing on system integration and production and sales of telecommunication products Manufacture and sales of network products Sales of network products Broadband transmission equipment and services Telecommunication and broadband network system services Operating in network communication products, provide system support services, integrated supply and import and export of network equipment Sale of network equipment, components and technical services Antenna design and production and sales of RF testing products Sales of network products International trade Telecommunication and broadband network system services Production and sale of broadband telecommunications products International trade International trade Investment Operating in network communication products, provide system support services, integrated supply and import and export of network equipment Broadband transmission equipment and services	310,112 114,000 176,000 5,543 51,092 2,033,915 260,497 400,000 4,811,000 1,227,928 10,358 511,688 189,523 - 80,000 108,750 1 172,179 126,091 1,511,735 90,082 59,604 20,000 36,236 96,930	310,112 - - 5,543 51,092 3,143,628 260,497 400,000 4,811,000 1,195,424 - - 189,523 50,000 80,000 108,750 - 172,179 126,091 1,511,735 90,082 59,604 20,000 - -	23,687 2,000 25 1 1,500 485,791 8,100 40,000 200,000 (Note 1) 2,600 7,127 2,575 - 8,000 1,751 - 5,850 16,703 (Note 1) 300 15 2,000 4,000 1,350	71.03% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 62.24% 100.00% 99.99% 31.66% 5.06% - 98.92% 0 0.01% 100.00% 32.82% 100.00% 100.00% 100.00% 100.00% 80.00% 6.00%	316,898 123,029 175,488 16,713 194,437 1,276,248 209,133 278,295 3,901,536 878,626 4,194 506,666 119,956 - 33,873 107,299 1 210,034 668,599 2,069,200 305,151 73,919 3,175 46,859 95,818	14,489 17,898 12,678 (345) 10,513 40,177 4,601 (4,659) (52,139) (141,277) (5,783) 79,846 286,766 8,573 (16,106) (64,988) - 11,959 286,766 (52,911) 15,710 56 (265) 8,573 79,846	- - - - - - - - - - - - - - - - - - - - - - - - -	Affiliates Affiliates Affiliates Affiliates Affiliates Affiliates Affiliates Affiliates Affiliates Affiliates Affiliates Affiliates Affiliates Affiliates Affiliates Associate Affiliates Affiliates Affiliates Affiliates Affiliates Affiliates Affiliates Affiliates Associate

(Note1)There was no shares as the company is a limited liability company.

～ 90 ～

QISDA CORPORATION Information on investments in Mainland China

For the year ended December 31, 2024

(Amounts in thousands of New Taiwan dollars and other currencies, unless specified otherwise)

Table 8

A. Qisda Corporation

1. Information on investments in Mainland China:

Investee Company Name	Main Businesses and Products	Total Amount of Paid-in Capital	Method of Investment	Accumulated Outflow of Investment from Taiwan as of January 1, 2024	Investment Flows	Investment Flows	Accumulated Outflow of Investment from Taiwan as of December 31, 2024	Net Income (Loss) of Investee	% of Ownership of Direct or Indirect Investment	Investment Income (Loss)	Carrying Value as of December 31, 2024	Accumulated Inward Remittance of Earnings as of December 31, 2024
					Outflow	Inflow
Wangcheng Medical Technology (Chengdu) Co., Ltd (“Wangcheng”) BenQ Guru Software Co., Ltd. (“GSS”) Nanjing Silvertown Health & Development Co., Ltd. (“NSHD”) Guangxi Youshan Medical Technology Co., Ltd.(“Youshan”) BenQ Biotech (Shanghai) Co., Ltd. (“BBC”) Suzhou BenQ Investment Co., Ltd. (“BIC”) BenQ Hospital Management Consulting (Nanjing)Co., Ltd.(“NMHC”) Nanjing BenQ Hospital Co., Ltd. (“NMH”) Suzhou BenQ Hospital Co., Ltd. (“SMH”) ShengCheng Trading(Shanghai) Co., Ltd. (“BQsha_EC2”) BenQ Technology (Shanghai) Co., Ltd. (“BQls”) BenQ Intelligent Technology (Shanghai) Co., Ltd.(“BQC_RO”) Qisda Optronics (Suzhou) Co., Ltd. (“QCOS”) Qisda Precision Industry (Suzhou) Co., Ltd. (“QCPS”) Qisda (Shanghai) Co., Ltd. (“QCSH”) Qisda Electronics (Suzhou) Co., Ltd. (“QCES”) BenQ Medical (Shanghai) Co., Ltd. (“BMSH”) Qisda (Suzhou) Co., Ltd. (“QCSZ”)	Sales of medical consumables and equipment R&D and sales of computer information systems Medical services Sales of medical consumables and equipment Manufacture and sales of medical consumables and equipment Investment and holding activity Medical management consulting Medical services Medical services Sales of brand-name electronic products Sales of brand-name electronic products Sales of electronic products in China Manufacture of projectors Manufacture of plastic parts Manufacture of monitors Manufacture of LCD module Sale of medical consumable and equipment Manufacture of monitors and communication devices	2,426,090 (USD 74,000) 44,588 (USD 1,360) 386,863 (USD 11,800) 408,501 (USD 12,460) 2,180,203 (USD 66,500) 163,925 (USD 5,000) 98,355 (USD 3,000) 6,557 (USD 200) 3,279 (USD 100) 6,295,212 (USD 192,015) 2,703,771 (CNY 601,975) 32,785 (USD 1,000) 983,550 (USD 30,000) 449,150 (CNY 100,000) 432,762 (USD 13,200) 898,300 (CNY 200,000) 26,949 (CNY 6,000) 8,983 (CNY 2,000)	(Note 1) (Note 10) (Note 1) (Note 1) (Note 1) (Note 1) (Note 1) (Note 1) (Note 11) (Note 1) (Note 1) (Note 1) (Note 9) (Note 12) (Note 1) (Note 2) (Note 14) (Note 14)	2,327,735 (USD 71,000) - 386,863 (USD 11,800) 408,501 (USD 12,460) 1,573,680 (USD 48,000) 155,729 (USD 4,750) 98,355 (USD 3,000) 6,557 (USD 200) - 9,082,166 (USD 277,022) 3,510,060 (USD 107,063) 62,587 (USD 1,909) 207,791 (USD 6,338) 179,957 (USD 5,489) 318,015 (USD 9,700) 1,077,960 (CNY 240,000) - -	- - - - - - - - - 327,850 (USD 10,000) - - - - - - - -	- - - - - - - - - - - - - - - - - -	2,327,735 (USD 71,000) - 386,863 (USD 11,800) 408,501 (USD 12,460) 1,573,680 (USD 48,000) (Note 8) 155,729 (USD 4,750) 98,355 (USD 3,000) 6,557 (USD 200) (Note 7) - 9,410,016 (USD 287,022) 3,510,060 (USD 107,063) 62,587 (USD 1,909) 207,791 (USD 6,338) 179,957 (USD 5,489) 318,015 (USD 9,700) (Note 6) 1,077,960 (CNY 240,000) (Note 14) (Note 14)	1,189,833 (39,917) 4,604 130,983 (36,096) 32,537 898,879 14,118 (3,143) 451,667 257,087 (662) 169 (155,221) (8,024) (169,494) 24,008 2,537	100% 100% 100% 100% 100% 100% 100% 100% 100% 95.02% 95.02% 95.02% 95.02% 14.25% 100% 70.00% 38.50% 38.50%	1,189,833 (Note 3) (39,917) (Note 4) 4,604 (Note 3) 130,983 (Note 3) (36,096) (Note 4) 32,537 (Note 4) 898,879 (Note 3) 14,118 (Note 4) (3,143) (Note 4) 429,174 (Note 3) 244,284 (Note 3) (629) (Note 4) 161 (Note 4) (22,119) (Note 4) (8,024) (Note 4) (118,646) (Note 4) 9,243 (Note 4) 977 (Note 4)	13,584,546 (18,845) 1,939,436 4,849,358 (1,610,087) 514,057 3,036,152 127,060 66,969 4,476,817 1,918,961 20,947 825,094 152,205 (Note 16) 7,211 571,881 36,201 6,637	- - - 478,759 (USD 14,603) - - - - - - - - - - - - - -

～ 91 ～

Investee Company Name	Main Businesses and Products	Total Amount of Paid-in Capital	Method of Investment	Accumulated Outflow of Investment from Taiwan as of January 1, 2024	Investment Flows	Investment Flows	Accumulated Outflow of Investment from Taiwan as of December 31, 2024	Net Income (Loss) of Investee	% of Ownership of Direct or Indirect Investment	Investment Income (Loss)	Carrying Value as of December 31, 2024	Accumulated Inward Remittance of Earnings as of December 31, 2024
					Outflow	Inflow
Jiangsu Yudi Optical Co., Ltd (“Yudi”) Guigang Donghui Medical Investment Co., Ltd. Shanghai Filter Technology Co., Ltd (“Filter”) Shanghai Perfusion Medical Technology Co., Ltd. Shanghai Zhenglang Medical Equipment Co., Ltd	R&D and manufacture of medical consumables and equipment Sales of medical consumables and equipment Medical services Sales of medical consumables and equipment Sales and Manufacture of Optical Lens	368,303 (CNY 82,000) 44,915 (CNY 10,000) 3,337,292 (CNY 743,024) 26,949 (CNY 6,000) 363,273 (CNY 80,880)	(Note 14) (Note 14) (Note 13) (Note 14) (Note 15)	- - - - -	- - - - -	- - - - -	(Note 13) (Note 14) (Note 14) (Note 14) (Note 15)	(11,795) (10,879) (354,740) 11,598 17,141	70.00% 35.70% 24.01% 35.70% 20.01%	(8,257) (Note 4) (3,884) (Note 4) (85,173) (Note 4) 4,140 (Note 4) 3,430 (Note 4)	243,723 11,380 854,454 (Note 16) 19,226 458,614 (Note 16)	- - - - -

• (Note 1) Indirect investment in Mainland China is through a holding company established in a third country.

• (Note 2) Direct investment in Mainland China.

• (Note 3)Investment income or loss was recognized based on the audited financial statements issued by the auditors of the company or International CPA firm that has a cooperative relationship with ROC CPA firm. (Note 4)Investment income or loss was recognized based on the unaudited financial statements of the company.

• (Note 5)The above amounts were translated into New Taiwan dollars at the exchange rate of US$1 ＝ NT$32.785 and CNY$1=NT$4.4915.

• (Note 6) The amount of GRHK reinvestments US$3,500 thousand were excluded.

• (Note 7) The amount of QCES reinvestments US$800 thousand were excluded.

• (Note 8) The amount of QCES reinvestments US$18,500 thousand were excluded.

• (Note 9) The investment was from the operating capital of BBM.

• (Note 10) The reinvestments were from the distribution of dividends of QLLB.

• (Note 11) The reinvestments were from the distribution of dividends of BQHK.

• (Note 12) NSHD is established by NMH's asset division.

• (Note 13) The investment was from the operating capital of NMH.

• (Note 14) The investment was from the operating capital of BBC. (Note 15) The investment was from the operating capital of QCES.

• (Note 16) Accounting for investments using equity method.

2. Limits on investments in Mainland China:

Accumulated Investment in Mainland China as of December 31, 2024	Investment Amounts Authorized by Investment Commission, MOEA	Upper Limit on Investment
19,723,806 (USD 568,731 and CNY 240,000)	25,166,159 (USD 767,612)	(Note 17)

(Note 17) Since the Company has obtained the Certificate of Headquarter Operation, there is no upper limit on investment in Mainland China.

1. Significant transactions with investee companies in Mainland China:

The transactions between parent and investee companies in Mainland China have been eliminated when preparing the consolidated financial statements. Please refer to section “Information on Significant Transactions” for detail description.

～ 92 ～

B. BenQ Material Corporation

1. Information on investments in Mainland China:

Investee Company Name	Main Businesses and Products	Total Amount of Paid-in Capital	Method of Investment	Accumulated Outflow of Investment from Taiwan as of January 1, 2024	Investment Flows	Investment Flows	Accumulated Outflow of Investment from Taiwan as of December 31, 2024	Net Income (Loss) of Investee	% of Ownership of Direct or Indirect Investment	Investment Income (Loss)	Carrying Value as of December 31, 2024	Accumulated Inward Remittance of Earnings as of December 31, 2024
					Outflow	Inflow
BenQ Materials (Wuhu)Co., Ltd. (“BMW”) BenQ Materials Medical Supplies (Suzhou) Co., Ltd. (“BMM”) BenQ Medical Aesthetics Materials Technology (Wuhu) Co., Ltd. (“BME”) Suzhou Sigma Medical Supplies Co., Ltd. (“SMSZ”) Daxon Biomedical (Suzhou) Co., Ltd. (“DTB”) BenQ Material (Suzhou) Co., Ltd.(“BMS”)	Manufacture and sales of optoelectronics film and cosmetics Manufacture and sales of medical consumables Manufacture and sales of cosmetics Sales of medical consumables and equipment Service and sales of medical consumables Manufacture of optoelectronics film	262,280 (USD 8,000) 49,407 (CNY 11,000) 359,320 (CNY 80,000) 67,373 (CNY 15,000) 22,458 (CNY 5,000) 23,671 (USD 722)	(Note 1) (Note 4) (Note 1) (Note 4) (Note 4) (Note 3)	262,280 (USD 8,000) - 179,660 (CNY 40,000) - - 23,671 (USD722)	- - - - - -	- - - - - -	262,280 (USD 8,000) - 179,660 (CNY 40,000) (Note 5) 23,671 (USD 722) - -	22,984 4,475 31,776 7,561 (851) (1)	100% 100% 100% 100% 100% 100%	22,984 (Note 2) 4,475 (Note 2) 31,873 (Note 2) 7,561 (Note 2) (851) (Note 2) (1) (Note 2)	1,976,081 43,742 (243,048) 55,356 21,609 1,113	- - - - - -

2. Limits on investments in Mainland China:

Investee Company Name	Accumulated Investment in Mainland China as of December 31, 2024	Investment Amounts Authorized by Investment Commission, MOEA	Upper Limit on Investment
BMC	441,940 (USD8,000 and CNY40,000)	580,952 (USD8,000 and CNY70,950)	(Note 7)
SGM	(USD722) 23,671	23,671 (USD722)	80,000

(Note 1)[Indirect investment in Mainland China is through a holding company established in a third country.]

(Note 2)[Investment income or loss was recognized based on the audited financial statements issued by the auditors of BMC.]

(Note 3)[Direct investment in Mainland China.]

(Note 4)[The reinvestments were from the distribution of dividends of BMLB.]

(Note 5)[The amount of BMLB reinvestments CNY$10,950 thousand were excluded.]

(Note 6) The above amounts were translated into New Taiwan dollars at the exchange rate of US$1＝NT$32.785 and CNY$1=NT$4.4915.

(Note 7)[Since BenQ Material Corporation has obtained the Certificate of Headquarter Operation, there is no upper limit on investment in Mainland China.]

3. Significant transactions with investee companies in Mainland China:

The transactions between BMC and its investee companies in Mainland China have been eliminated when preparing the consolidated financial statements. Please refer to section “Information on Significant Transactions” for detail description.

～ 93 ～

C. BenQ Medical Technology Corp.

1. Information on investments in Mainland China

Investee Company Name	Main Businesses and Products	Total Amount of Paid-in Capital	Method of Investment	Accumulated Outflow of Investment from Taiwan as of January 1, 2024	Investment Flows	Investment Flows	Accumulated Outflow of Investment from Taiwan as of December 31, 2024	Net Income (Loss) of Investee	% of Ownership of Direct or Indirect Investment	Investment Income (Loss)	Carrying Value as of December 31, 2024	Accumulated Inward Remittance of Earnings as of December 31, 2024
					Outflow	Inflow
BenQ Intelligent (Shanghai) Medical Co., Ltd. (“BQSH”) K2 (Shanghai) International Medical Inc. BenQ Medical Technology (Shanghai) Ltd. (“BMTS”)	Sales of medical consumables Sales of medical consumables and equipment Agency of international and entrepot trade business	65,570 ( USD 2,000) 6,885 ( USD 210) 40,981 (USD 1,250)	(Note 2) (Note 1) (Note 2)	32,785 ( USD 1,000) 6,885 ( USD 210) 63,373 (USD 1,933)	32,785 ( USD 1,000) - -	- - -	65,570 ( USD 2,000) 6,885 ( USD 210) 63,373 (USD 1,933)	(869) (6,193) 19,833	100% 40% 100%	(6,193) (Note 3) (869) (Note 4) 7,933 (Note 3)	47,710 318 54,686	- - -

(Note 1) Indirect investment in Mainland China is through a holding company established in a third country.

(Note 2) Direct investment in Mainland China.

(Note 3) Investment income or loss was recognized based on the audited financial statements issued by the auditors of BMTC.

(Note 4) Investment income or loss was recognized based on the unaudited financial statements of the company.

(Note 5) There was no shares as the investee company is a limited liability company.

(Note 6) The above amounts were translated into New Taiwan dollars at the exchange rate of US$1 ＝ NT$32.785.

2. Limits on investments in Mainland China:

Investee Company Name	Accumulated Investment in Mainland China as of December 31, 2024	Investment Amounts Authorized by Investment Commission, MOEA	Upper Limit on Investment
BMTC	65,570 (USD 2,000)	65,570 (USD 2,000)	673,235
SGM	6,885 (USD 210)	6,885 (USD 210)	126,246
K2	(USD 1,933) 63,373	(USD 1,933) 63,373	392,603

(Note 7) In April 2024, Lily sold its entire ownership of BQSH to BMTS. As of December 31, 2024, the capital has not been remitted and the investment in Mainland China has not been cancelled.

1. Significant transactions with investee companies in Mainland China:

The transactions between BMTC and its investee companies in Mainland China have been eliminated when preparing the consolidated financial statements. Please refer to section “Information on Significant Transactions” for detail description.

～ 94 ～

D. Partner Tech Corp.

1. Information on investments in Mainland China

Investee Company Name	Main Businesses and Products	Total Amount of Paid-in Capital	Method of Investment	Accumulated Outflow of Investment from Taiwan as of January 1, 2024	Investment Flows	Investment Flows	Accumulated Outflow of Investment from Taiwan as of December 31, 2024	Net Income (Loss) of Investee	% of Ownership of Direct or Indirect Investment	Investment Income (Loss)	Carrying Value as of December 31, 2024	Accumulated Inward Remittance of Earnings as of December 31, 2024
					Outflow	Inflow
Partner Tech (Shanghai) Co., Ltd.(“PTCM”)	Sales, purchase, import and export of electronic products	114,748 (USD 3,500)	(Note 1)	114,748 (USD 3,500)	-	-	114,748 (USD 3,500)	376	100%	376 (Note 2)	59,941	-

(Note 1) Indirect investment in Mainland China is through a holding company established in a third country.

(Note 2) Investment income or loss was recognized based on the unaudited financial statements of the company. (Note 3) The above amounts were translated into New Taiwan dollars at the exchange rate of US$1 ＝ NT$32.785.

2. Limits on investments in Mainland China:

Investee Company Name	Accumulated Investment in Mainland China as of December 31, 2024	Investment Amounts Authorized by Investment Commission, MOEA	Upper Limit on Investment
PTT	114,748 (USD 3,500)	226,413 (USD 6,906)	735,862

3. Significant transactions with investee companies in Mainland China:

The transactions between PTT and its investee companies in Mainland China have been eliminated when preparing the consolidated financial statements. Please refer to section “Information on Significant Transactions” for detail description.

～ 95 ～

E. DFI Inc.

1. Information on investments in Mainland China

Investee Company Name	Main Businesses and Products	Total Amount of Paid-in Capital	Method of Investment	Accumulated Outflow of Investment from Taiwan as of January 1, 2024	Investment Flows	Investment Flows	Accumulated Outflow of Investment from Taiwan as of December 31, 2024	Net Income (Loss) of Investee	% of Ownership of Direct or Indirect Investment	Investment Income (Loss) (Note 2)	Carrying Value as of December 31, 2024	Accumulated Inward Remittance of Earnings as of December 31, 2024
					Outflow	Inflow
Yan Ying Hao Trading (ShenZhen) Co., Ltd. (“DYTH”)	Wholesale, import and export of industrial motherboards and component	15,393	(Note 1)	-	-	-	-	9,702	100%	9,702	29,385	-

2. Limits on investments in Mainland China:

2. Limits on investments in Mainland China:
Investee Company Name	Accumulated Investment in Mainland China as of December 31, 2024	Investment Amounts Authorized by Investment Commission, MOEA	Upper Limit on Investment
DFI	- (Note 3)	16,393 (USD 500) (Note 5 and 6)	3,502,336 (Note 4)

(Note 1) Indirect investment in Mainland China is through a holding company established in a third country.

(Note 2) Investment income or loss was recognized based on the audited financial statements issued by the auditors of DFI.

(Note 3) The reinvestments and authorized amount of DFI's subsidiaries is excluded from DFI's accumulated investment amounts and the investment amounts authorized by Investment Commission, MOEA. (Note 4) Pursuant to “Principle of Investment or Technical Cooperation in Mainland China”, investment amounts in Mainland China shall not exceed the 60% net worth of the company.

(Note 5) The investment amount of Dongguan Ri Tong Trading Co., Ltd. that has been liquidated was approved by Investment Commission, MOEA in August 2014 and had been deducted in the investment amount. (Note 6) The earnings that has been remitted to DFI by DYTI was approved by the Investment Commission of the MOEA in February 2017 and had been deducted in the investment amount. (Note 7) The above amounts were translated into New Taiwan dollars at the exchange rate of US$1 ＝ NT$32.785.

3. Significant transactions with investee companies in Mainland China:

The transactions between DFI and its investee companies in Mainland China have been eliminated when preparing the consolidated financial statements. Please refer to section “Information on Significant Transactions” for detail description.

～ 96 ～

F. Aewin Technologies Co., Ltd.

1. Information on investments in Mainland China

Investee Company Name	Main Businesses and Products	Total Amount of Paid-in Capital	Method of Investment	Accumulated Outflow of Investment from Taiwan as of January 1, 2024	Investment Flows	Investment Flows	Accumulated Outflow of Investment from Taiwan as of December 31, 2024	Net Income (Loss) of Investee	% of Ownership of Direct or Indirect Investment	Investment Income (Loss)	Carrying Value as of December 31, 2024	Accumulated Inward Remittance of Earnings as of December 31, 2024
					Outflow	Inflow
Aewin Beijing Technologies Co., Ltd. Aewin (Shenzhen) Technologies Co., Ltd.	Wholesale of computer peripheral products and software Wholesale of computer peripheral products and software	46,129 15,265	(Note 1) (Note 2)	46,129 -	- -	- -	46,129 -	1,288 (38,355)	100% (Note 7)	(38,355) (Note 3) 1,288 (Note 3)	112,472 (Note 7)	- -

2. Limits on investments in Mainland China:

2. Limits on investments in Mainland China:
Investee Company Name	Accumulated Investment in Mainland China as of December 31, 2024	Investment Amounts Authorized by Investment Commission, MOEA	Upper Limit on Investment
AEWIN	46,129	49,178 (USD 1,500)	840,667 (Note 5)

(Note 1) Indirect investment in Mainland China is through a holding company established in a third country.

(Note 2) Invested in Mainland China through Aewin Beijing Technologies Co., Ltd.

(Note 3) Investment income or loss was recognized based on the audited financial statements by the auditors of AEWIN.

(Note 4) The above amounts were translated into New Taiwan dollars at the exchange rate of US$1 ＝ NT$32.785.

(Note 5) Pursuant to “Principle of Investment or Technical Cooperation in Mainland China”, investment amounts in Mainland China shall not exceed the 60% net worth of the company.

(Note 6) There was no shares as the investee company is a limited liability company.

(Note 7) Aewin (Shenzhen) Technologies Co., Ltd. completed its liquidation in June 2024 and completed its deregistration in July 2024.

3. Significant transactions with investee companies in Mainland China:

The transactions between AEWIN and its investee companies in Mainland China have been eliminated when preparing the consolidated financial statements. Please refer to section “Information on Significant Transactions”for detail description.

～ 97 ～

G. Ace Pillar Co., Ltd.

1. Information on investments in Mainland China

Investee Company Name	Main Businesses and Products	Total Amount of Paid-in Capital	Method of Investment	Accumulated Outflow of Investment from Taiwan as of January 1, 2024	Investment Flows	Investment Flows	Accumulated Outflow of Investment from Taiwan as of December 31, 2024	Net Income (Loss) of Investee	% of Ownership of Direct or Indirect Investment	Investment Income (Loss)	Carrying Value as of December 31, 2024	Accumulated Inward Remittance of Earnings as of December 31, 2024
					Outflow	Inflow
Standard International Trading (Shanghai) Co., Ltd. Tianjin Ace Pillar Co., Ltd. Grace Transmission (Tianjin) Co., Ltd. Suzhou Super Pillar Automation Equipment Co., Ltd. Advancedtek Ace (TJ) Inc.	Sales of semiconductor optoelectronics equipment and consumables and equipment repair services Sales of automation mechanical transmission system and component Manufacture of automation mechanical transmission system and component Manufacture of automation mechanical transmission system and component Electronic system integration	1,157,212 9,836 47,538 15,737 -	(Note 1) (Note 1) (Note 1) (Note 1) (Note 1)	63,931 5,246 4,918 (Note 2) 15,737	- - - - -	- - - - -	63,931 5,246 4,918 (Note 2) 15,737	- 419 7,101 13,878 (51,736)	100% 100% (Note 7) 100% 100%	(51,736) (Note 3) - 419 (Note 3) 7,101 (Note 3) 13,878 (Note 3)	459,253 3,086 118,611 89,689 (Note 7)	125,533 160,279 - - -

2. Limits on investments in Mainland China:

2. Limits on investments in Mainland China:
Investee Company Name	Accumulated Investment in Mainland China as of December 31, 2024	Investment Amounts Authorized by Investment Commission, MOEA	Upper Limit on Investment
ACE	(USD 5,119) 167,826	(USD 5,119) 167,826	1,740,480 (Note 5)
STC	15,737 (USD 480)	15,737 (USD 480)	120,638 (Note 5)

(Note 1) Indirect investment in Mainland China is through a holding company established in a third country.

(Note 2) Established by Cyber South's reinvestment.

(Note 3) Investment income or loss was recognized based on the audited financial statements by the auditors of ACE. (Note 4) There was no shares as the investee company is a limited liability company.

(Note 5) Pursuant to “Principle of Investment or Technical Cooperation in Mainland China”, investment amounts in Mainland China shall not exceed the 60% net worth of the company.

(Note 6) The above amounts were translated into New Taiwan dollars at the exchange rate of US$1 ＝ NT$32.785 and CNY$1=NT$4.4915.

(Note 7) Grace Transmission (Tianjin) Co., Ltd. approved its dissolution in January 2022 and completed its liquidation in January 2024.

1. Significant transactions with investee companies in Mainland China:

The transactions between ACE and its investee companies in Mainland China have been eliminated when preparing the consolidated financial statements. Please refer to section “Information on Significant Transactions”for detail description.

～ 98 ～

H. Data Image Corporation

1. Information on investments in Mainland China

Investee Company Name	Main Businesses and Products	Total Amount of Paid-in Capital	Method of Investment	Accumulated Outflow of Investment from Taiwan as of January 1, 2024	Investment Flows	Investment Flows	Accumulated Outflow of Investment from Taiwan as of December 31, 2024	Net Income (Loss) of Investee	% of Ownership of Direct or Indirect Investment	Investment Income (Loss) (Note 2)	Carrying Value as of December 31, 2024	Accumulated Inward Remittance of Earnings as of December 31, 2024
					Outflow	Inflow
Data Image (Suzhou) Corporation	Manufacture and sales of LCD	534,081	(Note 1)	511,884	-	-	511,884	18,598	100%	18,598	506,552	-

2. Limits on investments in Mainland China:

2. Limits on investments in Mainland China:
Accumulated Investment in Mainland China as of December 31, 2024	Investment Amounts Authorized by Investment Commission, MOEA	Upper Limit on Investment
USD 15,654	USD 16,952	(Note 3) 1,665,497

(Note 1) Indirect investment in Mainland China is through a holding company established in a third country. (Note 2) Investment income or loss was recognized based on the audited financial statements issued by the auditors of DIC. (Note 3) Pursuant to“Principle of Investment or Technical Cooperation in Mainland China”, investment amounts in Mainland China shall not exceed the 60% net worth of DIC.

3. Significant transactions with investee companies in Mainland China:

The transactions between DIC and its investee companies in Mainland China have been eliminated when preparing the consolidated financial statements. Please refer to section “Information on Significant Transactions” for detail description.

～ 99 ～

I.DIVA Laboratories. Ltd.

1. Information on investments in Mainland China

Investee Company Name	Main Businesses and Products	Total Amount of Paid-in Capital	Method of Investment	Accumulated Outflow of Investment from Taiwan as of January 1, 2024	Investment Flows	Investment Flows	Accumulated Outflow of Investment from Taiwan as of December 31, 2024	Net Income (Loss) of Investee	% of Ownership of Direct or Indirect Investment	Investment Income (Loss) (Note 2)	Carrying Value as of December 31, 2024	Accumulated Inward Remittance of Earnings as of December 31, 2024
					Outflow	Inflow
Suzhou Diva Lab. Inc.	Wholesale and import and export of medical equipment	52,643	(Note 1)	52,643	-	-	52,643	(861)	100%	(861)	9,081	-

2. Limits on investments in Mainland China:

2. Limits on investments in Mainland China:
Accumulated Investment in Mainland China as of December 31, 2024	Investment Amounts Authorized by Investment Commission, MOEA	Upper Limit on Investment
USD 1,725	USD 2,000	633,301 (Note 3)

(Note 1) Indirect investment in Mainland China is through a holding company established in a third country.

(Note 2) Investment income or loss was recognized based on the audited financial statements issued by the auditors of DIVA.

(Note 3) Pursuant to“Principle of Investment or Technical Cooperation in Mainland China”, investment amounts in Mainland China shall not exceed the 60% net worth of DIVA.

3. Significant transactions with investee companies in Mainland China:

The transactions between DIVA and its investee companies in Mainland China have been eliminated when preparing the consolidated financial statements. Please refer to section “Information on Significant Transactions” for detail description.

～ 100 ～

J. Simula Technology Inc.

1. Information on investments in Mainland China

Investee Company Name	Main Businesses and Products	Total Amount of Paid-in Capital	Method of Investment	Accumulated Outflow of Investment from Taiwan as of January 1, 2024	Investment Flows	Investment Flows	Accumulated Outflow of Investment from Taiwan as of December 31, 2024	Net Income (Loss) of Investee	% of Ownership of Direct or Indirect Investment	Investment Income (Loss) (Note 2)	Carrying Value as of December 31, 2024	Accumulated Inward Remittance of Earnings as of December 31, 2024
					Outflow	Inflow
Simula Technology (ShenZhen) Co., Ltd.	Manufacture of electronic connector, socket and plastic hardware	191,437	(Note 1)	141,375	-	-	141,375	(42,332)	100%	(42,332)	94,714	-

1. Limits on investments in Mainland China:

2. Limits on investments in Mainland China:
Investee Company Name	Accumulated Investment in Mainland China as of December 31, 2024	Investment Amounts Authorized by Investment Commission, MOEA	Upper Limit on Investment
Simula	247,212	297,274	1,166,166

(Note 1) Indirect investment in Mainland China is through a holding company established in a third country.

(Note 2) Investment income or loss was recognized based on the audited financial statements by the auditors of Simula.

3. Significant transactions with investee companies in Mainland China:

The transactions between Simula and its investee companies in Mainland China have been eliminated when preparing the consolidated financial statements. Please refer to section “Information on Significant Transactions” for detail description.

～ 101 ～

K.Alpha Networks Inc.

1. Information on investments in Mainland China

Investee Company Name	Main Businesses and Products	Total Amount of Paid-in Capital	Method of Investment	Accumulated Outflow of Investment from Taiwan as of January 1, 2024	Investment Flows	Investment Flows	Accumulated Outflow of Investment from Taiwan as of December 31, 2024	Net Income (Loss) of Investee	% of Ownership of Direct or Indirect Investment	Investment Income (Loss) (Note 2)	Carrying Value as of December 31, 2024	Accumulated Inward Remittance of Earnings as of December 31, 2024
					Outflow	Inflow
Alpha Networks (Changshu Trading) Co., Ltd. Alpha Networks (Changshu) Co., Ltd. Alpha Networks (Chengdu) Co.,Ltd. Alpha Networks (Dongguan) Co., Ltd. Mirac Networks (Dongguan) Co.,Ltd.	Production and sale of network products Production and sale of network products Research and development of network products Production and sale of network products Production and sale of network products	420,426 97,023 107,131 (Note 9) 1,925,920 17,378	(Note 10) (Note 1) (Note 1 ) (Note 1) (Note 1)	420,426 114,197 307,326 1,925,920 -	- - - - -	- - - - -	420,426 114,197 (Note 6) 307,326 1,925,920 -	32,493 5,990 16,405 4,138 (1,071)	100% 100% 100% 100% -	16,405 (1,071) 4,138 32,493 5,990	496,289 (Note 8) 32,725 1,251,808 10,412	147,231 692,935 - - -

2. Limits on investments in Mainland China:

2. Limits on investments in Mainland China:
Investee Company Name	Accumulated Investment in Mainland China as of December 31, 2024	Investment Amounts Authorized by Investment Commission, MOEA	Upper Limit on Investment
Alpha	2,634,897 (Note 3、4 and 7)	3,496,798	(Note 5)

• (Note 1) Indirect investment in Mainland China is through a holding company established in a third country.

(Note 2) Investment income or loss was recognized based on the audited financial statements by the auditors of Alpha. (Note 3) Accumulated investments in Alpha Dongguan did not include the previously invested by D-Link Corporation HKD69,387 thousand (equivalent to approximately $303,055 thousand).

• (Note 4) Alpha indirectly investment the subsidiary Tongying Trading (Shenzhen) Co., Ltd., has liquidated all rights and obligations in March 2008 and cancelled the registration.Accumulated outflow of $9,828 thousand in Tongying Trading (Shenzhen) Co., Ltd., less the remittance amount of $4,367 thousand equals $5,461 thousand. It is still necessary to include in the accumulated investment amount by the principle of Investment Commission, MOEA.

• (Note 5) As Alpha has obtained the certificate No. 11120417620 of being qualified for operating headquarters issued by Ministry of Economic Affairs on June, 8 2022, the upper limit on investment in mainland China pursuant to “Principle of investment or Technical Cooperation in Mainland China”issued by Investment Commission, MOEA on August, 29, 2008 is not applicable.

• (Note 6) The investment of $46,412 thousand is from the operating capital of D-Link Asia, so the accumulated investment amount from Taiwan is excluded at the end of the period.

• (Note 7) Alpha indirectly investment the subsidiary Mingzhen (Changshu) has liquidated all rights and obligations on July 23, 2018 and cancelled the registration. Accumulated outflow of $164,622 thousand is still necessary to include in the accumulated investment amount by the principle of Investment Commission, MOEA.

• (Note 8) On December 28, 2023, Alpha entered into a stock transfer agreement to dispose its entire ownership in D-Link Asia and Alpha DGF, which were classified as non-current assets held for sale. The abovementioned transaction has been completed in the second quarter of 2024.

(Note 9) On December 19, 2022, the related registration of capital reduction has been completed while the capital has not been remitted as of December 31, 2024.

• (Note 10) Alpha CD was previously reinvested through D-Link Asia. D-Link Asia entered into an agreement with Alpha to transfer the entire ownership of Alpha CD to Alpha on June 15, 2023.

• Significant transactions with investee companies in Mainland China:

The transactions between Alpha and its investee companies in Mainland China have been eliminated when preparing the consolidated financial statements. Please refer to section “Information on Significant Transactions” for detail description.

～ 102 ～

L.Hitron Technologies Inc.

1. Information on investments in Mainland China

Investee Company Name	Main Businesses and Products	Total Amount of Paid-in Capital	Method of Investment	Accumulated Outflow of Investment from Taiwan as of January 1, 2024	Investment Flows	Investment Flows	Accumulated Outflow of Investment from Taiwan as of December 31, 2024	Net Income (Loss) of Investee	% of Ownership of Direct or Indirect Investment	Investment Income (Loss) (Note 2)	Carrying Value as of December 31, 2024	Accumulated Inward Remittance of Earnings as of December 31, 2024
					Outflow	Inflow
IHC HSZ HJT	Technical consultation on electronic communication, technology research and development, maintenance and after-sale service Research and development of broadband telecommunications products Sale of broadband network products and related services	171,245 31,139 2,907	(Note 1) (Note 1) (Note 3)	171,245 31,139 12,048	- - -	3,194 - -	171,245 31,139 8,854	1,177 11,962 (4)	100% 100% 32.82%	11,962 (4) 402	209,891 3,797 3,082	- - 30,079

2. Limits on investments in Mainland China:

2. Limits on investments in Mainland China:
Investee Company Name	Accumulated Investment in Mainland China as of December 31, 2024	Investment Amounts Authorized by Investment Commission, MOEA	Upper Limit on Investment
Hitron	211,238	214,432	2,975,972

(Note 1) Indirect investment in Mainland China is through a holding company established in a third country.

(Note 2) Investment income or loss was recognized based on the audited financial statements by the auditors of Hitron. (Note 3) IHC is a China based investment company which was originally invested by Hitron (Samoa) , however, IHC has been 100% owned by IDT due to the Group's restructuring decision resolved in year 2012.

3. Significant transactions with investee companies in Mainland China:

The transactions between Hitron and its investee companies in Mainland China have been eliminated when preparing the consolidated financial statements. Please refer to section “Information on Significant Transactions” for detail description.

～ 103 ～

M.Grandsys Inc.

1. Information on investments in Mainland China

Investee Company Name	Main Businesses and Products	Total Amount of Paid-in Capital	Method of Investment	Accumulated Outflow of Investment from Taiwan as of January 1, 2024	Investment Flows	Investment Flows	Accumulated Outflow of Investment from Taiwan as of December 31, 2024	Net Income (Loss) of Investee	% of Ownership of Direct or Indirect Investment	Investment Income (Loss) (Note 1)	Carrying Value as of December 31, 2024	Accumulated Inward Remittance of Earnings as of December 31, 2024
					Outflow	Inflow
SYSAGE TECHNOLOG (SHANGHAI) CO., LTD Grandsys Technology & Service Corp.	R&D and manufacture of computer software and hardware and equipment, network technology, system integration and sales of self-produced components and technical services R&D and manufacture of computer software and hardware and equipment, network technology, system integration and sales of self-produced components and technical services	36,064 (USD1,100) 32,785 (USD1,000)	(Note 2) (Note 2)	36,064 (USD1,100) 32,785 (USD1,000)	- -	- -	36,064 (USD1,100) 32,785 (USD1,000)	(5,757) 7	100% 100%	(5,757) 7	53,796 6,178	- -

2. Limits on investments in Mainland China:

2. Limits on investments	in Mainland China:
Investee Company Name	Accumulated Investment in Mainland China as of December 31, 2024	Investment Amounts Authorized by Investment Commission, MOEA	Upper Limit on Investment
Grandsys	68,849 (USD2,100)	68,849 (USD2,100)	2,444,291

(Note 1) Investment income or loss was recognized based on the unaudited financial statements of the company.

(Note 2) Direct investment in Mainland China. (Note 3) The above amounts were translated into New Taiwan dollars at the exchange rate of US$1 ＝ NT$32.785.

3. Significant transactions with investee companies in Mainland China:

The transactions between Grandsys and its investee companies in Mainland China have been eliminated when preparing the consolidated financial statements. Please refer to section “Information on Significant Transactions” for detail description.

～ 104 ～

105

Qisda Corporation

Statement of Cash and Cash Equivalents

December 31, 2024

(Expressed in Thousands of New Taiwan Dollar)

Items Demand deposits Foreign currency deposits (Note)	Description Amount $ 385,759 USD：44,916 thousand 1,472,576 AUD：99 thousand 2,025 Others 1,545 $ 1,861,905

Note: Foreign currency deposits were translated at the spot exchange rate on December 31, 2024 as follows: USD ： NTD = 1 ： 32.785

AUD ： NTD = 1 ： 20.396

－ Statement of Financial Assets at Fair Value through Profit or Loss Current

Name of Financial Instrument Listed stocks－ITH Corp. Foreign currency forward contracts Foreign exchange swaps	Share Amount 3,000 $ 164,400 - 3,755 - 1,608 $ 169,763

(Continued)

106

Qisda Corporation

Statement of Notes and Accounts Receivable

December 31, 2024

(Expressed in Thousands of New Taiwan Dollar)

Client Name		Amount
Customer A	$	5,460,187
Customer B		1,358,326
Customer C		983,776
Customer D		650,714
Customer E		625,692
Others (Note)		1,904,322
		10,983,017
Less: loss allowance		(15,703)
	$	10,967,314
Note: The amount of each item in others did not exceed 5% of the account balance.

(Continued)

107

Qisda Corporation

Statement of Inventories

December 31, 2024

(Expressed in Thousands of New Taiwan Dollar)

Item Raw materials Work in progress Finished goods Work in process－outsourced Inventories in transit	Amount	Amount
	Carrying Amount (Note) $ 1,023,478 174,184 5,522,270 356,532 43,780 $ 7,120,244	Net Realizable Value
		1,082,188 174,184 5,668,997 356,532 43,780
		7,325,681

Note: Provision of inventory obsolescence has been deducted.

Statement of Other Current Assets

	Item		Amount
Prepaid software expenses		$	17,481
Excess business tax paid			15,821
Deferred modeling expense			1,656
Others			11,611
		$	46,569

(Continued)

108

Qisda Corporation

－ Statement of Changes in Financial Assets at Fair Value through Profit or Loss Non-Current

December 31, 2024

(Expressed in Thousands of New Taiwan Dollar/Shares)

Name Privately held stocks－Fong Huang 6 Privately held stocks－Dunpin No.1 Privately held stocks－Dunpin No.2	Balance as of January 1, 2024 Share Amount - $ - - - - - $ -	Balance as of January 1, 2024 Share Amount - $ - - - - - $ -	Addition Decrease Balance as of December 31, 2024 Share Amount Share Amount Share Amount Collateral Note 29,500 295,000 - - 29,500 287,871 - - 3,000 30,000 - - 3,000 31,598 - - 3,000 30,000 - - 3,000 31,572 - - 355,000 - 351,041
	Share		Share 29,500 3,000 3,000
	- - -	$ - - - $ -

(Continued)

109

Qisda Corporation

－ Statement of Changes in Financial Assets at Fair Value through Other Comprehensive Income Non-Current

For the year ended December 31, 2024

(Expressed in Thousands of New Taiwan Dollar/Shares)

Name Listed stocks－AU Optronics Corp. (“AU”) Emerging stocks－APLEX Technology, Inc. (“APLEX”) Privately held stocks－TXOne Networks Inc. Privately held stocks－SCT Holdings Privately held stocks－DRAGONFLY UNMANNED AIRCRAFT SYSTEMS CO., LTD.	Balance as of January 1, 2024 Share Amount 530,879 $ 9,635,452 1,388 72,150 909 - 800 2,134 - - $ 9,709,736	Addition Share Amount - - - - - - - - 1,000 40,000 40,000	Decrease Share Amount - - 1,388 71,595 - - - - - - 71,595	Unrealized Gain(Loss) (1,858,076) (555) - (2,134) - (1,860,765)	Balance as of December 31, 2024 Share Amount Collateral 530,879 7,777,376 - - - - 909 - - 800 - - 1,000 40,000 - 7,817,376
	Share 530,879 1,388 909 800 -	Share - - - - 1,000	Share - 1,388 - - -		Share 530,879 - 909 800 1,000

(Continued)

110

Qisda Corporation

－ Statement of Other Financial Assets Non-Current December 31, 2024 (Expressed in Thousands of New Taiwan Dollar)

Item		Amount
Refundable deposits	$	48,931
Statement of Other Non-Current Assets
Item		Amount
Deferred cost－issuance cost from syndicated loan	$	24,985
Prepayments for investments		15,000
	$	39,985

(Continued)

111

Qisda Corporation

Statement of Changes in Investments Accounted for Using the Equity Method

For the year ended December 31, 2024

(Expressed in Thousands of New Taiwan Dollar/Shares)

Name of Investee	Balance as of January 1, 2024	Balance as of January 1, 2024	Additions	Additions	(Note 1)	Decrease (Note 2)	Decrease (Note 2)	Decrease (Note 2)		Investment Income (Loss)	Other Adjustments (Note 3)	Other Adjustments (Note 3)	Balance as of December 31, 2024	Balance as of December 31, 2024	Balance as of December 31, 2024	Balance as of December 31, 2024	Market Value or Net Assets Value Unit Price Total (in NTD) Amount Collateral 28.87 9,239,160 - 157.65 18,011,224 - 43.55 2,526,118 - 16.82 4,323,576 - 29.01 3,149,461 - 7.81 390,438 - 52.31 313,880 - 30.00 1,309,770 - - 65,805 - 96.95 96,949 - 143.50 3,184,070 - 9.10 6,822 - 9.68 28,464 - 24.24 1,056,306 - 74.50 3,844,945 - 1.02 28,534 - 10.20 1,020 - 12.43 74,571 - 35.15 10,397,265 - 45.65 1,109,067 - 93,673.00 93,673 - 50.80 4,919,523 - 85.57 492,028 - - 334,056 - - 700,470 - 38.36 1,150,800 - 18.51 336,884 - 105.89 499,824 - 44.52 117,434 - 50.40 69,955 -
	Share	Amount	Share		Amount	Share		Amount					Share	Percentage of Ownership		Amount	Unit Price (in NTD)
BenQ QLLB DFN APV BBHC QLPG Darly BMC QJTO QALA Norbel H2 Energy Co., Ltd. Marketop Smart PTT DFI BDT QTOS Q.S.C Alpha DIC EASC MTG Topview QVH BBC Simula GSC TCI Gene Rapidtek APLEX Less: adjustments of unrealized profits and losses resulting from transactions with subsidiaries and associates	320,000 114,250 58,005 201,181 108,555 50,000 6,000 43,659 - 1,000 10,000 150 - 43,577 51,610 28,000 100 6,000 295,797 20,000 1 96,841 5,750 - - 30,000 17,500 4,720 2,638 -	$ 9,074,526 16,325,539 2,546,239 3,804,909 2,816,442 366,535 275,239 715,694 40,250 70,580 1,710,470 1,331 - 1,335,090 2,718,415 36,561 1,017 69,424 7,725,175 410,107 91,688 2,737,028 530,708 304,885 795,686 565,240 322,588 514,309 137,042 - 56,042,717 (343,769) $ 55,698,948	- - - 55,878 - - - - - - 5,220 600 2,940 - - - - - - 4,295 - - - - - - 700 - - 1,388		- - - 280,000 - - - - - - 913,500 6,000 29,400 - - - - - - 283,534 - - - - - - - - - - 1,512,434 - 1,512,434	- - - - - - - - - - - - - - - - - - - - - - - - - - - - - -		(1,381,982) (422,552) (232,019) - - - - (52,391) - - (60,968) - - (43,577) (154,830) - (12) - (298,755) (71,089) - (266,313) (17,250) - - - - (4,720) - - (3,006,458) - (3,006,458)		1,203,784 929,913 127,484 161,217 224,716 (8,753) 29,487 29,875 21,088 21,340 (746) (573) (936) 45,203 97,735 (8,027) 15 5,816 (82,611) 64,626 (4,547) 55,992 38,274 10,537 (118,300) (53,543) 14,296 (3,346) (19,594) - 2,780,422 126,008 2,906,430		342,832 1,178,324 (41,907) 77,450 108,303 32,656 9,154 14,240 4,467 5,029 (72,814) 64 - 11,235 133,672 - - (669) 125,958 (102,089) 6,532 14,012 - 18,634 23,084 7,027 - (6,419) (14) 71,595 1,960,356 - 1,960,356	320,000 114,250 58,005 257,059 108,555 50,000 6,000 43,659 - 1,000 15,220 750 2,940 43,577 51,610 28,000 100 6,000 295,797 24,295 1 96,841 5,750 - - 30,000 18,200 4,720 2,638 1,388	100.00 100.00 21.02 100.00 44.32 100.00 100.00 13.61 100.00 100.00 40.66 25.00 49.00 58.04 45.08 100.00 100.00 20.00 54.60 31.11 54.00 51.41 20.00 100.00 70.00 37.51 50.00 17.84 8.79 3.74		9,239,160 18,011,224 2,399,797 4,323,576 3,149,461 390,438 313,880 707,418 65,805 96,949 2,489,442 6,822 28,464 1,347,951 2,794,992 28,534 1,020 74,571 7,469,767 585,089 93,673 2,540,719 551,732 334,056 700,470 518,724 336,884 499,824 117,434 71,595 59,289,471 (217,761) 59,071,710	28.87 157.65 43.55 16.82 29.01 7.81 52.31 30.00 - 96.95 143.50 9.10 9.68 24.24 74.50 1.02 10.20 12.43 35.15 45.65 93,673.00 50.80 85.57 - - 38.36 18.51 105.89 44.52 50.40

Note 1: Additions arose from the increase in investment for a cash consideration of $1,512,434. Note 2: Decrease arose from cash dividends received from investees.

Note Note	1: Additions arose from the increase in investment for a cash consideration of $1,512,434. 2: Decrease arose from cash dividends received from investees.
Note	3: Other adjustments
	Foreign currency translation differences	$	2,009,036
	Unrealized loss from investments in equity instruments measured at FVOCI		(177,357)
	Change in capital surplus		250,172
	Difference between consideration and carrying amount arising from acquisition or
	disposal of shares of subsidiaries (capital surplus and retained earnings)		(172,150)
	Remeasurements of defined benefit plans		53,425
	Gain on disposal of investments		(74,365)
	Reclassification from financial assets at fair value through other comprehensive income		71,595
		$	1,960,356

(Continued)

112

Qisda Corporation

Statement of Notes and Accounts Payable

December 31, 2024

(Expressed in Thousands of New Taiwan Dollar)

	Vendor Name		Amount
Vendor A		$	565,093
Vendor B			168,462
Vendor C			124,285
Vendor D			111,053
Others (Note)			1,083,714
		$	2,052,607

Note: The amount of each item in others did not exceed 5% of the account balance.

Statement of Short-Term Borrowings

Type of Loan	Creditor First Commercial Bank Land Bank of Taiwan The Export-Import Bank of the Republic of China Bank of Taiwan Yuanta Commercial Bank DBS Bank DBS Bank (Taiwan) Sumitomo Mitsui Bank HSBC Bank Taipei Fubon Bank	Ending Balance $ 500,000 550,000 600,000 1,500,000 500,000 900,000 900,000 1,000,000 900,000 944,550 $ 8,294,550	Contract Period 2024/06~2025/06 2024/07~2025/07 2024/04~2025/04 2024/05~2025/05 2024/08~2025/08 2024/10~2025/10 2024/10~2025/10 2024/07~2025/07 2024/07~2025/07 2024/08~2025/08	Interest Rates 0.68%~1.99%	Credit Facilities Collateral 500,000 - 550,000 - 600,000 - 1,500,000 - 500,000 - 983,550 - 983,550 - 1,000,000 - 983,550 - 2,000,000 -
Unsecured loan Unsecured loan Unsecured loan Unsecured loan Unsecured loan Unsecured loan Unsecured loan Unsecured loan Unsecured loan Unsecured loan

(Continued)

113

Qisda Corporation

Statement of Other Payables

December 31, 2024

(Expressed in Thousands of New Taiwan Dollar)

Item		Amount
Salaries and bonus payables	$	641,006
Accrued compensated absence		110,115
Others (Note)		749,872
	$	1,500,993
Note: The amount of each item in others did not exceed 5% of the account balance.

Statement of Other Current Liabilities

	Item		Amount
Government grants received in advance		$	30,209
Others			45,554
		$	75,763

(Continued)

114

Qisda Corporation

Statement of Lease Liabilities (Including Current and Non-Current)

December 31, 2024

(Expressed in Thousands of New Taiwan Dollar)

Item Buildings Current Non-current	Lease Term 2017/08～2027/07	Discount Rate (%) Balance at December 31, 2024 1.797% $ 370,048 $ 143,029 $ 227,019

Statement of Other Non-Current Liabilities

Item		Amount
Defined benefit liabilities	$	197,719
Others (Note)		9,972
	$	207,691
Note: The amount of each item in others did not exceed 5% of the account balance.

(Continued)

115

Qisda Corporation

Statement of Long-Term Debt

December 31, 2024

(Expressed in Thousands of New Taiwan Dollar)

			Loan
Creditor	Description		Amount	Contract Period	Interest Rates	Collateral
Bank of Taiwan and	5 yeas syndicated loan	$	12,000,000	2023/10~2028/10		-
other banks
Bank of Taiwan and	5 years syndicated loan		6,630,000	2021/12~2026/12		-
other banks
Bank of Taiwan and	5 years syndicated loan		3,030,000	2024/12~2029/12		-
other banks
Bank of Taiwan	7 years syndicated loan		280,471	2019/10~2026/10		-
Taiwan Business Bank	2 years loan		1,000,000	2024/06~2026/06		-
Yuanta Commercial Bank	3 years loan		500,000	2024/08~2027/08		-
Hua Nan Commercial Bank	2 years loan		1,700,000	2024/02~2026/02		-
Bank of China	2 years loan		1,400,000	2024/03~2026/03		-
			26,540,471		1.77%~2.1838%
Less: current portion of long-term debt			(3,055,306)
		$	23,485,165

Statement of Operating Revenue

For the year ended December 31, 2024

	Item		Amount
IT products		$	67,309,744
Digital media products			8,263,094
Others			2,579,221
Less: Sales returns and allowance			(1,448,546)
		$	76,703,513

(Continued)

116

Qisda Corporation

Statement of Operating Cost

For the year ended December 31, 2024

(Expressed in Thousands of New Taiwan Dollar)

Items		Amount
Raw materials
Raw materials, beginning of year	$	878,928
Add: Work in process－outsourced, beginning of year		469,966
Purchase of raw materials		11,619,532
Less: Raw materials, end of year		(1,082,781)
Work in process－outsourced, end of year		(356,532)
Transferred to other expenses		(2,730)
Scrap of raw materials		(8,519)
Sales of raw materials		(174,810)
Raw materials used		11,343,054
Direct labor		199,311
Manufacturing overhead		1,377,620
Manufacturing cost		12,919,985
Add: Work in process, beginning of year		141,245
Less: Work in process, end of year		(174,184)
Transferred to other expenses		(3,682)
Sales of work in process		(1,346,445)
Scrap of work in process		(3,203)
Cost of goods manufactured		11,533,716
Add: Finished goods, beginning of year		4,690,138
Inventories in transit, beginning of year		49,658
Purchase of finished goods		60,988,800
Less: Finished goods, end of year		(5,523,599)
Inventories in transit, end of year		(43,780)
Transferred to other expenses		(1,903)
Scrap of finished goods		(4,419)
Cost of goods sold		71,688,611
Write-down of inventories		46,114
Royalty cost		74,898
Sales of raw materials and work in process		1,521,255
Warranty cost		3,796
The deduction of other costs		(113,133)
Cost of revenue	$	73,221,541

(Continued)

117

Qisda Corporation

Statement of Selling Expenses

For the year ended December 31, 2024

(Expressed in Thousands of New Taiwan Dollar)

	Item		Amount
Salaries		$	432,897
Warehouse rental expense			291,293
Insurance expense			100,742
Others (Note)			286,774
		$	1,111,706

Note: The amount of each item in others did not exceed 5% of the account balance.

Statement of Administrative Expenses

	Item		Amount
Salaries		$	276,890
Depreciation expense			153,443
Professional service fees			83,671
Insurance expense			38,211
Others (Note)			187,859
		$	740,074

Note: The amount of each item in others did not exceed 5% of the account balance.

(Continued)

118

Qisda Corporation

Statement of Research and Development Expenses

For the year ended December 31, 2024

(Expressed in Thousands of New Taiwan Dollar)

	Item		Amount
Salaries		$	1,282,016
Inspection and test fees			188,256
Modeling expense			113,485
Insurance expense			99,670
Others (Note)			265,474
		$	1,948,901

Note: The amount of each item in others did not exceed 5% of the account balance.

For details on statement of Accounts Receivable (Payable) from Related Parties and Other Receivables (Payables) from Related Parties, please refer to note 7.

For details on statement of Changes in Property, Plant and Equipment, please refer to note 6(h).

For details on statement of Changes in Accumulated Depreciation of Property, Plant and Equipment, please refer to note 6(h).

For details on statement of Changes in Right-of-Use Assets, please refer to note 6(i).

For details on statement of Changes in Investment Property, please refer to note 6(j).

For details on statement of Changes in Intangible Assets, please refer to note 6(k).

For details on statement of Changes in Deferred Income Tax Assets, please refer to note 6(s).

For details on statement of Contract Liabilities, please refer to note 6(v).

－ For details on statement of Provisions Current/Non-Current, please refer to note 6(p).

For details on statement of Bonds Payable, please refer to note 6(n).

For details on statement of Deferred Income Tax Liabilities, please refer to note 6(s).

For details on statement of Other Income, please refer to note 6(x).

For details on statement of Other Gains and Losses, please refer to note 6(x).

For details on statement of Finance Costs, please refer to note 6(x).